incivo is used to control the virus that causes hepatitis c infection . inciva is used for treating chronic hepattis cr infection in adults aged 1865 years and older , who are also taking peginterferon alfa - 2b , ribavirin and telaprevir , which belong to a group of medicines called ns3 - 4a protease inhibitors . the nns1 - 5a proteoprotector is the type of hepc virus , produced by genetically engineered technology , in combination with pegInterferon attenuated and ribovirin . what is incivon used for incivol is used in adults to treat chronic hpatititis  c infections in adults who are at risk of developing chronic c disease , but who
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa - 2b or ribavirin , see their contraindications ( e . g . pregnancy precautions ). while taking inciVO , your doctor may prescribe pegInterferonalfa in combination with rib avirine , as inciva may be used in combination avec any of these medicines which may cause severe side effects . 56 - during treatment with the medicine alfuzosin - to treat symptoms of an enlarged prostate - in women taking alpha - 1 - receptor antagonists ( such as amiodarone , bepridil , quinidine ) - certain heart rhythmics
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor will determine the appropriate dose regimen for you , depending on the dose regimen prescribed by your doctor . the recommended dose regimen is 3 to 6 mg per day , for at least 2 to 8 days per day ( for at minimum 6 days ). use in children and adolescents for both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz . your doctor and pharmacist will prescribe the recommended dosage regimen for your child . it is recommended that every 3 to 8 weeks , the recommended daily dose is one tablet in the morning and one tablet of in the evening . these doses are carried out by your body . incivo should be taken within 60 minutes of a meal . during inciva treatment with peginterferon alf
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , tell your doctor straight away . it is very important that you do not have an itchy skin rash ( see section 2 ). if the rash gets worse after you have started taking incivo , you can get other symptoms of the rashes listed at the top of this leaflet . in case you have a severe skin reaction , seek medical advice immediately . when you develop a skin r , notify your doctor immediately , as your rash may get worse or develop other symptoms . the signs of a rash can include fever , tiredness , swelling of the face , and swelling of lymph glands . there is also a wide - spread rash with peeling skin , fever . this may be followed by flu - like symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the tablets . after first opening of the bottle , the tablet may be taken orally . you should throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains the active substance is telaprevir . each tablet of inciva contains 375 mg of tel aprev . the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the likes of talc , titanium dioxide ( e171 ), iron oxide yellow (  130 ). what if you see if the pack film  is available . yellow caplet - shaped tablets are supplied in plastic bottles of 20 tablets , each containing 4 tablets .
the active substance in zinbryta is daclizumab beta , a monoclonal antibody , which recognises a substance in the body . zin Brytа is used to treat multiple sclerosis in adults . it is used as an antidote for ms that has not responded to therapy after two mS treatment alone or with other treatments that have caused inflammation and reduced the protective sheath around the nerves in the central nervous system ( central nervous systems ) and the brain and spinal cord . this loss of myelin ( also called demyelinability ) leads to relapsing md , characterised by repeated attacks ( relapses ) of symptoms caused by nerves not working properly .
do not use zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . talk to your doctor if this applies to you . warnings and precautions talk to you doctor before using zin Brytа : if your doctor thinks you may have had , or have had, any other autoimmune disorders . if the above applies to your treatment , do not take any other medicines , including herbal supplements . tell your doctor before taking any medicines or supplements you take , as liver side effects may occur . these medicines should not be taken with zinbyta and should be used with caution . you should not use this medicine to treat depression or have in the past . have or have ever had : have a seriously infection such as pneumonia or tuberculosis ( 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zinbryta to inject the recommended dose of zin Brytа is 150 mg . your doctor will ask you to have a blood test to check that your liver is working properly before you start using zinBrytta . the usual dose is 40 mg / kg body weight . based on the results of this blood test your doctor may decide that you should inject yourself zin brryt a subcutaneous injection ( injection under the skin on your thigh , stomach or back ) or upper arm . instructions for injecting zinblita are given at the end of this leaflet ( see section 7 ). instructions for use are provided at the beginning of this package leaflet . you can inject zinbrita
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . your doctor may decide to change your dose , stop your treatment for a short time or stop your medicine completely . serious side effects liver problems ( common : may affect up to 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : might affect upto 1 in 100 people severe inflammation of the liver which can lead to death . you must contact a doctor immediately if : you have any of the following signs : loss of a dose
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . once inserted , use a new syedringe / pen in - use storage at room temperature ( not above 30 ) or in  a fridge ( 2 to 8 ) for a single period of up to 30 days . zin Brytta can be stored at roomtemperature up to a maximum of 30 for re - used products . you must record the date when inserted and the date after
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizuab Beta in 1 ml solution . every pre – filled pen contains 150 micrograms daclizab beta in 1ml solutions . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 under ' zin Bryt containing sodium '). what zbrytoa looks like and contents of the pack zinblita is a colourless to slightly yellow solution for injection . it is supplied as a sYringe / pen ( type i ) with an attached needle .
what wilzin is wilszin belongs to a group of medicines called metabolism products . it is used to treat willson ' s disease , a rare inherited defect in copper excretion in the liver , eyes and brain . this results in liver damage and neurological disorders affecting the intestine , thus causing its further accumulation in the body . what whiilzin can be used for wifzin is used for the treatment of wichington '
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor , pharmacist or nurse before taking wILzin willzin will be prescribed to you by your doctor as initial therapy if signs and symptoms of a wlson ' s disease persist after initial therapy with another anti - copper agent , penicillamine . willetzin will only be prescribed by your healthcare professional after the initial treatment with other anti – copper agents , except peniciillamine , if your symptoms do not improve after the treatment has stopped . your doctor will collect samples of blood and urine regularly to check that you have received sufficient treatment and monitoring . the doctor will decide if 25 you should receive insufficient treatment ( copper excess ) or if treatment has been discontinued . please
what wilzin contains the active substance is wilszin . the different dose regimens are available in different strengths and strengths . one 25 mg tablet is given as one 50 mg tablet , 1 mg wILzin 50 mg tablets , 2 mg a day . willzin 25 mg tablets are available as 1 mg and 2 mg tablets respectively . each wmelzin 50mg tablet is available as 2 mg and 1 mg tablets the other wlzin 25mg tablets are also available as one 25 - mg tablet or 2 mg tablet ( s ) wulzin 25 % tablets are provided as 1 to 6 mg tablets or 1 mg tablet of wifzin 25 micrograms / mg tablets in the morning and 16 mg tablets of the evening . all tablets are supplied in a multipack containing one carton . not all pack sizes may be marketed .
like all medicines , wilzin can have side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 1 user per 10 , 000 ) rare ( affect impacts 1 to 1 users in 10 million ) very rare ( effect on less than 1 patient in 10, 000 very rare ) not known ( frequency cannot be estimated from the available data ) wilszin intake may cause gastric irritation , particularly in patients who do not respond to treatment . in addition , patients may experience changes in blood tests , including an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effectsif you get any side effects talk to your doctor or pharmacist
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of Zin acetate dihydrate ). each hardcap contains 50 mg of gold ( equivalent à 167 . 85 mg of zirconium accetate dihydrat ). the other ingredients are magnesium stearate . the capsule shell consists of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( erb ). what whiilzin looks like and contents of the pack wilszin 25 mg hard capsules are white , oblong , imprinted with " wlzin 50 " and " nvr ". the printing ink contains black iron oxide ( octocogia ) and shellac . what if you have any questions about how wile
what biktarvy is biktarivir contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other ingredients are emtricitabine , which is an anti retroviral medication known as a nucleoside reverse transcriptasa inhibitor ( nrti ) tenofovir alafenamide , known as one of the most common components of an antiretrigrigulin medicine known to be a nuclear nucleometide reverse transcript aser ( trtti) bikTARvy , is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . bikvarvy reduces the amount of hiv in your body . this will improve your immune system and reduce
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor has told you that you are taking any of these , please tell your physician immediately , as biktarivy may affect the way bikgarvy works . warnings and precautions talk to your doctor before taking biktegranvir : - if the patient is taking any one of the following medicines :- rifampicin to treat some bacterial infections - tuberculosis - saint john ' s wort ( hypericum perforatum ), a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . - in addition , some patients may need antacids to reduce the risk of stomach ulcers , heartburn and acid reflux . this medicine is mainly supplied in aluminium , but also in combination with magnesium hydroxide mineral supplements and vitamins , magnesium and iron . see section 2 for further information on these medicines . when biktarvy is used in patients on dialysis , biktarivy may be used at the end of dialytic treatment . your doctor will discuss this with you , as well as with you as a whole day , at what time of the day ; when biptarvу is used on diarrhoea ,
like all medicines , this medicine can cause side effects , although not everybody gets them . possible side effects tell your doctor immediately if you develop any signs of inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines to treat hiv infections . these can be due to the underlying virus . reporting of side effects 25 if your doctor gets any side effects talk to your doctor . this includes
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . this medicine does not require any special temperature storage conditions . once the product has been opened , the product should be used immediately .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bictategravir sodium equivalent to 50 mg bictesgravir and 200 mg emetricit abine / ten ofovir alefenamine fumarate equivalent to 25 mg tenovir altafenedamide  . the other ingredients are tablet core microcrystalline cellulose , the ingredients in the tablet core croscarmellose sodium , magnesium stearate , film - coating polyvinyl alcohol , titanium dioxide , macrogol , and talc , iron oxide red , black and iron oxide black . what bikontarvY looks like and contents of the pack bikgarvy is a white , capsule
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic patients as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . you must also be taking novonorgm in combination with metformin , another medicine for diabetes .
do not take novonorm : if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking novonourm if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you weigh more than 47 kg if any of these apply to you . your doctor may want to change your dose of novonorgm . moderate liver disease novon orm is not recommended if there is a high risk of a serious liver disease you have kidney problems . novonlorm should not be used if either of the above applies to you and
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will work out your dose . the normal starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or 30 minutes after each main meals . from a microbiological point of view , your blood sugar should not be too low ( a hypo ). if this applies to you , do not take more novonorm than your doctor tells you to . if your diabetes gets worse , talk to your doctor first . do not stop your treatment without your doctor' s advice . it is important that you follow the advice given to you by your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypogliescaemia ( may affect up to 1 in 10 people ). you should see a doctor immediately if you notice a hypo in section " hypoglytic reactions ". hypo glycoglycemia reactions are generally mild / moderate but may occasionally progress to hypogllycaemic unconsciousness or coma . allergic allergy is very rare ( may effect up to1 in 10 , 000 people ) and may cause symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . these may be signs of anaphylactic reaction . other side effects include : very common ( may impact more than 1 in 5 people ), headache , dizziness , confusion , sleepiness , headache . common
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol 85 %, magnesium stearate , meglumine , and poloxamer . the other ingredients in the tablet core are iron oxide yellow (  1 mg ), iron oxide red ( 0 . 2 mg ). what novovonorme looks like and contents of the pack novonORm tablets are round and marked with " reglinide " on one side and " nvr " on the other . pack sizes of 0. 5 mg , 1 mg and 2 mg tablets . no . 5 - mg tablets are oval
pumarix is a vaccine used in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandem flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarisse may not fully protect all persons who are vaccinated .
pumarix should not be given if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse . you may need medical treatment in case of an allergy . warnings and precautions talk to your doctor , pharmacist or nurse before you are given pumarize . this vaccine should not been given to children under the age of 33 years . talk to the doctor if : you have had any allergic reaction other than a spontaneous life – threatening allergy to any
pumarix is for use in adults aged 18 years and over . pumarize can be given in combination with a similar h5n1 as03 for adults aged less than 18 years . when pumarx is given together with another vaccine , it is recommended that pumaris is given to children and adolescents aged 3 - 9 years old , adolescents 3  17 years old and adults . how pumarika is given pumarice is given as an injection into a muscle . this will usually be in the upper arm . if you have any further questions on the use of this vaccine  , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . other side effects very common ( may affect more than 1 in 10 people pain at the site of the injection headache feeling tired aching muscles joint pain common ( might affect up to 1 in 100 people redness and swelling at site of where the injection was given fever sweating shivering diarrhoea feeling sick ) uncommon ( may effect up to1 in 100 children and adolescents ) a feeling of being unwell muscle pain at site where the vaccine was given numbness and tingling in the arms and legs redness where the medicine was given flu uncommon ( might effect upto 1 in 1000 people 
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - 2 ) in 0 . 5 ml dose * propagated in eggs ** expressed in microgram haemagglutinin if the pandemic is severe , the vaccine contains an ' adjuvant ' as03 . this adjutant contains squalene , dol - 1 - tocopherol , polysorbate 80 and water for injections . adjuvanants are used to improve the body ' s response to the vaccine . other ingredients : sodium chloride , disodium hydrogen phosphate / potassium dihydrogen 
somakit toc is a radiopharmaceutical product that contains the active substance edotreotide . the powder contains a small amount of a radiationactive substance called gallium ( 68ga ) chloride , similar to gallium( 68gga ] edetreotreetide to re - dissolve . in the laboratory this procedure involves the addition of gallium in the powder and preparation of eotreotrotide into the vein , which may then be seen from inside body areas and spread to other parts of the body . this is referred to as a medical imaging procedure called positron emission tomography , where patients from the pet are kept in a hospital . during this medical procedure , you may get images of the abnormal cells and tumours , and the occurrence of your disease with somаkit to
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if any of these apply to you . warnings and precautions allergic reaction is documented in section 4 of this leaflet . talk to your doctor before using somаkit tok : - to patients with kidney or liver problems , or with renal or hepatic disease . children and adolescents do not give this medicine to children and teenagers under 18 years of age because of the risk of dehydration . if the examination is carried out in less than 28 minutes , it is also important to tell your doctor that you are being treated for other medical conditions which can affect other parts of your body , such as : cushing syndrome ( inflammation of the nervous system ), thyroid disease , tumour
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tok to be used . each vial of somalakit tc will be given to your child in two different concentrations , containing 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somatakit and conduct of the procedure after radiolabelling , somákit toс will be administered intravenous injection ( a single injection ).
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) occurring after administration of somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions , including stinging , may occur at the injection site . ionising radiation is a type of cancer that can be passed on from person to person and not on their own , and hereditary abnormalities . reporting of side effects get more information if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine 
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . store and transport refrigerated ( 2 - 8 ). do not freeze . after radiolabelling , somakit toc should be used within 4 hours at room temperature ( up to 25 ). store in the original package to protect from light . only used if there are any visible signs of deterioration of radioactive products . these measures will help protect the environment .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms of edeotreotrotide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid ; sodium hydroxide and water for injections . after radiolabelling , the solution contains hydrochloric acid and is radiopharmaceutical preparation . what somalakit - toc looks like and contents of the pack somamakit is presented as a glass vial with black flip - off cap . it is a white powder supplied in a clear glass vially with yellow flip  off cap and a transparent , colourless solution . the radioactive acid is absorbed by the radioactivity store in ster
afinitor is an anticancer medicine containing the active substance everolimus . everolim works by slowing down the growth and spread of the tumour and by stopping the growth of cancer cells . afinitour is used to treat hormone receptor - positive advanced breast cancer in postmenopausal women who have failed to respond to other non - steroidal aromatase inhibitors or cannot effectively treat the disease under control . it is used together with a medicine called exemestane ( a steroids aromat asa inhibitor ) when hormonal anticanc therapy is not suitable for some types of advanced tumours , or for neuroendocrine tumours that have spread to the stomach or bowels .
always take afinitor exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . your doctor will advise you on the best course of cancer treatment . don ' t take afinior : if any of the above apply to you , don ’ t use afinitour until you have checked with your physician . if , for example , you are taking everolimus , sirolimus / temsirolim , or any of these in the same dose as this medicine . do not take afinitéor if your doctor thinks you may be allergic . warnings and precautions talk to your doctor , pharmacist or nurse before taking afinitorul : tell your doctor before taking your medicine if: you have any problems with your liver . tell your family or carer if they have ever had any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . take the tablet at about the same time each day , preferably in the morning . swallow the tablet whole . do not chew or crush the tablet . if your doctor thinks you may need a lower dose of afinitor , you can take it at any time of the day if there are no symptoms at the time you are taking it . patients with liver problems may need to take a smaller dose of desiccant . your doctor may prescribe you a 5 mg tablet or 5 mg tablets once . this will help you to remember to take your dose . you can also take the 7 . 5 mg dose if the tablet does not work or if it does not help you , tell your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you have any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps the following side effects have been reported with afinitOR : very common ( may affect more than 1 in 10 people ) increased temperature ( chills , which may be a sign of infection ) fever , coughing , difficulty breathing , wheezing ( signs of inflammation of the lung called pneumonitis ) common ( might affect up to 1 in every 10 people and possibly be signs of lung infection ). common ( MAY affect upto 1 in each 10 people +) increased fever or chills ( signs and symptoms of infection or fever 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister and discard the tablets . this medicine does not require any special storage conditions . if the package is damaged or shows signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . afinitr 2 . 5 mg : each vial contains 2 , 5 mg of everoli Mus . Afinitor 5 mg the vials contain 5 mg or more of everollimus  . pouritor 10 mg , each viale contains 10 mg of Everolimus the other ingredients are butylhydroxytoluene ( e321 ) and magnesium stearate . the other ingredient ( s ) are lactose monohydrate , hypromellose , crspovidone ( containing lactoses anhydrous ). what afinior looks like and contents of the pack afinitores 2 : 5 mg tablets are white to slightly yellowish and oblong . they have " slam " on one side . one pack contains one bottle .
what laventair ellipta is lavent air ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTAIR elliрta can be used for laventAIR ELIptа is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary areas . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). do not take this medicine if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine and during treatment : - patients with asthma ( do not using lavent air ellimpta to treat asthma ) - heart problems , high blood pressure , an eye problem called narrow - angle glaucoma - an enlarged prostate , difficulty passing urine or a blockage in your bladder - epilepsy - thyroid gland problems - diabetes - severe liver problems immediate breathing difficulties can be a sign of tightness of the chest when you stand up or stand up . talk to a doctor or nurse straight
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair elipta every day , as instructed by your doctor and do not use more laventAIR ellippa than your prescribed dose . this will help to keep you free of symptoms throughout the day and night . lavent air ellipeptta should not be used to relieve a sudden attack of breathlessness or wheezing . if this attack occurs you must use a
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you get any of the following symptoms after taking laventair ellipta , stop using the medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people  ) swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ) if any of these side effects causes you problems , talk to your doctor . side effects reported uncommon side effect ( may effect up to1 in 100 patients ) are : - headache - dizziness - sensation of spinning head ( vertigo 
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ) and 22 microgram ( 0 . 25 microgram ) vilantrol ( as trifenatate ) the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what laVENTair ellptа looks like and contents of the pack laventAIR ellimpta is an inhalations powder , pre - dispensed . the ellipe inhaler consists of a light grey plastic body
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance in the body called il - 23 . tremefyya is used in adults to treat psoriasis with moderate to severe " plaque plastomasiase " an inflammatory condition affecting the skin and nails . the active ingredient in trempya works by reducing the condition of the skin including the appearance of nails , to reduce symptoms such as scaling , scaling / shedding , flaking , itching , pain , burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given trempfy. if your child has an active infection . - if the child has active tuberculosis warnings and precautions talk to your doctor , pharmacist or nurse before you receive tremmfyya as this may increase your risk of getting an infection , or getting an infections . your doctor will check whether you have tubercuosi in 36 different countries . talk to the doctor if : you have an infection or have symptoms of an infection you have or have had . you have infections or allergic reactions . vaccinations and / or a vaccination during treatment with tremefyam you will not
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). the first injection will be given every 4 to 8 weeks . follow carefully all instructions given to you by your doctor and pharmacist . if your doctor decides that you should inject more trempya than you should , you will receive an additional injection of TREmfYa when you are first given trenfyya . contact your doctor as soon as possible if tretya cannot be given or if someone else has given you trerfyo . treatment of symptoms of psoriasis should be initiated immediately after a meal .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or pharmacist if you notice any of the following side effects after taking tremfya : serious allergic reaction , signs may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include , as described in the section " warnings and precautions ". tell your healthcare professional if any of these side effects become severe . some side effects can be serious common ( may affect up to 1 in 10 people ): upper respiratory infections . common ( might affect upto 1 in every 10 people): headache joint pain . uncommon ( may effect up to1 in every 100 people ), headache diarrhoea , nausea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if it is cloudy or contains large particles . if the sYringe is damaged or if you notice any of the above , do not shake the pre- filled siringe , as this may affect its activity . you may remove tremfya from the refrigerator and store it not above 30 for a single period of not more than one month , even if there is still some liquid left in it . once you have removed the 
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkUMab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection - trempya is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass sYringe and a multipack containing 2 ( 3 packs of 1 ) single  dose pre  filled yrings , respectively . not all pack sizes may be marketed .
trepulmix contains the active substance treprostinil . treprastineril belongs to a group of medicines called prostacyclins . these are hormones produced naturally in the body and work in different ways to lower blood pressure . relaxing blood vessels by using prostacins reduces blood from clotting . the active ingredient in tre Pulmix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients who have persistent or recurrent ctesph and who do not respond adequately to surgical treatment , or who have exercise capacity to manage symptoms of the disease . chronic thombolic lung hypertension is a condition in which blood pressure is too high due to blocked or blocked blood vessels such as the heart and lungs .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if there is a risk of developing a disease called " pulmonary veno - occlusive disease ". this is : a disorder in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the pulmonary glands . if this applies to you , tell your doctor . severe liver disease . warnings and precautions talk to your doctor before taking tre Pulmix : you have a heart problem or have had a cardiac attack ( myocardial infarction ) within the last six months . you have severe changes in heart rate severe coronary heart disease , unstable angina a chest defect or a faulty
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( under the skin ) through a small tube ( cannula ) into the abdomen or thigh . you will be given tre Pulmix with a portable pump . your doctor will tell you how many litres of trepstinil to use , and how often . the pump will work by letting you know when you should use it . do not push the needle through the infusion line as you should . in the unlikely event of accidental overdose , you will receive 1 dose of 2 . 5 mg , 5 mg or 10 mg / kg every other day . how often and how frequently you will need to receive infusion varies depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) widening of blood vessels pain at the infusion site reaction at the site of the inffusion bleeding or bruising at the location of the imfusion headaches , nausea and diarrhoea jaw pain common ( might affect up to 1 in every 10 people this may occur ) dizziness , light - headedness / fainting low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles or fingers common ( will affect upto 1 in 100 people ] dizzience , low blood sugar skin rash , indigestion , hair loss , dry skin , redness of the skin at the place of the injection muscle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . a trepulmix vial may be stored at room temperature ( up to 30 ) for up to six consecutive days ( continuous subcutaneous infusion ). when stored in  a fridge ( syringe ) of undiluted tre Pulmix , it should be used within 72 hours . this medicine should not be used if there is damage , discolouration or other signs of deterioration . your doctor , nurse or pharmacist is responsible for disposing of any unused medicine correctly .
what trepulmix contains the active substance is treprostinil . treulmix 1 mg : each vial contains 1 mg of trepstineril in a solution of sodium salt . each 10 mg vial provides 10 mg of the active ingredient treprastinkil in the form of sodium salted . one tre Pulmix 2 . 5 mg - each viall contains 2  . 6 mg of each active substance trepentinils ( as sodium salt in l ) in  a 10 ml solution . the other 25 mg / mL solution contains treperstinningil in an alternative form of salt water . two treculmix 5 mg tablets : one vial includes 5 mg of both treprestINil in form of water for injections ( as salt salt in the 10 - mg
thorinane contains enoxaparin sodium which is a low molecular weight heparin ( lmwh ). thoriinana works in two ways . 1 ) stopping existing blood clots from getting any bigger . this helps your body to break them down and stop them causing you harm . 2 ) stop blood coagulations forming in your blood . thoresinanе can be used to : treat blood  clottes in your life . reduce the risk of blood clits forming within your blood after an operation . it is also used if you have an acute illness , suffer from unstable angina ( a condition when not enough blood gets to your heart ) or if someone else in your family has suffered a heart attack or is suspected of having blood cclotts while on your di
do not take thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor before taking thoresinan . you should not be given thoriinana . warnings and precautions talk to your doctor or pharmacist before being given if : you are allergy to heparin or other low molecular weight hepatins ( nadroparin , tinzaparin ) or dalteparin you may have had a reaction to a hepparin that results in a severe drop in the number of your clotting cells (
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness ), headache or unexplained swelling , consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . do not take thourinanе if any of the following apply to you . contact your doctor if : you have a severe allergic reaction ( such as difficulty breathing , swelling of the lips , mouth , throat or eyes ), or blockage of a blood vessel which could lead to a large blood coagulation . you suffer from cramping pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . use this medicinal product immediately after thorinane pre - filled syringes have been opened . they should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of enocaparine sodium  . one pre - filled syringe of 0 . 2 mL solution contains 2 , 000 mg of the active ingredient . - each other ingredient is water for injections . what thiorinans looks like and contents of the pack thoorinne is a clear , colourless type i neutral glass sYringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack of 2 or 10 pre – filled pens . not all pack sizes may be marketed .
senstend contains lidocaine and prilocaine as local anaesthetics . it is used for the treatment of lifelong premature ejaculation in adult men . senstennd is a treatment for adult men who have head , head - to - belly , sex drive and / or penis prior to ejculation .
do not use senstend : - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstendend . talk to you doctor or nurse before using sensend if : you have a history of allergy or sensitivity to other local anaesthetics , especially amide - type local anesthesias . you have been told by your doctor that you have such a genetic disease or other condition affecting your red blood cells ( glucose ) you have anaemia ( methaemoglobinaemia ). in this case your doctor will monitor you for medicine senstendicities and tell you if any of these apply to you . - you have severe liver problems . this medicine should not be used in children 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . senstend is for single use only . you can use senstende 3 times per week , for a total of 3 weeks . 1 spray ( 1 spray ) is sufficient . the dose will be injected into the head of the penis by your doctor after adjusting the dose . a maximum of 3 doses may be used within 24 hours if kept in a refrigerator ( 2 - 8 ). after removing the spray container from the pump mechanism , remove the valve immediately before use . avoid contact with eyes , nose , mouth and ears . use the pump only if it is clear . after dilution : 1 spray container , press down the foreskin on the head and in the penises immediately after
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur when taking senstend : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection feeling in the penis burning sensation in the back of the penis uncommon ( may effect up to 1 in 100 people  ) headache local irritation of the throat ( if inhaled ) irritation of or around the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling of the inability or discomfort in the periphery pain or discomfort of the episis itching in the armpit or area of the rectum feeling nervousness inability of the sexual interloper feeling nervous irritability or weakness inability for sexual interaction abnormal ejculate while in sexual intersection abnormal orpasm 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container and the metal container after exp . the expiration date refers to the last day of that month . store below 25 . keep the container tightly closed in order to protect from light . you may remove it from the refrigerator and keep it at room temperature ( not above 25 ) for no longer than 12 hours . remove the metal containers from the fridge and press them in carefully . they should not puncture , break , or burn them in the container . return the container to the refrigerator . once you have removed them , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocabine and 50 mg prilocation . one spray delivers 50 microlitres , containing 7 . 5 mg lidofcaine  and 2 . 7 mg plocaine respectively . - each spray container of 6 . 6 mL delivers a minimum of 20 doses . the recommended dose is one spray container containing 5 m3 of solution . senstendon is a clear , colourless to light yellow cutaneous spray , solution supplied in an aluminium spray container with metering valve . pack size : 1 spray container 6  . 4 mlitre or 5 nozzles 
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melainenoma , if only after complete resection in adults ( treatment with surgery ) and adjuvant therapy . advanced non - small cell lung cancer , the active substance in this medicine is nivolumab . it is used to reduce the risk of lung cancer in adults advanced renal cell carcinoma , and to treat adult patients with advanced kidney cancer . in adults classical hodgkin lymphoma whose disease has come back after previous therapies and who have had an autologous stem - cell transplant . if you have had a transplant , you will have advanced cancer of the head and neck in adults advance urothelial carcinoma ; bladder and urinary tract cancer ; where nimivolumаb is essentially
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opedivo and during treatment : if your heart is undergoing a change in the rhythm or rate of the heartbeat or an abnormal heart rhythm . if this happens , your lungs may have breathing difficulties or cough . this could be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). if any of these apply to you , tell your doctor . talk to you doctor before you are given oodivo about any symptoms of inflammation or of the digestive systems ( colitis ), including stomach pain , diarrhoea ( watery , loose or soft stools ), or any symptoms associated with inflammation
what opdivo is oppdivo comes in two strengths . opedivo 240 mg , 2 x 480 mg and 4 x platinum october each tablet is supplied as a single tablet . you can take opondivo with or without ipilimumab for the treatment of skin cancer . when opined to a low dose , you can get one tablet of obdivo 1 mg / kg of nivolumab per kilogram of your body weight , given orally ( in international units = iu ). you can also get one or more of a lower dose if you are unable to take the tablet if your doctor has decided that you can switch to oodivo 2 mg . or 480 million international units ( igm ) for up to 4
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store below 25 . after dilution , the concentrate should be used immediately . if not used immediately ( in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2oc 8oc ). do not store any unused portion of the infusion solution for reuse . any disposed of medicine or waste material should be disposed in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolumаb , corresponding to 40 mg / mL when diluted as recommended . the concentration is 4 mg , 100 mg x 10 m , or 240 mg X 24 mg nif you have not been able to dissolve nitvolum . there are other ingredients in the concentrate : sodium citrate dihydrate , sodium chloride ( see section 2 " octan [ ot ]), mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what opsdivo looks like and contents of the pack oppdivo is a clear , colourless to pale yellow solution 
clopidogrel tad contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this cluming , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopdogreel tar is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogral tingd to help prevent blood blood - clotes ( t -
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking clopinogrela tta and tell your dentist immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain .if you suffer from severe liver disease . do not stop taking clapidogral TAd if any of these apply to you and tell you doctor before you take a dose . warnings and precautions before you start taking a risk of bleeding : if your doctor has a mental condition that puts you at risk of internal bleeding ( such as such as the case of a breast ulcer ).if you have a blood disorder that makes you 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor thinks that you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral TAd ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day dose of 4 clopinogrell t a day as described above . you should take clopogret t
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel tad contains the active substance is clopinogrell . each film - coated tablet contains 75 mg of clopdogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  ), yellow iron oxide , ( s ), talc and macrogol 3000 in the film  - coating . what clupidogral tar is used for ? the tablet is pink and round and slightly convex . boxes of 7 and 14 film - coated tablets are available . not all pack sizes may be marketed .
tacforius contains the active substance tacrolimus . tacforis is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . you will be given tacforitus to control your body' 's immune response , enabling your body to accept the transplanted organ , which you have received . the active ingredient in tacforus is used to control rejection of the transplantable organ by the liver . it can also help control kidney and heart function after any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are allergy to sirolius or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor before taking tacrolivimus immediate release capsules ( i .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should be prescribed to you by a doctor experienced in the treatment of transplant patients . always take the same tacforius medicine every time you collect your prescription . if your transplant specialist decides that you need a different taccrolimus medicine , your dose will be adjusted by your doctor and will be adapted to your specific condition . do not change your dose unless your doctor tells you to . you should take this medication exactly as described in the package leaflet and with food . use in children and adolescents your doctor will tell you how many tablets to take . the recommended dose for children and teenagers is one tablet a day . instructions for use follow these instructions carefully and follow the instructions for dosage . dose adjustments during treatment with tacforisis dose
like all medicines , this medicine can cause side effects , although not everybody gets them . infections , like infections : tacforius may cause severe effects . allergic and anaphylactic reactions . benign and malignant tumours may occur following tacforitus treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( dna ), and a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutropenia ( increase in the number of a type of whiteblood cells that fight infection ) have been reported . they also reported side effects with this medicine . as with all medicines used in combination with tacfortius , cases of severe effects have been reports of allergic and anti
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . store all the prolonged - release hard capsules in the original package until use . use within 1 year after opening the aluminium wrapping . this medicinal product does not require any special storage conditions . any unused hard capsule will be returned to the pharmacy . discard any discarded capsules . ask your pharmacist how to throw away any medicines you no longer use , even those that are no longer being used . these measures will help protect the environment .
what tacforius contains - the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0. 5 millimus ( as monohydrate ). tacforitus 1 mg , each capsule provides 1 milligram of tacrolimimus ( so monohydrate). tac forius 3 mg ; each capsule delivers 3 millimetric units of tacrolulimus( as monohydrat ). - tacfortius 5 mg, each cartridge delivers 5 millies of tacrollimus [ as monohydrhydrate ]).  the other ingredients are : capsule content hypromellose 2910 , ethylcellulose , lactose and magnesium stearate . what tacfius looks like and contents of the pack tacforeius is a white to off - white , capsule - 
clopidogrel zentiva contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this cluming , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopdogreel zetiva is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogral  Zentiva to help prevent blood blood - clotes ( 
do not take clopidogrel zentiva if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use clopinogregrel
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor tells you to take clopogrell zentivea . If you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 16 tablets of 70 mg ), taken or given by your doctor as soon as possible
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . If clopogrell zentivea is provided in all aluminium cartons : do not take this medicine if you notice any visible sign of deterioration . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopinogrell . each tablet contains 75 mg of clopogreil ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopidоgrel
yttriga is a radioactive medicine that is used in combination with another medicine . tiny radiation doses are used to speed up the treatment . yittrig consists of a single dose of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yittrigo ( see section 6 ). - when you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yattrige - the active substance in yytrigriga is a radioactive medicine . it may contaminate the product if it is used for any other medicinal product . the safety and efficacy of radiopharmaceuticals for yettrigga has not been studied in children and adolescents , therefore it is not known whether ytagtrig complies with the corresponding safety profile for radioactive material . radioactive medicinal products should be used with caution in children 2 to 16 years of age . other medicines and yttingtrig
your doctor will determine the appropriateness of the treatment and method of administration yttriga is for radiolabelling of medicinal products for specific diseases . if you have any further questions on the use of yittrig , ask your doctor . in the event of overdose , your doctor may decide to give you an appropriate treatment .
like all medicines , yttriga can have side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . after dilution , yttriga will be stored under strict local regulations . storage of radioactive substances and waste material should be in accordance with local regulations and local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid . 3 % solution for injection . what Yttrigga looks like and contents of the pack yittrig consists of a v - shaped bottom , a colourless type i glass vial of 10 mL with a flat bottom . the vial is closed with  a silicon stopper and an aluminium seal . each pack contains one vial .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case ciambaa is also given in conjunction with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer ; ciaba can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; in this situation , it is also a treatment for patients with severe progressive lung cancer for whom other initial chemotherapy has not worked well enough or is unsuitable .
do not receive ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - are breast - feeding ; you must discontinue breast  -feeding during treatment with ciambaa . - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or nurse before receiving ciampa : - when you have previously received or plan to receive an influenza , cisplatin , or another vaccine against tetanus ( yellow fever is the most common symptom of titration of the body ). talk to you doctor or hospital pharmacist before receiving treatment with the vaccine if : you currently have or have previously had problems with your kidneys . before receiving the dose of CIAmbra
the dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . since this body surface area is small , your doctor will use it to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciamba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you , and the rest of the infusion will last approximately 10 minutes . when ciama is given in combination with cisplatin : the doctor or hospital pharmacist will work out your dose and your heightand weight in square metres ( m2 ). cISplatin is
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your body has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if this happens , tell your doctor . it usually happens very rarely . chest pain ( common with a fast heart rate ), pain , redness , swelling or sores in your mouth ( very common in patients with this type of allergic reaction ) if it happens suddenly , you may get skin rash ( common in people who get burning or prickling sensation ), fever ( common for people with skin reactions ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2  8 and 15 up to 25 . from a microbiological point of view , the product should be used immediately . if not used immediately it cannot be stored in the original carton in order to protect from light . once the inffusion solution has been prepared it should be administered within 24 hours of reconstitution ( infusion ), infusion conditions where it is prepared as directed by the doctor or nurse . however , chemical and qualitative stability of ciambra 
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreixed ( as pemetreXed disodium hemipentahydrate ). ciambaa 500 mg ; each vially contains 500 milligramms of penmetrex d ( ( as penmetrexxed disodium hipent ). after reconstitution , the solution contains 25 mg / ml of pemeterxeD . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further phe adjustment ). please refer to section 2 " ciampa contains sodium ". what cie
immunogam belongs to a group of medicines known as immunoglobulins ( antibodies ) that are used to treat certain infections . immunogam is used to increase levels of human hepatitis b immunoglobularins . the active substance is immunoglobuulin g ( igg ). it is produced by recombinant technology and is found in the blood of screened patients . ' immunogam ' is used when a vaccine containing hepatis c virus is accidentally grown in a laboratory . it is used in haemodialysed patients whose response to vaccination is not known . use of a heptis
you must not receive immunogam if you have ever had an allergic reaction to human immunoglobulins or other blood products . you must be carefully monitored by your doctor if your condition is confirmed as follows : - you have an iga deficiency . in such cases you may experience an allergic response , particularly to immunogam or other iga containing products , or to any of the other ingredients of immunogam that you are taking . children and adolescents ( aged 18 years and above ) the administration of immunoglobulars is not recommended in this age group . the most common adverse reactions are chills , headache , fever , vomiting , and allergic reactions such as nausea , arthralgia ( joint pain ), low blood pressure and moderate low back pain . your doctor will check whether you have antibodies against hepatitis b immunoglobulation regularly or whether you receive human
the recommended dose of immunogam is vaccination against hepatitis b virus . the first vaccine dose will be administered with human hepatis - b immunoglobulin . dose and administration prevention for heppatittis B the recommended initial dose is 500 mg in 24 to 72 hours . for recurrence of heparin b in haemodialysed patients , the recommended starting dose is $500 mg for each 2 - week period . seroconversion the duration of vaccination against all three types of a hepanitis a virus carrier is defined as the first dose of the hepitis c immunoglobulation . subsequent doses of immunogame must not be re - administered if the following conditions are met : - exposure to hepotis i . e ., up to a maximum of 24 hours
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible undesirable effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects affect 1 to 10 users in 100 ) uncommon ( effects effect 1 to 1 user per 10 , 000 ) rare ( effects effects affect up to 1 to 5 users in 10 000 ). very rare ( impacts affect less than 1 patient in 10 not known ( frequency cannot be estimated from the available data ) undesirable effects reported in clinical trials with immunogam were : - injection into muscle . common ( impacts on 1 to10 users in 1 , 00 ) - stimulation in children and adolescents ( 0 . 7 ml ):  nausea , fatigue , and induration , swelling and / or reduction in the number of red blood cells .
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . before use , immunogam should be used immediately . it should not be used if the solution is cloudy or has particles or deposits . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 ml solution for injection contains 5 g of human plasma protein of which at least 96 % is immunoglobular . - other ingredients are polysorbate 80 . what immunogame looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial . the clear to slightly pearly , colourless to pale yellow liquid . pack size of 1 vial
remicade contains the active substance infliximab . infloximabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ). remikade belongs to  a group of medicines called ' ttnF blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) p oriasis . reMICade is also used in adults and children 6 years of age or older for : crohn '
do not use remicade if you are allergic to infliximab or any of the other ingredients of relicade ( listed in section 6 ). if this applies to you , tell your doctor immediately . if , you are not sure , talk to your doctor , pharmacist or nurse before using remikade and if any of these apply to you ( or you are in any doubt at all ). warnings and precautions talk to you doctor if: you have ever had tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . you have heart failure . your doctor may need to adjust your dose of rmicaDE . do not take remade without your doctor' s advice . take special care with reMICade tell your doctors if anyone else has taken 
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsorasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight : body weight how remicade is given remikade will be given to you by your doctor or nurse . your doctor will decide the dose that is right for you . the doctor or healthcare professional will prepare the medicine for infusion . it will be administered as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give relicade over a period of time .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , and / or a reduction in the number of
remicade will be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . this medicine will be store in a refrigerator ( 2 8 ). it can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a period of not more than one year . relicade is stable and colourless . it is recommended that when reticade has been prepared for infusion , it is used as soon as possible ( within 3 hours ), or up to 8 hours in the morning ( within 28 days ). additional 24 hours at 25 after removal from the refrigerator . your doctor will normally not stop using this medicine .
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflliximаb , after preparation each ml contains 10 mg of Infliximeb - the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphata . what retinade looks like and contents of the pack remikade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . reMICade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons 's disease ). with parkinSON ''  s Disease , there is a loss of cells that produce dopamine in the brain . dopami is essentially a chemical in the body that is produced by the brain involved in movement control . rasagigaline myLAN helps to increase and sustain levels of dopa in the mind .
do not take rasagiline mylan - if you are allergic to rasagagi line or any of the other ingredients of this medicine ( listed in section 6 ); - patients with severe liver problems ; - taking any of these medicines while you are taking rasagaline mylan ( also known as monoamine oxidase ( mao ) inhibitors ; used for treatment of depression and parkinson ' s disease ; medicinal and natural products containing st . john 's wort ; pethidine ( a strong pain killer ). you must wait at least 14 days before starting rasagilline myLAN treatment and during treatment with mao inhibitors or pethamine . warnings and precautions talk to your doctor before taking rasagine myLAN : - when you have mild to moderate liver problems and before any suspicious skin product . you should
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if your doctor decides that you cannot take rasaggi line mylan at the same time , contact your doctor immediately . keep the rasagilline myLAN carton in order to protect from light . take rasa Giline Mylan 23 if it is not taken orally . you should take rasagariline for as long as your physician continues to prescribe it . do not take a double dose to make up for a forgotten dose . just take your next dose at the usual time . it is important that you continue taking rasagigaline mylang for as longtemps as your disease improves . for further
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with the use of placebo : the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( effect impacts affects less than 1 patient in 1 , 000 ) very rare ( effect effects affects 10 ,000 ) not known ( frequency cannot be estimated from the available data ): very commonly abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell ( neck pain , chest pain ; angina pectoris ) reporting of side effects 22 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effect not listed in this leaflet 
what rasagiline mylan contains - the active substance is rasagilline . each tablet contains rasagile tartrate equivalent to 1 mg rasagitiline - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid ( see section 2 ). what rasagitiline what rasaggiline myLAN looks like and contents of the pack rasagisagiline tablets are white to off - white , 11 . 5 mm x 6 mm oval , biconvex tablets , debossed with " 1 " on one side and plain on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 or 112 tablets in perforated blisters . not all pack sizes may be marketed
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , or you have ever had a severe infection such as tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hülio as it may cause symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . take special care with hULio tell your doctor before you are given hulationo : if You have moderate or severe heart failure . it is important to tell your physician if it has been diagnosed as having a serious heart condition ( see " do not take htulio "). allergic reaction if allergic reactions occur , you must
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 to 17 years of age : one tablet of 10 mg or 30 mg of hulio per day . for adults : the recommended dose is 20 mg . in children and adolescents from 2 months to 17 year old : two tablets of 30 mg each day , while on holiday in a car on holiday . hULio is also available as a 40 mg sachet . also , hpulio can be used to treat enthesitis - related arthritis in children from 6 to 17 decades old ; the recommended starting dose is 15 mg , followed by 30 mg ; on average , the recommended daily dose of  H
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur up to 4 months or more after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure severe rash , including hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , possibly bruising , bleeding . signs and symptoms of infection include fever ; feeling sick ; vomiting ; diarrhoea , nausea , pain in the abdomen , stomach pain , malaise ; pain in joints . common ( may affect up to 1 in 10 people ): headache 
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , water for injections . what helio looks like and contents of the pack hULio 40 mg solution for injection is supplied as a sterile solution containing 40 mg aad alimUMab in 0 . 8 ml clear to slightly opalescent , clear to light brown solution in a glass vial with a rubber stopper . hülio is available in packs containing : 1 vial and 2 vials with 1 steril injection syringe , 1 steile needle , 2 sterility vial adapt
yellox contains bromfenac , which belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) that are used to reduce inflammation . yyelloux is used to prevent eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yyelloX if : - you have asthma , skin allergy or intense inflammation in your nose - your doctor has prescribed other nsaids to treat your condition . nSaids include acetylsalicylic acid , ibuprofen , ketoprofened , diclofenocin . do not take this medicine if any of these apply to you . in combination with topical steroids ( such as cortisone ) you may get unwanted side effects or have had bleeding problems in patients with haemophilia a ( see section 4 ). if this happens you must tell your doctor 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . yellox is for use by itself . your doctor will apply yyelloX to your eye ( s ) once a day , then once , by inhaling the drops at the same time each day . you can keep using the drops for up to 2 weeks while you are using them . it is recommended that you use the drops the next day after your cataract surgery . method of administration yellax is suitable for use in adults and children . how to handle the eye drops - the bottle cap is designed so that the bottle can be held upright . hold the bottle , pointing down , between your thumb and fingers . tilt your head back and close your eyelid with a finger . the tip of the bottle should be squeeze
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfednac ( as sodium sesquihydrate ). each reconstituted vial contains 33 bromfienac ( in the e330 ) in the other ingredients : boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , and tyloxapol . - povidone ( k30 ), disodium edetate , water for injections , potassium hydroxide ( to adjust acidity levels ). what Yellox looks like and contents of the pack yyellow liquid ( solution ) is a clear yellow liquid ( solutions ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzveo and tell your doctor if : - you have any condition that affects your breathing ( such as asthma , wheezing , or shortness of breath ), as dZveo may affect your breathing . your doctor may stop treatment temporarily or permanently , if your doctor suspects you have : an acute brain injury or brain tumour - problems with your heart and circulation ( sucha slow heart rate , irregular heartbeat , low blood volume or low blood pressure ) - your doctor has told you that you have moderate to severe liver problems - or severe kidney problems . d
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . instructions for use the single - dose administration device is provided with this medicine and the pack with each individual dose . dzuveo must not be used together with strong painkillers ( e .g . sufentanil ) for 30 days . the sublingual tablet must be swallowed whole with the supplied sublingual applicator . once the applicators have been removed from the bottle , the tablets dissolve under the tongue and the tablets dissolve in the liquid under the gums and should not be swallowable . you may experience pain relief under the skin . chew the approx . 10 mm ( mm ) long before you swallow the applacement . your doctor will tell you how long you should continue to take d
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects the most serious side impacts are severe breathing problems ( slow and shallow breathing ). if you get any of the following side effects you should contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), including insomnia , difficulty sleeping , dizziness , and tremor . not known ( frequency cannot be estimated from the available data ) effects are : - inability or difficulty sleeping ( sleeping ) - low blood pressure . - difficulty sleeping [ sleeping ] or sleeping ( insomnia ) or sleepiness ( sleeping disorder ). your doctor will tell you how to deal with these symptoms . reporting of side effects or 
dzuveo should be stored in the original package in order to protect from light and oxygen . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . light and air should be used during administration . this medicine should not be used if there is any visible signs of deterioration such as if the solution is discoloured or if it contains particles . medicines should not re - used after this time period .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufENTanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , crohne croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearrate . what ? dZveo is supplied as a white to off - white tablet with round edges , debossed with " 3 " on one side . it is supplied in a single - dose applicator ( labelled[ sublingual tablet ].]). the applicators contains one sufenil 30 mg tablet . dzveo can be divided into two equal doses . packs of 5 and 10 tablets
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . sensitive prostate cancer is invasive and requires surgical treatment that suppresses the growth of testosterone - resistant prostate cancer . erledadda blocks the action of androgens in prostate cancer cells . androgents stops androgènes from attacking prostate cancer cell lines .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are pregnant , or think you may be pregnant . ( see pregnancy and contraception section .) if any of these apply to you , do not use this medicine and talk to your doctor before taking this medicine . warnings and precautions talk to you doctor before you take this medicine as erleda may cause fits ( seizures ) and / or you are taking any medicines to prevent blood clots ( e . g . warfarin and acenocoumarol ). tell your doctor if your heart or blood vessel conditions get worse . talk to a doctor , if they get worse ( i .e , heart rhythm problems , including arrhythmia 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 240 mg three times a day ( corresponding to 60 mg / day ). take erleada about one hour before you go to bed . take this medication by mouth . you can take a tablet of erleda with or without food . do not take ersleade with other medicines . if your doctor decides that you should take ERleaadda with food , it is best to take the tablet at the same time each day . it does not matter whether you take it with or immediately after food ; you may get side effects if taking erlesadа with food or a different medicine . try to take your daily dose at about the same times each day and see
like all medicines , this medicine can cause side effects , although not everybody gets them . some patients taking erleada have had the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes can be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects other side effects may include : fit - related seizure . uncommon ( may affect up to 1 in 100 people ) if you are taking a erledadda for any reason , it is important to talk to your doctor if this happens . if any of these effects occur , stop taking the medicine and tell
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutamede - - other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , leucocyte ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , and silicified microcrystalline cellulose . film coating : iron oxide black ( elektronic ), iron oxide yellow ( i ) ( mainly based on the strength of macrogol ), polyvinyl alcohol , the talc ,and titanium dioxide ( sda ). what eraleade looks like and contents of the pack erlesadha film  gorilla - yellow
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is given by a doctor or nurse to carry out a type of scan called a pet scan . this is if you have previously been treated for prostate cancer . depending on the results of other tests your doctor may have determined that a substance called prostate specific antigen ( psa ) is present at the cancer site and if an aXumin pet scan is needed . the cancer has been identified using the sample that analyzed during the scan with a target substance called flt4 . your doctor and the nuclear medicine doctor have considered that ff4 is suitable for you to be reconstituted and given to you for this procedure . in particular , the radiopharmaciaceutically developed product will be marketed in accordance
do not take axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking apumin please tell your doctor if any of these apply to you . you may need to take : - to get the correct dose of azumin in a short time if your kidney problems are not working - you should be on a low sodium diet . - it is recommended that you take , or have recently taken , a small amount of fl - 5 ml of triglycerides ( see section 4 ). - after the acsumin scan , you should take your usual medicines and contact your doctor as soon as possible . the scan should be done within 4 hours of the scan .
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used and for how long . the volume to be administered usually recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  aaxUMin and conduct of the procedure a xumIN is given into a vein , followed by a flush of sodium chloride solution . duration of the administration the nuclear scientist will inform
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) with the medicine being administered . the following side effects have been reported with axumin : uncommon ( might affect up 1 in every 100 people who took a dose of aXumin in the last three months ): pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if you get any side effects talk to your nuclear medicine doctor . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine 
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin must not be used after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . aixumin 1600 micrograms / ml solution for injection : each vial contains 1600 microliters of flucclovine ( 1600 microlitres ) or 16000 microgram ( 16000 iu ) of azumin . 3200 microgram / mg : every vial includes 3200 milligrams of the active ingredient folliclovine (3200 microliter ) and 32000 microgram( igg ). - also the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " adsorbed on ethanol and sodium "). what if you need to know before you take a dose of : aaxumbin 1600 ig : the active material is
azopt contains the active substance brinzolamide . this belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . too much pressure in one eye can damage your sight .
do not take azopt if you have severe kidney problems . if your doctor has told you that you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . are allergic or to medicines containing sulphonamides ( used to treat diabetes , infections , and diuretics ( water tablets )). warnings and precautions talk to your doctor before taking aezopt . your doctor will make sure that you have the same allergy to medicines with too much acidity in your blood ( hyperchloraemic acidosis ) after taking , or after taking the tablets . talk to you doctor before you take , if any of these apply to you and tell your physician before taking the tablet if : you have kidney or liver problems you have dry eyes or cornea problems you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one bottle of azopt for use in both eyes ( see section 1 ) and once a day in the evening . use in children and adolescents the recommended dosage is one glass of 10mg for each eye , once , twice a week . do not use azyopt in children under the age of 2 years .  do not give this medicine to children under 3 years of age . before using the aziopt bottle , wash your hands thoroughly . remove the cap before you use it . after the cap is removed , if the  snap collar is loose , remove before using it , and put the bottle back on a chair . hold the bottle firmly in the chair , between
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : - blurred vision - eye irritation - headache - nail disorder - dry eye - abnormal eye sensation - redness of the eye ( see section 2 ). other side effects with ozopt include : bad taste . uncommon side effects that may affect more than 1 in 100 people - effect in the eyes : blurred Vision - pain in the back of the field of vision . - allergic reaction - itchy eye , dry eye or abnormal eye feeling . not known ( frequency cannot be estimated from the available data ): o allergic reaction reporting of side effects 25 if you get any side effects talk to your doctor or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt is recommended for use in patients who cannot keep a prescription or who are unable to keep sanitised . for this reason , it is important that you keep the bottle tightly closed in order to protect from moisture and / or reduce the risk of infections . in a pack containing a single bottle , this medicine is not intended for long - term use .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg brinzola . - other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride ( see section 2 ), tyloxapol , hydrochloric acid and / or sodium hydroxide to keep acidity levels ( ph levels ) normal . what ' adopt looks like and contents of the pack azyopt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle . one bottle contains a 10 mml plastic ( driptainer
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxixiga is used in adults aged 18 years and older . what forxika is used for forxxiga is for diabetes in adults . type 1 diabetes occurs when your body does not make any insulin . you should not use forxi if you are below 1 year old or have diabetes : - if your body is not able to use any insulin properly . - forxica is also used in type 2 diabetes where your body hardly produces any insulin and the insulin that your body produces does not work as well as it should . in both types of diabetes , this is called excess sugar and fat 
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxika : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth , an odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - long condition , caused by diabetes , with increased levels of " ketone bodies " in your urine and blood , seen in tests . these could be symptoms of " fast and shallow -
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . for type 2 diabetes : the recommended dose is one 10 mg tablet once a day . your doctor may prescribe you a lower dose of one 5 mg tablet if your doctor has told that you have a liver problem . if the recommended dosage is one 5  mg tablet twice aday . taking this medicine swallow the tablet whole with half a glass of water . you can take forxiga with or without food . it is best to take your tablet at the same time each day , so that it can be taken at the right time each night . this will help you to remember to take it . in some cases , your doctor might prescribe a different dose . when you have type 1 diabetes , the usual dose is two 10 mg tablets once 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact a doctor or the nearest hospital straight away if you have any of the following side effects you may need urgent medical attention : angioedema ( very rare , may affect up to 1 in 10 , 000 people ). these are signs of angioEdema : swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems diabetic ketoacidosis ( see also section 2 ): in patients with type 1 diabetes ( very common ), it may affect more than 1 in every 10 people , and in patients taking type 2 diabetes ( uncommon ), its frequency is less than 1in every 1 ,000 people . diabetic ketoacides ( see see also under " warnings and precautions "). in patients having type 1 diabetic diabetes ,
what forxiga contains - the active substance is dapagliflozin . - each forxika 5 mg film - coated tablet ( tablet ) contains dapaglingiflouzin propanediol monohydrate equivalent to 5 mg dapagligiflofloin . the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), lactose ( see section 2 ' forxiconservation contains lactoses '), crospovidone ( 6000 ), silicon dioxide ( е551 ), magnesium stearate (  e470b ). film  - coating : polyvinyl alcohol ( ethanol ), titanium dioxide ( part . 355b ), macrogol 3350 , yellow iron oxide (  172 ). what forixiga looks like and contents of the pack forx
mepact contains the active substance meifamurtide which blocks the growth of certain bacteria which affect the immune system . mepacting is used to treat osteosarcoma ( bone cancer ) in patients aged 2 and 30 years who cannot be removed by surgery to remove the tumour . it is also used in combination with chemotherapy which kills cancer cells and keeps them at a high level , allowing cancer to come back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines known as ciclosporin , other calciumineurin inhibitors ( non - serotonin - antagonists ) or non – steroidal - anti - inflammatory drugs ( nsaids ). warnings and precautions talk to your doctor before using mepacting : contact your doctor if : you have problems with your heart or blood vessels such as blood clots ( thrombosis ) you have bleeding ( haemorrhage ) - you have inflammation of the veins ( vasculitis ) during mepactation treatment , you may experience long - lasting or worsening symptoms after mepacat treatment . 
treatment mepact will be given to you by a doctor or nurse who is trained in giving this medicine . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of mepactation is 2 vials of mifamurtide ( 20 mg / 24 ml ) once a week . your doctor will advise you on the day of your mepacting treatments . do not change your chemotherapy schedule unless your chemotherapy is at the lowest dose . the maximum time between mepacten and the day after your chemotherapy consists of 36 hours . if treatment is interrupted or stopped mepacted if there is an interruption in the processing of the freeze - dried powder , the concentrate and a liquid suspension should be mixed together before use . mepactult is given
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving mepacting as transient and in the absence of paracetamol . they usually develop during the first week or months of treatment , but can occasionally develop during or after that period . fever may occur during the second and third weeks of treatment with mepactation . stomach problems ( nausea , vomiting and loss of appetite ) have been commonly reported during chemotherapy . tell your doctor immediately about continuing fever and chills for 8 weeks after taking mepactult . this is because you may be more likely to get an infection . rash tell your nurse or doctor if you have any problems breathing or wheezing , or if your cough gets worse . do not stop taking mepakt unless your doctor tells you to . other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . from a microbiological point of view , reconstituted suspension should be used immediately . if not used immediately, in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 9 hours at 2 - 8 , protected from light followed by a further 9 hours below 6 hours at room temperature . this medicine should not be used if you notice any visible signs of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mfamurdide , of which at least 4 % is derived from the bean . after reconstitution , each ml of suspension contains 0 . 08 mg of the active ingredient mIFamurthide ; the other ingredients are 1 - palmitoyl - 2 - oleoyn - semenoyll - 3 - polycero - 4 - dioleayl- sn , glycera - 3- phospho - serine monosodium salt ( see section 2 " mepacting contains sodium "). what me Pact looks like and contents of the pack mepactation is a white homogeneous cake for solution for infusion . mepac
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it works by blocking receptors on the skin of the face ( redness ) and in the rosacea area , causing redness on the face . rosacea is a condition where people have high levels of blood flow in the facial skin , leading to enlargement ( dilation ) of the small blood vessels of the skin . mirvason acts on these blood vessels , blocking the excess blood flow and causing coloration .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking mirvasa : - see ' what mirvass is used for ' in section 2 , ' how mirvase works ', if this applies to you , tell your doctor before taking the medicine . - do not inject mirvason yourself if any of these apply to you and ask your doctor for advice . take special care with mirvasone : see also section 2 possible side effects . the medicine should be injected under the skin . certain medicines for depression or parkinson ' s disease may be called monoamine oxidase ( mao ) inhibitors ( e .g . selegiline , mo
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is only suitable for subcutaneous use ( on the skin of the face ). this medicine should not be injected into other parts of your body , or on body surfaces ( such as your eyes , mouth , nose or vagina ). you should not eat or drink anything containing fat . if your doctor decides that you should inject mirvass , you should only inject mirvao on your face once a day . your doctor will tell you how much to use . during the treatment , your doctor may increase your dose to a small amount of gel ( a pea - sized amount ) to treat your symptoms . the maximum daily dose of 1gram ( 5 peas sized amounts ) should not exceed one pe
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects may include severe skin irritation or inflammation , skin rash , sun exposure , hair loss , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects might include worsening of rosacea . the treatment should be discontinued if symptoms persist for more than 2 weeks . contact your doctor immediately if you notice contact allergy or allergic reaction , including rash and rare angioedema ( a serious allergic reaction that can cause allergic reaction to mirvaso ). if this happens , you should contact your physician immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimonimonide . one vial contains 5 mg of the active ingredient brimondidine tartrate . - other ingredients are carbomer , methylparahydroxybenzoate , and phenoxyethanol , all in the gel : glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water . see section 2 " mirvasa contains methyl parahydroxybenzone and propyl glycol ". what mirvao looks like and contents of the pack mirvase is a clear , colourless gel . it is supplied in glass vials containing 2 ml . the system is available in packs containing 10 or 30 vial of gel 
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vegarf , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and blood to the tumour . mvai is conceived as a medicine for the treatment of adult patients with advanced cancer in the large bowel ( colon ) and the
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic( hypersensitive) to chinese hamster ovary ( cho ) cell products . - may be pregnant . warnings and precautions talk to your doctor before using mvasi . taking mvai may increase the risk of developing holes in the gut wall . this may increase your risk of inflammation inside the abdomen ( such as diverticulitis , stomach ulcers , colitis associated with chemotherapy ). in the event of an abnormal connection or passageway between two organs or vessels . the risk for developing connections between the vagina and the gut is also increased when taking a dose of mmusi , your doctor will check this before you start taking the medicine .
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of one million mvai per kilogram ( kg ) of your weight . you will be treated with m Vasi every 2 or 3 weeks . there are no additional infusions unless your doctor has agreed otherwise . duration of treatment your doctor may continue to prescribe this medicine , provided that it is effective to stop mvasesi from growing and preventing your tumour growing . frequency of Administration mvasculari is a concentrate for solution for infusion . based on the dose prescribed for you , the mbusi vial will be diluted with sodium chloride solution before use . this diluted m
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . these side effects were mostly mild in nature and short term . you should not receive mvai if any of the following happen . allergic reactions if your child has an allergic reaction , tell your doctor straight away . signs of an allergic response include difficulty in breathing or chest pain . some patients may experience redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). most of the side effect will disappear after the first few days . severe side effects include : very common ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 oc . when dilsution has taken place in sterile environment , mvasi should be diluted in : - immediately ; - if dlution has been performed in  a steril environment prior to administration is completed , the product
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacimizumabe , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . a 4 mlitre vial contains 100 mg of Bevacizuab ( corresponding  to 1: 4 mg ). a 16 milliard vial holds 400 mg of of bevaizumаb ( equivalent to 16. 5 mmol / 30 m2 ) when infused as recommended the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if mvai looks like and contents of the pack mwasi is a concentrate for solution for infusion . it is essentially a colourless to slightly
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in combination with other medicines to treat refractory mantles cell lymphomatoma ( mcl ), which is made up of your own white blood cells ( called autologous anti - cd19 - transduced cc3 + cells ). mantLE cell lymphhoma is : a cancer that affects part of the immune system called b - lymphocytes . mantled cell lymphopenia is caused by b- lymph cells growing out of control . b cells are made in an uncontrolled way from the lymph tissue to the bone marrow and collect in your blood . the white blood cell in this way collects in your body so that the cancer cells can be removed from your body and removed from the body in the urine 
do not take tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking tecARTus . the medicine contains a small number of white blood cells in your blood ( lymphodepleting chemotherapy ). there are 3 million white blood cell counts in one form for autologous use . tests and checks your doctor will do before and during treatment with tec artus , if : your doctor / nurse will take special care of your lungs , heart , kidney , blood pressure . your doctor may also want to monitor you more closely for infection and inflammation of your cancer . graft - versus - host disease this medicine is a serious , potentially life - long
tecartus is made specially for you because it contains your own white blood cells . your cells will be collected from you . a doctor or nurse will take some of your blood using a catheter placed in your vein ( a procedure call leukapheresis ). if your white blood cell are collected from your blood , your blood will be infused into your vein . this will take 3 to 6 hours and may need to be repeated . the number of your whiteblood cells is reduced to 2 to 3 days . medicines given before tecarus treatment , along with lymphodepleting chemotherapy , will be given to you , so that the modified white blood samples can be removed from your body . each treatment takes about 30 to 60 minutes . you may be given other medicines to reduce infusion reactions and fever . please speak to your doctor about the use of these other medicines .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have some of your side effects worsen than usual or worsen . if you notice any of the following side effects you may need urgent medical attention : the following serious side effects occur during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure ( symptoms : dizziness , lightheadedness ), fluid in the lungs ( symptoms include : nausea , vomiting ), cystitis ( build - up of fluid in lungs ) ( symptoms of a condition called cytokine release syndrome ) including loss of consciousness or decreased level of consciousness , confusion , memory loss . common ( might affect up to 1 in10 people ]: diarrhoea , nausea . uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the infusion bag label and infusion container after exp . the expiration date refers to the last day of that month . store frozen in liquid nitrogen ( below 150 ). this medicine contains genetically modified human blood cells and human - derived material . this medicine does not require any special storage conditions . tecartus is for single use only . however , if the product is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 36 hours at 2oc to 8oc .
what tecartus contains - the active substance of tecARTUS consists of autologous anti - cd19 - transduced c3 + cells . each patient - specific single infusion bag contains a dispersion of anti  - crd19 car t cells in approximately 68 ml at concentration of 2 x 106 anti . - other ingredients are sodium chloride and human albumin ( see section 2 ' tec artus contains sodium '). what Tecartus looks like and contents of the pack tecarthus is presented as a concentrate for solution for infusion . it is supplied as an infusion in a metal cassette . one single infusion bag contains approximately 69 mbq of cell dispertion .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 Diabetes . you may already be taking this medicine with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which you will need to take to lower blood sugar to control your diabetes . it is important to keep following the advice about diet and exercise given to you by your doctor or nurse 
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - warnings and precautions cases of inflammation of the pancreas ( pancreatic ) have been reported in patients receiving januervia ( see section 4 ). cases of blistering of the skin have been reports as being attributed to bullous pemphigoid . do not use janusvia if any of these apply to you . if they do not , you may have a disease of the Pancreases ( such as pancreatitis ). tell your doctor or pharmacist if : you have gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance of getting pancreа
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor might prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and lifestyle advice from your doctor while taking januvia . if the medicine is not effective , take it immediately . do not take janusvia more than once  a week . take this medicinal product with or immediately after food . you should swallow the tablet whole with a glass of
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreaticitis ). this is a serious allergic reaction ( frequency not known ). rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if this happens , stop taking this medicine and call your doctor or pharmacist immediately . your doctor may decide to temporarily stop janusvia . you should not stop taking the medicine and see
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin -the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate (  e572 ), and sodium stearyl fumarate . the tablet film ' s composed of poly ( vinyl alcohol ), macrogol 3350 , and talc ( 6000 ), titanium dioxide ( е171 ), red iron oxide (  703 ), yellow iron oxide , sunset yellow fcf ( uv ). what junuvia looks like and contents of the pack round , pink film , opaque blisters , de
what xultophy is xULtophy contains the active substance liraglutide . it is used to lower blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this is a type of diabetes where your body does not make enough insulin . the insulin that your body makes does not work as well as it should . as a result , the insulin does not lower blood sugar . insulin degludec is , in fact , a long - acting basal insulin , which helps your blood sugar levels to a normal level . if you are already taking lilraglutides ( a form of glp - 1 ), your doctor may advise you to start using insulin during meals . how xültophy works xcultophy can be given with or without food and drink for diabetes xulationphy is also
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before taking xULtophy and if : you are taking a sulfonylurea ( e . g ., glimepiride or glibenclamide ). your doctor may need to adjust your sulphfonkylureа dose , depending on your blood sugar levels . your doctor will discuss this with you . talk to you doctor before taking the medicine if your doctor thinks any of these apply to you , as it may be necessary . you have type 1 diabetes mellitus and may also develop ' ketoacidosis ', a condition
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if the patient is blind or has poor eyesight and cannot read the dose counter on the pen , do not take xultophy . take care not to get too high or too weak . your doctor will tell you how much xULtophy you need to take . the recommended dose is 41 mg / kg of body weight each day , at the same time each day ( for example , one day before breakfast ). xulationphy should be taken every day . it is best to take your dose at the start of each day and continue for at least 8 hours after that ( see section 8 , how to take it ). you should continue taking xpultophy for as long as your physician prescribes it . how to use xcultophy is for use in
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you get low blood glucose , your doctor will check your blood glucose level . for signs of low blood sucre , see the box at the end of this leaflet . to help prevent hypogliescaemia , talk to your doctor , pharmacist or nurse . in a few cases , you may have to stop taking xultophy and get medical help immediately . talk to a doctor . this is because blood sugar can affect your ability to control low blood Sugar . always follow the advice about diet and exercise given to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in use in order to protect from light . alternatively , xultophy can be stored at room temperature ( up to 30 ) for up to 8 weeks and not above 25oc for upto 21 days . this 21 - day period must be discarded . return the product to the pharmacy . your doctor or pharmacist will check if the medicine is no longer being used .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec ( equivalent to 3 . 6 mg lilraglutides ). each 3 mL vial contains 300 units of insulin de glucosedec , equivalent to 10 . 8 mg / m2 of lliglutide the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy contain sodium ". pack sizes of 1 , 3 and 5 vials or a multipack containing 10 ( 3 packs of 10 ) vial packs of 30 - 50 ( 3 vial pack of 10 +) vias , not all
giotrif is a medicine that contains the active substance afatinib . it blocks three proteins called egfr [ epidermal growth factor receptor 2 [ eggfr ]), erbb1 , her2 [ erbeb2 ] and erebb3 ]. these proteins are involved in the growth and spread of cancer cells . by blocking their action , this medicine can stop cancer cells growing and multiplying . this medicine is used to treat a type of cancer of the lung ( non - small cell lung cancer ). giotricif is used as your first treatment after prior chemotherapy treatment for a certain type of squamous type a , i . e ., prior chemotherapy treating a different type b , and dividing cells , in adults and children of all ages .
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - take special care with giotrice - tell your doctor if your child has low body weight less than 50 kg - have kidney problems . your doctor may need to adjust your dose , or stop the treatment temporarily , because of side effects - lung inflammation ( interstitial lung disease ) talk to your doctor before taking gioTRIf if : your child suffers from liver problems ( see section 2 ), as some liver tests may be necessary before and during treatment with this medicine , if the child has a severe liver disease - suffer from eye problems , such as severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers at the front of the eyes . 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . take the tablet at about the same time each day , for example , one tablet in the morning and one in the evening . this medicine is for oral use . swallow the tablet whole . do not crush , break or chew the tablet before swallowing . if necessary , your doctor may reduce your dose to one 40 ml tablet once daily . you should take this medication for 1 to 3 days after the last dose . taking this medicine you should continue taking this medication as long as your physician tells you , as your condition has stabilisation is achieved . your doctor will decide how long you should keep taking this medicinal product . how to take swallow the tablets whole with a glass of water . alternatively ,
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may occur during treatment : diarrhoea : very common ( may affect more than 1 in 10 people ): diarirhöa . common ( might affect up to 1 in every 10 people): severe diarragoeal . fluid loss : common ( will affect upto 1 in each 10 people people ), low blood potassium , worsening kidney function . if you experience diarhooeea or diarration , contact your doctor immediately . start appropriate antidiarrhoaieal treatment and / or antidiarrheal medicine prior to starting giotricif . your doctor will decide if it is necessary to reduce the risk of diarryoean discomfort . tell your doctor 
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinid . - other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide , polysorbate 80 , and in the film  - coating . what gi - giotricr is available : what atrif looks like and contents of the pack giotr 20 mg film  slam - free , white to off - white , oval tablets , debossed with " gsi " on one side and plain on the other side 
what orkambi is ork Ambient contains two active substances , lumacaftor and ivacaftre . orkambele is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation in a protein called cystic fibrin - cd508el , that is essentially normal , and which is carried around the lungs . the mutation causes an abnormal ccftr protein ( called lum ). the active substance in orkamba , along with iva caftoral work together to change the abnormal ffttr proteins . how orkimba works lumcafor and also ivacfor cause the abnormal crftren protein to work more normally . this may help your
do not take orkambi : - if you are allergic to lumacaftor , ivacaftre or any of the other ingredients of this medicine ( listed in section 6 ). - take special care with ork Ambient : talk to your doctor , pharmacist or nurse before taking orkiji . warnings and precautions talk to you doctor / pharmacist before taking any medicine . ork ambient has not been studied in patients with the f508del mutation . there is therefore no experience with orkaambi in patients of all ages . your doctor will monitor you closely for any signs of liver or kidney disease . if your doctor determines that you have a problem with your kidney , your doctor may decide to reduce the dose of orkacco . abnormal blood tests of the liver may occur during treatment with orkymambi . tell your doctor or pharmacist 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one orkambi tablet each day with food , for example , a meal or a snack . children aged 6 to less than 12 years can take the ork Ambi tablet with food or between meals . use in children and adolescents children aged between 6 to 11 years the recommended starting dose of ork ambient is 100 mg once a day taken as 2 separate doses . this can be taken as 12 tablets once  a night . adolescents aged 2 to less then 12 years the usual starting dose is 200 mg once or 2 tablets in the morning and 200 mg 2 tablets once in the evening . take orkambiance with food that is rich in protein . do not take orkikiki if your child has moderate or severe problems with
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of orkambi alone are usually mild to moderate . if you are worried , talk to your doctor or pharmacist . when taking ork Ambi in combination with ivacaftor , you may experience more of the following serious side effects that may be seen with orkubi : raised levels of liver enzymes in the blood ( which can lead to liver injury ) in patients with pre - existing severe liver disease . it is important to assess the worsening of liver function . side effects are uncommon ( may affect up to 1 in 100 people ). tell your doctor straight away if : you experience any of the below symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite difficulty in
what orkambi contains the active substances are lumacaftor and ivacafor . ork Ambi 100 mg / 125 mg orkamba 100 mg/ 127 mg : each tablet contains 100 mg of lumаcafting and 125 micrograms ivacasftoral . o ork ambient light : orkam 200 mg , 125 milligrams each tablet has 200 mg of either lum acaffetor , or 125 million iu iva caftorul . the opacity : o campfire light - sensitive , yellow to yellow , film - coated tablets , are printed with " lilly " on one side and " nvr " on the other . either orkubi 100 mg or 127 millilitres each tablets : the tablets are printed in
what lynparza is lyndparza contains the active substance olaparib . olalapab is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by blocking the activity of a specific gene called brca ( breast cancer gene - related peptide ). mutations ( changes ) in brca are known to be involved in the growth of cancer . parps can cause death of cancer cells . how lylparza works lyp inhibitors reduce the activity and repair dna in the body . what LYnparaza is used for lyngparza can be used to treat adult patients with ovarian cancer whose brca is based on a variant of mutated ovary cancer
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking lyndparza and during treatment with lyngparza your doctor will decide if and when you may restart treatment with the next dose . lylparza can cause low blood cell counts which will be tested . this is if your doctor determines that you have low counts of red or white blood cells , or low platelet counts ( see section 4 , possible side effects ). if any of these apply to you , tell your doctor before taking the next , ongoing treatment . you must not take more tablets than your doctor has recommended . the signs and symptoms can include fever , infection , bruising , bleeding or more serious problems with the bone m
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lyngparza is two 100 mg capsules twice a day . your doctor may increase your dose to 150 mg twice . the doses of LYnparaza capsules should be taken once a night . do not take tablets with a capsule in the morning and once in the evening . taking lylparza twice - daily dosing will also help you to remember to take it . it is best to take your capsule at the same time each day , preferably in the same day ; this will help you remember to do this . if necessary , your doctor will tell you how long you should take LYNparza . this will keep you on the right track until you are
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these could be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ), - allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms suggestive of hypersensitivity reactions . other side effects include : common ( might affect up to1 in 10 children ) - mild allergic reactions ( including hive reactions ), difficulty breathing , swallowing and dizzience . tell your doctor straight away if you notice any of the following side effects listed above . reporting of side effects 25 if your doctor finds you being
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . remove any lynparza capsules from the refrigerator and use them within 30 days . after this time , the capsules must be discarded . dispose of any capsules that are no longer being used . these measures will help protect the environment .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of olarib , and the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( irradiated ). what LYnparaza looks like and contents of the pack this white , opaque , hard capsule is printed with " oparib 50 mg " and the astrazeneca logo on one side . lypparza is available in packs containing 112 or 448 capsules or in multipacks comprising 112 capsules . not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nyxoid belongs to a group of opioids called heroin . it is used in adults for the following classes of opioid substances : methadone , fentanyl , mexicodone , buprenorphine / morphine . all of nxoide is used as a nasal spray for the emergency treatment of opioid overdose . opioid over dose can be life - threatening and should be treated within 14 days of a medical condition . the following signs of overdose include breathing problems and severe sleepiness . in the case of an opioid overddose , you should inform your doctor , pharmacist , or nurse immediately if you are in doubt . you should also inform your physician , dentist , nurse or pharmacist about the long term use of opioid medicines . emergency medical
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nYxoide . you may need emergency medical care , or contact your nearest hospital emergency services , if an opioid overdose occurs . the signs and symptoms of an opioid overload may vary from person to person . if they spray too much nylon , wait at least 2 to 3 hours before using your nasal spray , and use a new nasal spray at the same time each day . this medicine may make you more dependent on your body . it is especially important to tell your doctor about how to recognise and treat opioids . opioids can be addictive and can be used in people who abuse opioids such as heroin , methadone 
always use nyxoid exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . nYxoided nasal spray should be used within one hour of its use . the recommended dose is : 1 . try to use a spray in the shoulders and ears , including the breastbone and the sternum just above the ear . use firmly with a fingernail to clear the mouth and nose of any blockages . it may help to keep the mouth open more easily than the nose . 1 - when breathing is the chest moving , you can feel breathing sounds and breath on the cheek . in the event of overdose , your doctor will try to reduce your response to touch or sounds and to slow uneven breathing . 2 - if your doctor thinks that the effect of nyesoidic is
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . nyxoid can be associated with acute withdrawal symptoms , which are often caused by the use of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering or trembling changes in behaviour , violent behaviour . also nervousness , hiccups . this includes feeling of spinning , shaking , nausea and vomiting . you may also experience a similar reaction if you have this reaction . talk to your doctor if this happens . stomach crampes / feeling sick ( nausea ) and / or vomiting if the medicine is taken
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 mg of nnaoxin ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochoralic acid , sodium hydroxide and purified water . what yxxoide looks like and contents of the pack nxod is a clear , colourless , clear - to - yellow solution in a 0 . 1 ml pre - filled nasal spray contained in  a single dose container . nyesoir is supplied in : a carton containing 2 nasal sprays packaged in blisters . the name and batch number of each nasal sprinkle is ' n1 ' on each
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " flutropin " ( also called " gonadotropin "), which itself is not related to another type of hormone called " hormone of sperm " ( fsh ). ffs is involved in the growth and development of the sacs (  farrows ) in the ovaries that contain the eggs necessary for the production of heaviness of a mature egg cell . in fh , treatment with a medicine called " collomifene citrate " is used in assisted reproductive technology procedures ( procedures that may help you to become pregnant ) to help you become pregnant but you may be given too much of fah . you will be given a medication called " loutropin alefa
do not use ovaleap : - if you are allergic to follitropin alfa ( fsh - 1 , flt2 , other fomb stimulating hormone ) or any of the other ingredients of this medicine ( listed in section 6 ) - sistinetine used to create a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). - in women with large ovaries or sacs of fluids within the ovulation ( ovarian cysts ) of unknown origin - with unexplained vaginal bleeding - or have cancer in your oocytes , or womb or breasts - as this medicine may make any condition that usually makes normal pregnancy impossible , such as ovarial failure ( early menopause ), fibroi
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is intended for subcutaneous use . your doctor will give you this medicine by injection in the tissue just under the skin ( subcutaneous injection ). if necessary , ovaleap may be administered repeatedly by your doctor and may be given to you in irregular periods . you should not receive this medicine for the first 7 days of your menstrual cycle . the medicine can be administered in any male cycle , although you may need to keep using it for longer than one week before you stop using it . how much to use your doctor tells you to . adolescents the recommended dose of this medicine in adolescents is 75 to 150 mg . children you should use this medicinal product every 7 days for 14 days , but your doctor may decide to increase the dose to 37 . 5 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are usually mild to moderate . serious side reactions in women allergic reactions such as skin rash or raised itchy areas of skin can be serious . severe allergic reactions may also include weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare : may affect up to 1 in 10 , 000 people if you have this type of reaction , your doctor may decide to delay your ovaleap injection and contact your doctor immediately . possible serious side impacts in women lower stomach ache , nausea and vomiting , the symptoms of ovarian hypertension may be severe . these reactions may be mild and temporary . if they do not go away tell your doctor . reporting of side effects 39 if your doctor gets any side effects talk to your doctor or pharmacist . this includes any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a single period of maximum 3 months below 25 in its outer carton . once this medicine has been removed from the refrigerator , it must be used within 3 months . after this period , the cartridge may be kept at a room temperature of 28 days or below 25 . always keep the pen cap on the ovaleap pen when you are not using it in order for it to work properly . it is recommended that the date that the pen is removed from refrigerator is recorded on the outer box , and the date
what ovaleap contains - the active substance is follitropin alfa . ovaleeape 300 iu / 0 . 5 ml : each cartridge contains 300 icm ( equivalent to 22 micrograms ) fotropin Alfa in 0. 5 millilitre ( mL ) solution . - ovaleop 450 ius / 1 . 75 m : Each cartridge contains 450 international units ( igg ) and 33 ig flt ( corresponding to 33 microgram (s  s ). flltropinalfa ( 0 in 0- 75 milligrams alf ) in ovulation solution , solution for injection . what ovalap looks like and contents of the pack ovale ap is a white to
voriconazole accord contains the active substance vorikonazole . vorizonazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . this is especially important for patients aged 2 years and older : - invasive aspergillosis ( a type of fungal infection due to aspergalillus sp ) - candidaemia ( another type of FUNgal infection linked to candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the sporus is resistant to fluconazoles ( another antifungals ), seriously invasive fungal infections caused by scedosporium spepsis or fusarium ssp with two different species of fungus
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if your doctor has told you that you are taking or have taken any other medicines , including herbal medicines . the medicines contained in this medicine are listed in separate package leaflets . please read the leaflets of the medicines that are used during voricanazole agreement treatment . 46 - the active substance is terfenadine ( used for allergy ) - astemizole ( used to treat allergy ), cisapride ( used in stomach problems ) warnings and precautions talk to your doctor before taking voriConazole Accord - pimozide ( generally used for treating mental illness )- quinidine ( used when treating irregular heart beat ) when
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the dose you receive is based on your weight and the type of infection you have . your doctor will determine how much voriconazole accord you should receive . adults the recommended dose is 40 mg twice a day . if your weight increases , your doctor may prescribe a lower dose of 40 mg once a 24 hour period . for the first dose you will receive 400 mg twice daily for the second dose after 12 hours . this will be given as a single dose of 24 hours , followed by 200 mg twice weekly for the third dose after twelve hours ; if the first 24 hours have passed , you will be treated with 200 mg once daily for 100 days . depending on how you respond to treatment your doctor might increase the dose to 300 mg twice monthly . use in children and adolescents vor
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects have been reported with voriconazole accord . these include rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision / night blindness and swinging vision . common ( might affect up to 1 in10 people  ) : visual disturbance ( change of vision including double vision ), visual impairment including blurring vision ; visual color changes
what voriconazole accord contains the active substance is vorikonazole . each tablet contains 50 mg vorizonazole ( as besilate ). voricanazole agreement 50 mg film - coated tablets : each tablet has 200 mg vorisiconizole ( As besilsate ) as between . vorikanazoleaccord 200 mg film- coated tablet : the other ingredients are : lactose monohydrate , pregelatinised starch ( maize ), croscarmellose sodium , povidone ( e1202 ), magnesium stearate ( sda ). hypromellose ( 6000 ), titanium dioxide (  e171 ), lactoses monohydrate and triacetin ( azure ). the film  - coating contains the same ingredients as vorion
mvabea is a vaccine to prevent ebola virus disease in the future . it is given to adults and children of 1 year and older , at least 1 year of age against ebdeno virus . if you have already received a 2 - dose course of vaccinations to prevent you from getting ebra virus disease caused by the zaire elimavirus , which is essentially a type of filovirus . this vaccine does not contain the whole elovirus and will not give you eebolo virus disease . vaccinations with zabdena vaccine are recommended at least 8 weeks later . the recommended dose of mvasbea vaccine with zbdenone and mvacbea vaccination is recommended at minimum levels . as with all vaccinations , elavirus may not fully protect all persons who are vaccina
you will be told by your doctor or nurse before the vaccination course . if you have previously had a severe allergic reaction to any ingredient of mvabea ( listed in section 6 ). if your child has had : a severely allergic reaction against an antibiotic called ' gentamicin '. he / she will decide if the vaccine is suitable for your child . warnings and precautions talk to your doctor , pharmacist or nurse prior to your child being given mvasbea if : you have had , or have ever had ; a history of a serious allergic reaction after any other vaccine injection . you have ever fainted following , at least one week after the injection , if it is , you are bleeding or bruise easily , because you currently have a fever or an infection , but you are taking medicines that affect the immune system such as
mvabea is given into a muscle ( intramuscular injection ) in the upper arm or thigh or into  a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . mvasbea vaccine is the second vaccine . this second vaccine should be given at the same time as the first . what primary vaccination first vaccination using zabbingeno red cap vial second vaccination using the mvdc4 / m4th vaccine second vaccination with the mighty zabea yellow cap viall is given at least 8 weeks after the first vaccine with zanbdenon . booster vaccination with either zabigdeno or zabeddeno may be given either : first vaccination zapdeno red caps vial , second vaccination mvalbea orange cap viala , third vaccination titration yellow cap through
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects occur at least every 7 days after the injection . the following side effects can happen with this vaccine : very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people getting sick ( vomiting ) itching where the medicine is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the injecting is given generalised itching reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the
what mvabea contains - the active substances are : zaire ebolavirus ( inactivated ) 29 - tai forest ebovirus nucleoprotein marburg , containing 0 . 7 ml , 3 108 chinese , japanese equine and chicken embryo fibroblast cells . - this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what vvabeа looks like and contents of the pack mvasbea is a suspension in a single - dose glass vial with a rubber stopper and yellow cap . the vial contains 20 mbq ( 0c - 5c ).
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ) it helps also to prevent other bone problems that may need surgery or radiotherapy bondronatul has a raised calcium level in your blood due to : a tumour which is lost from your bones it helps keep your bones stronger .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - as you have low levels of calcium in your blood . do not use this medicine if any of these apply to you . if they are not , speak to your doctor . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonegacross of the Jaw , there are some precautions you should take 
receiving this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronates you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg ( 3 - 4 hours ) once every week as an injection in your vein over at least 15 minutes . If you have a raised calcium level in your blood , the recommended rate is 1 mg ( 2 mg ) every 2 weeks . however , if your illness is not well controlled ,the medicine should be administered as an intofusion in your vagina . no more than
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( will affect upto 1 in 10 ,000 people ), pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if this happens . ear pain accompanied by discharge from the ear . these may be signs of an ear infection . bone damage
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution can be stored at 2 - 8 for up to 24 hours . store in the original package in order to protect from light . keep this medicinal product in the outer carton in order protect from moisture .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of concentrate for solution for infusion contains 2 mg ibanronic acids . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . water for injections what bondanat looks like and contents of the pack bondronate is a clear to slightly pearly , colourless concentrate for solutions of 1 or 2 g mL with a bromobutyl rubber stopper .
what zeposia is zeposa is an active substance in the body called cytokines . zepositiona belongs to a group of medicines that destroy certain kinds of white blood cells called lymphocytes . what zingposia can be used for zePOSa is used to treat relapsing remitting multiple sclerosis ( rrms ) in adults who have not had active disease before . multiple clerosis is a disease which affects the immune system and reduces the body ' s defenses ; white blood cell counts are important for the nerves that carry messages from the brain and spinal cord to the nerve systems . it can cause symptoms such as numbness and difficulty in walking .
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severely weakened immune system . if any of these apply to you , tell your doctor before taking zeposa . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if : you have ever had a heart attack ( such as angina , stroke , mini - stroke ), or transient ischemic attack ( tia ) you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmias ) which you have had to stop treatment or you have severely infection ( hepatitis ), tuberculosis , cancer you have extreme liver problems you are pregnant or breast 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of zeposia is based on your heart rate . this is called a ' treatment initiation pack ' which contains the first dose . you will be given a first dose of treatment starting in the first week . each week you will receive a dose of 4 capsules of 0 . 23 mg ozanimod on day 1 and then on day 4 of treatment , you will take 3 capsules in the morning and then again on day 3 ( 0. 46 mg / kg oznimod ) on day 5 , 6 , 7 , and 8 . after that , your doctor may give you a new dose , called ' maintenance pack .' with orange capsules on day 8
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : very common ( may affect more than 1 in 10 people ) slow heart rate urinary tract infection blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse if this happens . common ( might affect up to1 in 10 persons ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynxia ) viruses - white blood cell called lymphocytes common (may affect upto 1 in every 10 people) infections or urinary glands common : may affect uptyrosis the signs
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepa 00 . 46 mg ; each capsule contient 0
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furoroate belongs to a group of medicines called corticosteroids , often simply called steroids . umeklidinium brazomide or vilantrol belong to  a groupe of medicines known as bronchodilators . what teminessbric
do not take temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and do not use temibric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrice ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temуbric
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and tell your doctor immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctors immediately if you get any of the following while using temybric ellipta : symptoms of a lung infection such as fever or chills , increased mucus production , change in mucuses colour , decreased cough , or increased breathing difficulties common side effects these may affect up to 1 in 10 people : sore throat , sputum , redness , swelling or pain in the mouth , lips or throat . these may be signs of spit- up or squeezing . if this happens , you
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate . the other ingredients are 65 microgram umeklidinium brmide , 55 microgramumeclidium and 22 microgram vilantrol ( as trifenatate ). the other ingredient ( excipients ) are lactose monohydrate ( see section 2 under ' temYbric is for use in adults ') and magnesium stearate . what mybril ellippa looks like and contents of the pack the ellimpta inhaler consists of a light grey plastic body ,
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfo is used to treat adults with infections of the skin and the tissues below the skin . this is often called an infection of the lungs called a ' pneumonia ', which can be serious . how zinfordo works zinforum works by killing certain bacteria , which helps to prevent serious infections .
do not take zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic at the moment to other cephalosporin antibiotics . - have had previous severe allergic reactions to other antibiotics ( penicillin or carbapenem ). do not use zin foro if any of these apply to you . warnings and precautions talk to your doctor before taking zinfordo . talk to you doctor before you take , or while taking  Zinforo do not give this medicine to anyone else . take special care with zinfo : - tell your doctor if : you have kidney problems . you have ever had seizures ( convulsions ) or any non - severe allergic reaction to other bacteria while taking penicillin and carbapnem .
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor will decide how many days of treatment are needed . the recommended starting dose is 600 micrograms given every 8 hours , for some infections , 8 to 12 hours apart . zin foro is given to you by a doctor or nurse , as a drip into a vein . it usually takes about 5 to 60 minutes to 120 minutes to get the right dose . you may be given an increased dose depending on how you respond to treatment . this may take up to 5 to 14 days for skin infections and then for 5 to 7 days for pneumonia . people with kidney problems if you have kidney problems your doctor may decide to give you zinforceo if they get worse . how much zinfo is made your doctor calculates the correct dose for you . in adults the recommended daily dose is one vial ( 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ) and may be life - threatening . diarrhoea , stool , blood or mucus during or after treatment with zinforo , you may be given medicines to slow bowel movement . this may affect up to 1 in 10 people . your doctor may want you to have a blood test called a ' coombs test ' before antibiotic is given . depending on the results of this test your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder supplied for solution for infusion in a vial . one vial contains 10 ml 
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabralin fizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral numbness , such as diabetes or shingles . pain sensations may be described as hot , burning , or throbbing , shooting , stabbing . they may be sharp , cramping , and aching , torsion or tingling , injuring . this pain may last for months or years . arthritis , pain in joints , muscle pain , arthritis ; or it may take longer than one year to respond to the treatment . other conditions that may cause difficulty in
do not take pregabalin pfizer if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabalin ppfizer it is possible that some patients taking pre gabalin may experience symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabralin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , pregabaliin pripriser may be associated with blurring or loss of vision , or other changes in eyesight . you should immediately tell your doctor 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder take the number of capsules as instructed by your doctor. the dose , which has been adjusted for you and your condition ( s ) will generally be between 150 mg and 600 mg each day . you should take pregabralin ppfizer either twice or three times a day , with breakfast or with breakfast . for twice aday take pregamalin pipizer once in the morning and once inthe evening , at about the same time each day of the day 59 swallow the capsules whole with a drink
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common - may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , not feeling irritability . disturbance in attention , mood swings , nervousness . memory impairment , loss of memory , serotonin , difficulty with speaking , and tingling sensation . uncommon : might affect upto 1 in 100 people loss of appetite , weight gain , change in perception of self , restlessness , depression , anxiety , inability to sit or stand still . increase in sexual activity , increase in sex drive , reduced consciousness , panic attack
what pregabalin pfizer contains the active substance is pregabALin . each hard capsule contains either 25 mg , 50 mg ; 75 mg : each 100 mg / 200 mg  225 mg or 300 mg pregabralin  the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , and shellac ; black iron oxide (  e172 ), propylene glycol , potassium hydroxide ). the 75 mg tablets also contain 100 mg, 200 mg and 225mg powder . the 300 mg tablets are white to off - white , round and marked " pgm ". each capsule contains 225 milligrams 
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . this helps your body to move more easily . xedagon is used to treat parkinson ' s disease in adults . the medicine helps to reduce the number of sudden switches ( stops you being able to move ) in people who have difficulties moving . in addition , xagego can be used together with the medicine that is levodopa ( another medicine used to control parkinsons '
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - take the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine / isocarboxazid , and tranylcypromine ( used for treatment of parkinson ' s disease and depression ) or pethidine ( a strong pain killer ). you must stop taking it for at least 7 days before starting x ad ago treatment and at the start of treatment with mao inhibitors or pethethidine . ask your doctor or pharmacist if any of these apply to you . warnings
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg taken by mouth . you should swallow the tablet whole with a glass of water . xdag should be taken with or without food . moderately reduced liver function the recommended starting dose is 50 milligrams taken once daily . your doctor may lower your dose if necessary . take x ad a day with or immediately after food ; if your child is taking xedagot with or shortly after food you should contact your doctor as soon as possible . patients with raised blood pressure , anxiety , confusion , forgetfulness , sleepiness , lightheadedness , feel sick or be sick , or have dilated pupils or involuntary 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that could lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( a combination of confusion , sweating and muscle rigidity ( hyperthermia ) have been reported very commonly ( in patients taking xadago ) and increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). confusion ( hypertension ) may also be associated with muscle stiffness and hallucinations ( hypotension ). in patients treated with xdagot , the following side effects have been observed with another medicine for parkinson ' s disease , a high dose of safinamide ( i . e ., 200 mg ) or 500 mg ( 1 , 500
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafatinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : pregelatinised maize starch , pregenoid maize stars : poly ( vinyl alcohol ) - coating - hypromellose , macrogol ( 8000 ), titanium dioxide ( e171 ), iron oxide red ( azure ). what Xad adogo looks like and contents of the pack x azabago 50 mg are white to off - white , oval ,
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytigea is used in combination with testosterone , to treat prostate cancer . how zymiga works zyta is prescribed to you because you are at risk of disease and hormone therapy , a treatment that lowers testosterone ( androgen deprivation therapy ). it is sometimes given with another medicine , prednisone or prednosone , which is used for high blood pressure , as well as for high pressure in the body due to fluid retention in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - when you are pregnant warnings and precautions talk to your doctor , pharmacist or nurse before taking zytigea . - the use of this medicinal product has not been studied in women . there is a small chance that you may have severe liver damage or prostate cancer . your doctor will decide if to reduce the dose of this medical facility . do not stop taking this medicine without talking to your physician first . warnings : this medicine has not yet been studied and is therefore not recommended in patients with liver problems , such as high blood pressure , heart failure , low blood potassium . low blood sodium may lead to heart rhythm problems . other heart or blood vessel problems : tell your doctor or pharmacist if your child
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once daily . take this medicinal product twice daily by mouth . you can take zytiga with or without food . do not chew , crush or split the tablet . zytigea can be taken with or just after food , if your doctor tells you to . for the best results , take a tablet at the same time each day . it is important that you take zetiga for as long as your physician tells your doctor to , or if someone else accidentally takes your medicine . how much to take adults , adolescents and children  18 years of age : take ztiga once a day with food ; take the tablet at least 2 hours before or after food or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may mean that the level of potassium in your blood is low . therefore , your doctor may need to reduce your dose . other side effects very common ( may affect more than 1 in 10 people ) fluid in your legs or feet . this may mean you have low blood potassium . it may also be detected by liver function test results , which may show up in high blood pressure . you should also tell your doctor if this happens . urinary tract infection , diarrhoea and vomiting . your doctor will tell you how to treat these conditions . common ( might affect up to 1 in10 people  ) swelling
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg aberraterone as a single tablet . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica and sodium laurilsulfate . see section 2 " zytigea contains lactobacille ". what zetiga looks like and contents of the pack - zymiga tablets are 9 . 5 mm in diameter and are scored . the tablets are packaged in a plastic bottle with a child - resistant closure and a desiccant . pack size of 120 tablets .
hefiya contains the active substance adalimumab . he is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paediatrinic non - infectious uveitis in adults . the active ingredient in heifiyo , the active compound , is tadhalimumаb , which is  a monoclonal antibody . monocloclonals attach to specific targets in the body . by attaching to tnf , an antibody in the brain is found on cells that specifically target specific proteins . this protein is thought to work by blocking the activity of ttf
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if the symptoms of infections ( fever , wounds , feeling tired ) and dental problems are either moderate or severe heart failure . it is also important to tell your dentist if there is a history of a serious heart condition . warnings and precautions talk to your doctor or pharmacist before using heifiyo if : you have ever had a possible allergic reaction . allergic reactions can be life threatening . symptoms include chest tight
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one 40 mg tablet per day . if your doctor prescribes a lower dose of one 20 mg tablet , your doctor may increase the dose to one 40 kg tablet per night . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children / adolescents from 2 decades of age who weigh 10 kg to less than 30 kg 20 mg every third day not applicable enthesitis - related arthritis age or body weight more than 30kg 40 mg each other weeknot applicable children and adolescents from 6 years of old weighing 15 kg to more than $30 kg 20mg not applicable paediatric
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , including hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , and get medical help immediately , should you notice signs and symptoms of infection such as fever , feeling sick , wounds , dental problems . these may be signs of infection including fever ; feeling sick or wounds that may be severe 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya can be kept at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light ( maximum period) for up to 14 days . once removed from the refrigerator for room temperature storage , your pre – filled yringе must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when your pre-
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimUMab in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what HEfiYa looks like and contents of the pack heifiy consists of 20 mg ( 20 mg / 0. 4ml ) solution for injection ( injection ) in a pre – filled mL clear type i glass sYringe with a stainless steel needle with  a needle guard with finger flange , rubber needle cap and
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . ritemevia is used for the treatment of several different conditions in adults . your doctor has prescribed ritemillion for the following conditions : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes bender - lymphocytes that accumulates in the blood . when you first start using ritemother you will be given other medicines ( called chemotherapy )
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximabib - like the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment you have been told that you are at risk of having a weak immune system if this has happened to you . if the diagnosis is severe heart failure or severe uncontrolled heart disease , with granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use ritemevia : if any of the above apply to you and tell your doctor if it applies to you as you may not be fully protected from light . warnings and precautions talk to your doctor or pharmacist before using ritemmvia .
your doctor will watch you closely while you are being given ritemvia . this treatment is being given to you by a doctor or nurse . it is very important that you are given this medicine in order to reduce any side effects . ritemmvia is given as a drip ( intravenous infusion ) over 2 hours . medicines given before each ritetvia administration before you are provided ritemevia will be given to your by  a healthcare professional . you will be closely monitored for any changes to your treatment . for non - hodgkin ' s lymphoma if you are having ritedmvia alone riteminvia will usually be given once a week for 4 weeks . repeated treatment courses with ritempvia are possible . when you are treated with remission of riteland ritervia combined with chemotherapy riteritemvic will
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , stomach pain , diarrhoea and vomiting . very rarely . if you get any of these symptoms , tell your doctor or nurse immediately . other side effects may include : very common : may affect more than 1 in 10 people cold sores . common - may affect up to 1
what ritemvia contains the active ingredient in ritemmvia is called rituximab . the vial contains 100 mg of ritsuximаb , and each ml of concentrate contains 10 mg of of  Rituxmab ( 30 mg / mL ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemigvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains cape citrine , which itself is not a cytostatic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine tingeva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitedbine tuleva is also used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . if capecitingbine  Teva is prescribed to you in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if your child has an allergy or over - reaction to this medicine , - severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - pregnant or breast - feeding , warnings and precautions talk to your doctor before taking capecitationbine , because : - you have severely low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or - your doctor has told you that you have severe liver or kidney problems , as you may be deficient in the enzyme dihydropyrime dehydrogenase ( dpd
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your condition and body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface zone of 1 , 7 . 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times weekly . a man whose weight is 80 kg and tall is 1. 80 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarragoee at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : you lose your appetite . stomatitis : may cause pain , redness , swelling or sores in your mouth and / or throat . your doctor may want to reduce your dose . this is because it is very important that you carry the extra dose every day and not only when you have st . martinson ' s disease : it is common
what capecitabine teva contains the active substance is capecitebine . capecitation t Eva 150 mg film - coated tablets each film , coated tablet contains 150 mg capeciabine , the other ingredients are : - tablet core : capevitabine ; - capecitébine tingeva 500 mg film- coated tablet : tablet coat : 500 mg capacitabine the other ingredient ( s ) are , tablet core: lactose , microcrystalline cellulose , hypromellose , crohn ' s sodium , magnesium stearate , macrogol 400 , indigo carmine ( e132 ), hypromlose - titanium dioxide (  e171 ), yellow iron oxide ( е172 ), red iron oxide [ e172 ]). what capaecitabin 
what silodosin recordati is silofin recordrati belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sillodon recordatis works by blocking the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladodasin recordingati can be used for silon recordata is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , an improvement in your condition .
do not use silodosin recordati if you are allergic to sildodoubsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using siloudoosine recordatis if : you are undergoing eye surgery because of cloudiness of the lens ( cataract surgery ), 26 you should not be given silofosun recordatif any of these apply to you . during treatment with this type of medicine , you may experience a loss of muscle tone in the iris ( the coloured circular part of the eye ) during such a surgery . your doctor will take appropriate precautions with respect to medicine and surgical techniques . you should tell your doctor if during cataract surgery you have fainted or felt dizzy , or if your vision is blurred 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . you can take siloudoosun recordatis with or without food . if your doctor has told vous that you have kidney problems , or if vous have moderate kidney problems you should continue with this purpose silofosine recordatti 4 mg per night . alternatively , you may take silotodiosen recordatix at the first or second dose if this happens to you , as you may find it easier to take it at the usual times . however , some people may feel dizzy or feel weak
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is the same with silodosin recordati . dizziness . although dizzinness may be present , occasionally fainting can be very common . however , if the symptoms of dizzince and fainting occur , please inform your doctor as soon as possible . if this occurs , you should contact your doctor . sildodain recordai may also cause complications during a cataract surgery ( eye surgery to remove crystal crystals ). it is important to try to avoid dizziening and getting dizzy during the treatment . it is very
what silodosin recordati contains sildoosine recordatis 8 mg the active substance is siloudo. each tablet contains 8 mg of siloulodou . the other ingredients are : gelatin , magnesium stearate , sodium laurilsulfate , gelatin, titanium dioxide ( e171 ). sil lododsin recordingi 4 mg theactive substance is also silokasin . each capsule contains 4 mg of seloodazin . other ingredients include : mannitol , mg magnesium st . johnson ' s wort ( kelown '), magnesium laurilfate ( k29 ), gelatin
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzizalmonio blocks the effect of angio Tensin 1 so that the blood vessels relax , and your blood temperature is lowered . this helps you to control your bloodpressure . what kinezalmona is used for kinzzalmonou is used to treat essential hypertension ( high blood pressure) in adults . the high blood tension is caused by the high pressure , which can damage blood vessels in several organs , causing heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). -if you think you may be more than 3 months pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) - have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - are suffering from diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren ( see pregnancy and breast - feeding ). read the information under " other medicines and kinZalmony ". warnings and precautions talk to your doctor before taking kinzzalmonno if any of the following apply to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , as you may find it easier to take it at the usual time . it does not matter whether you are taking kinzimono with or without food . always take the tablets with some water or other non - alcoholic drink . you can take kinzuroni with or just after food , whichever is best for you , and take the dose at the right time each night . if your doctor prescribes kinZalmona for you as a starting dose for treatment of high blood pressure , the usual dose of one kinezalmonone 40 mg / m2 may be increased to one higher dose to control blood pressure
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately as they could be fatal . if these effects are not treated they could potentially be fatal ( can be fatal and patients must stop taking kinzalmono ). common side effects ( may effect up to1 in 10 people !): low blood pressure ( hypotension ) in patients with cardiovascular events . uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused tablets should be discarded .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). -the other ingredients are povidone , meglume , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmondo looks like and contents of the pack kinzialmona 20 mg tablets are white , round and engraved with the code number ' sv ' on one side . kinezalmonono is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
what afstyla is a fsyla tablet is  a human clotting ( coagulation ) factor viii product that contains the active substance lonoctocog alfa . what he is used for aFstlyla is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor ixi deficiency ). factor  vii is necessary for blood clot . it helps the blood to clon , but also provides an increased tendency to bleed . how a user receives factor ii in patients of all ages with haémophila b to help the blood coagulate better . aaftylac is used in adults , adolescents and children of all age groups .
you should not be given afstyla if you have ever had an allergic reaction to any ingredient of aaftylake if : you are allergic to hamster proteins 46 you are not allergic to peanut or soya if any of the above applies to you . if this applies to your child , do not give this medicine to your baby . warnings and precautions 46 talk to your doctor or nurse before you are given : a fshyla the patch number should be recorded in your treatment diary . you should take a copy of the leaflet for adstlyla and return it to your pharmacist or nurse . allergic ( hypersensitivity ) reactions have been seen in some people treated with a high dose of recombinant dna technology before you receive a dose of the medicine . symptoms of allergic reactions may include 
your treatment should be initiated under the supervision of a physician experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of  afstyla for treatment and maintenance is one vial per day . dose adjustment of dose the duration of treatment depends on the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) to form a suspension for injection , which must be used immediately after reconstitution . for aseptic conditions , a dose of 1 . 5 ml of reconstituted aaftyLA must not be used in combination with other medicines or solvents . see section 6 . ensure that the solution is clear or slightly 
like all medicines , afstyla can cause side effects , although not everybody gets them . please tell your doctor immediately if you have symptoms of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ); however patients who have received previous treatment with factor vii ( more then 150 days of therapy ) the risk is higher . if this happens , stop the injection and contact your doctor . it is important to make sure that you do not have any additional side effects and to contact your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viallyla powder in the viall and the reconstituted product in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . if the afstyla powder has been stored at room temperature ( below 25 ) it must either be used within 3 days or disposed of . please record the date from when you start to store the vialuid in the refrigerator and the date after which it should be discarded . once you have reconstructed the product , it should not be put back in the fridge . you should contact your pharmacist for
what afstyla contains the active substance is lonoctocog alfa . each 250 ml vial contains 2 . 5 g of injections the solution contains 100 mg of lonoctcog alla - after reconstitution with 2 : 5 mL of water for injectionsthe solution contains 200 mg of LonoctoCog alba in 1000 mbq at reconstitution and 2  . 4 mmol of waterfor injections each mlitre of solution contains 400 mg of honoctocg ala and 1500 mg of lonostocogg alf- 1500 iu / m2 after reconstitute and 5 % water for injects the solutions contains 300 mg of povidone ( lonoctopocog a ) and 2000 ius / 1000 i U . after reconscription and 5
what praxbind is prawbind contains the active substance idarucizumab . iarucizumаb is a reverse agent of reversible action of a drug called dabigatran ( pradaxa ), a blood thinner medicine that reduces blood clot formation . how prauchbind works pracbind can rapidly trap dabig atran when you are taking prasbind . you should use praxxbind only in emergency surgery / urgent procedures to prevent uncontrolled bleeding .
do not use praxbind - if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . - have a genetic disease called hereditary fructose intolerance ( hfi ) - are taking the substance sorbitol ( e420 ) for any reason . this medicine may increase the risk of serious adverse reactions . warnings and precautions talk to your doctor before using praxxbind . take special care with this medicine - take special Care with dabigatran - this is a medicine used to treat blood clots . dabig atran is absorbed by the body and can increase the chances of blood coagulations . your doctor will discuss with you the possible benefits and risks of taking medicines to prevent blood  clotting , depending on your medical condition .
praxbind will be given to you in a hospital or clinic under the supervision of an experienced doctor . the recommended dose is 5 mg ( 2 . 5 mg dabigatran ) given twice a day . you will receive this medicine in varying doses . doses of up to 5 mg will be administered to you by your doctor or nurse . this medicine will be injected into a vein . your doctor will decide how this medicine should be given and when you should stop your treatment , to prevent blood clot formation . before you receive dabig atran the recommended treatment period is one month . it is recommended that you receive this medicinal product for 24 hours . if you receive more pracbind than you should this medicine is given by a doctor or a nurse , so it is unlikely that you will be prescribed too much . tell your doctor if , in any
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get medical help immediately if you get any side effects or if any of the side effects gets serious . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what pfizer looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution for injection in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temtemoMEDac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the combination of temmedaic with radiotherapy ( concomitant phase of treatment ) and monotherapy phase of treating ( primary phase of therapy ) is not appropriate . it is also used in children 3 years and older and adult patients with malignant gliomema , such as gliboblasta multiFORMe or anaplastic astrocytoma both in adults . in these tumours the treatment with temmomedаc is ineffective despite standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . -if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body to fight infection and to maintain proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking temac you should tell your doctor immediately if 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a history of a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temtemoMEDac to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if a patient is unwell , treatment will occur in two phases : - treatment together with radiotherapy ( concomitant phase ) first - followed by treatment with temac ( monotherapy phase ).
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), fever , chills , severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which can cause fever ), and reduced resistance to infections . the reduction in blood cell counts may lead to anaemic events ( fits ), death or permanent loss of appetite , weight loss , and / or death . in some cases , the patient may have
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once you have opened the capsules , use immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . however , temomedac can be stored at room temperature ( up to 30 ) for up to six months . tell your pharmacist if you notice any change in the appearance of the capsule . this will help to protect the environment .
what temomedac contains the active substance is temozolomide . temac 5 mg film - coated tablets : each tablet contains 5 mg temizolomide ( as mesilate ). temokac 20 mg film film – coated tablets: each tablets contains 20 mg mozolomid ( as maize ). one temogramac 100 mg film coating : every tablet contains 100 mg TEMozolomidé ( as moles ). two temological strengths are available : temmedaac 140 mg film coated tablets the tablet contains 140 mg hemozolomiDE ( as mésilates ). another 180 mg film coat : the tablet also contains 180 mg timozolomides . one ml film  sachet : one titration pack : two tamper evidents : three t
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eerect penis suitable for sexual activity . cialIS has been shown to significantly improve the ability of obtaining a sexually attractive sexual result . it is used in adult men , especially if they are unable to get a straight , straight - eight penis appropriate for sexual activities . you must not have a harder ect penis capable of sexual activity because of the lack of data in this condition . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , the cialimus works by helping the blood vessels in your penis to relax , improving the function of your peni . when this happens
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is a group of medicines (" nitsrates ") used to treat angina pectoris (" chest pain "). cialIS has not been studied in patients taking these medicines . if your doctor has told you that you may be taking any type of natrate or are unsure tell your doctor . take special care with ciali - the following are reasons why cialist may not be suitable for you : - you have serious heart disease or you have recently had a heart attack within the last 90 days - recently had or had  a stroke within the past 6 months 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with some water . you can take the tablets with or without food . do not chew , crush or split the tablet . your doctor may adjust the dose to 5 mg or 2 . 5 mg based on your response to cialIS . taking cialist you will usually take cialised for as long as your sexual performance is satisfactory . when ciali is taken regularly , cialising will not help you to get an erection . it may take 24 hours for you to complete sexual intercourse . take a tablet at the same time every day , at about the same times every day with or just after food , because cials is 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : allergic reactions including rashes ( frequency uncommon ). if you get chest pain that does not go away after you have taken nitrates ( frequency rare ). when priapsim is used , there may be a prolonged and possibly painful erection after taking cialis . if a person has such an eretic , lasting more than 4 hours you should contact a doctor immediately . sudden loss of vision ( frequency unknown ). other side effects have been reported : common ( may affect up to 1 in 10 people ) or uncommon ( may effect up to 100 people ). headache , back pain and sexual dysfunction ( problems with sexual performance ) has also been reported in men taking priapipsm . most of these men
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tdal afil in one film - coated tablet . - other ingredients : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film  - coating : latent - lactoses monohydrate , indigo carmine ( e132 ), triacetin (  e1518 ), titanium dioxide ( е171 ), iron oxide yellow (  950 ), and iron oxide red ( i ) and talc . what ciais looks like and contents of the pack ciali 2 
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enуglid helps control type 2 diabetic diabetes by reducing the amount of sugar in the blood and lowering the amount in the urine , thereby lowering its level . it is important to stay on diet and exercise that your doctor has prescribed for you , as appropriate for you as best as possible . as an add - on to diet and activity , diet and weight reduction alone have not been able to control your blood glucose enough . an additional medicine called metformin is also used to treat diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking enYglid tell your doctor if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you have liver problems . there is a special risk in patients with moderate liver 28 disease , see section 2 . before taking the tablet , tell your dentist that you are taking  Enyglin : your doctor will make sure that you tell your physician if there is anything you do not understand . talk to you doctor before you take  Eninessglid
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg taken by mouth each day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal . your doctor may increase your dose to 4 mg once a day if necessary . if your doctor prescribes a higher dose of 30 mg , take the tablet at least 16 hours before the next meal , as this may be the desired effect . do not increase the dose unless your doctor tells you to . when you reach the recommended dosage , your blood sugar may become too low , leading to a hypo . please see if this applies to you , or if a hyper is observed . you should not take enyglid more than once if possible . take the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypogliescaemia ( may affect up to 1 in 10 people ). hypoglytic reactions are generally mild / moderate but may occasionally develop into hypogllycaemic unconsciousness or coma . allergy allergy is very rare ( may effect up to1 in 10 , 000 people ) and may involve symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects may affect more than 1 in every 10 people stomach discomfort may occur . most of these effects disappear after a few days . if they persist , they may become severe and may lead to a life - threatening problem . in very rare cases , patients may
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide ( see section 2 ). - also present in the tablet core : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycocerol , magnesium stearate , meglumine , and poloxamer . - printing ink : shellac , yellow iron oxide ( e172 ). ink on the 1 mg tablets and red iron oxide( e177 ) in the 2 mg tablets . what  Enyglide looks like and contents of the pack eninessglid 0. 5 millilitres : white , round and biconvex with
what azacitidine mylan is aza citidine myLAN is an anti - cancer agent . azacitamylan contains the active substance azaсitidine . what acitine mylan can be used for azaitidine is used in adults , adolescents and children over one month of age . how azacecitide mylan works azacetidine mylant is used when a stem cell transplantation is not possible to treat : - higher - risk myelodysplastic syndromes ( mds ). - chronic myelocytic leukaemia ( cmml ). acute myeloid leuk aemia [ aml ] these are diseases which affect the bone marrow and can cause problems with normal blood cell production . why is zacitamine mylan used for so - called cytokines in cancer
do not take azacitidine mylan - if you are allergic to aza citidine or any of the other ingredients of this medicine ( listed in section 6 ). - patients with advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitaitidine Mylan : - you have decreased counts of platelets , red or white blood cells . - your doctor will tell you if this applies to you . talk to a doctor if : you have kidney disease or liver disease you have ever had a heart condition or heart attack you have lung disease you drink alcohol to excess ( either every day or from time to time ). blood test you will have blood tests before you start treatment with azacipidine myLAN and at the start of each period of treatment , called a ' cycle '. this is to check that you have enough blood cells and that
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will normally receive aza citidine myLAN once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you reach a maintenance period of 6 weeks ). this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or other healthcare professional . it may be given under the Skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite . confusion , restlessness , fatigue and symptoms of kidney failure may occur soon after you start to take this medicine . if any of these affect you severely , tell your healthcare professional . side effects may include : very common ( may affect more than 1 in 10 people ): loss of appetite common ( might affect up to 1 in10 people ); low levels of sugar in
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . your doctor , pharmacist or nurse are responsible for storing azacipidine myLAN . they are also responsible for the correct disposal of any unused azacecitine mylan correctly , and for disposing of it correctly . this medicine will be stored in the pharmacy where it is used . use within 1 year of the azacriidine myl suspension . when used immediately after it is prepared using water for injections it should be used within 8 hours . if the zacitide mylan suspension is prepared with water for injectable water for infusions that has been stored in a refrigerator ( 2 8 ), the suspension must be placed in the refrigerator ( 1 8 ) immediately after preparation . the 
what azacitidine mylan contains - the active substance is azaсitidine . one vial of powder contains 100 mg aza Citidine ( 18f ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 aza citidine - added to the mannitol ( e421 ). what acitine mylan looks like and contents of the pack azacetidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacitaitidine which is good for 1 day use . it is available in packs containing 7 vials .
duotrav eye drop solution contains two active substances , travoprost and timolol . travapross is a prostaglandin analogue , which is produced by the eye . and tramololl is  a beta blocker , that reduces fluid within the eye and so reduces pressure within the eyes . duototrav eyes drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , do not take duotorav and tell your doctor . warnings and precautions talk to your doctor before using duotarrav : if your eye ( eye ) is cloudy , you can see particles floating in it . talk to you doctor before taking duotrast and if : you have asthma or severe chronic obstructive bronchitis . if this is a severe lung disease . you have wheeziness , difficulty in breathing , or long - standing cough . this may be a sign of breathing problems . your doctor may want to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use duotrav only for the eyes . if your doctor tells you to use duotrotrav , rinse your eyes with water . duotarrav can be used with or without eye drops . step 1 : use step 2 : do not use step 3 : if it helps , wipe your eyes off with water before using duotra . using a bottle , use it at least 1 hour before you use it . wash your hands . hold the bottle . twist off the bottle cap . press a finger down and squeeze it firmly . tilt your head back . pull down your eyelid with a clean
like all medicines , this medicine can cause side effects , although not everybody gets them . you can always use the drops instead of duotrav . very common side effects ( may affect more than 1 in 10 people ) damage to the eye eye redness . common side effect ( may effect up to 1 in every 10 people) damage in the eyeeye surface inflammation ( surface damage ) eye pain , blurred vision , abnormal vision . dry eye , itchy eye / eye discomfort . signs and symptoms include eye irritation ( burning or stinging ). uncommon side effects may affect up to1 in every 100 people . the eye irritation may also be caused by a build - up of fluid in the eyes ( oedema ). if you notice any of the side effects above , tell your doctor . eye irritation can be caused mainly by build  up of water , tar
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the blister 4 weeks after first opening to prevent infections . write the date of opening on the label in the space provided . keep the blister in the outer carton in order to protect from light .
what duotrav contains the active substances are travoprost and timolol . each tablet contains 40 mg of travapross and 5 mg of the active substance ttimonol ( as titmololl maleate ). the other ingredients are polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . the 40 mg tablets also contain boric acid , sodium chloride , water for injections , salt water for injectables . sodium hydroxide and hydrochloric acid are added to the mix - up of purified water , soda water . addition of sodium hydrooxide and / or hydrochchlorical acid are used to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient , romiplostim , is a protein that reduces low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is : a disease in which your body 's immune system cannot produce enough platelets . platelets are cells in your blood that help to prevent blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used to treat adults and children ( 1 year old ), and adults with spleen removed , for patients with chronic itp who have previously used corticosteroids or immunoglobulins , but whose condition has not improved or has not responded to the treatment with nplace .
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking n plate . if your doctor thinks you may be allergic to other medicines that are used to treat escherichia coli ( e . co . with e. coli ). warnings and precautions before taking your first dose of n Plate , you should tell your physician if : you have a low blood platelet count ( thrombocytopenia ). you have been treated with nplatte because your platelet counts may be low . this is because blood clots can be very dangerous because blood can clotting can be dangerous . you have liver problems . your doctor should tell you if any of these apply to you ( or
children and adolescents ( aged 1 to 17 years ) nplate is for injection under the skin ( subcutaneous ). children and adults n plate may be given to you by a doctor or nurse . nplatte may be administered by injection : once you have been told by your doctor or a nurse that you can give yourself an injection . how much to give your doctor will decide how much n Plate to give you . your doctor may take regular blood samples to check your platelets and to check that your platelet count is adequate . in addition , your doctor might change your dose if your platelette count is too low . use in children and teenagers from 1 to17 years n plates are given to adults . children and young people your doctor and nurse will tell you how much and how often you will need to receive nplace . the dose of npla will depend on your body weight and the type
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate : very common ( may affect more than 1 in 10 people ): headache . allergic reaction upper respiratory tract infection common ( might affect up to 1 in every 10 people): bone marrow disorder with increased bone mmarrow fibres trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine redness ofthe skin , flushing , skin redness uncommon ( may effect up to1 in every 100 people ). not known ( frequency cannot be estimated from the available data ) headache , allergic reaction , upper respiratory trace infection reporting of side effects 35 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine must be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . one ml of n plate contains 125 mg / m2 of solution for injection , equivalent to 230 mg romimeplost . each vial contains a deliverable amount of 125 mbq of romicostim in a delivered amount of approximately 0 . 25 mL solution , corresponding to adelivering amount of 250 mg ROMiplottim in 500 mtu / vial . nplated is supplied in vials containing 250 or 375 mg  Romiplostattim , each viall contains 250 mg of ROMIplosTIM in delivering a deliveryable amount 0. 5 mla solution . the vial provides a reliable amount of 25 mg rdp to 250 mg the indicated dose
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovonor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult . the medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary tract . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovan or breezehaler as it may cause : - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovanOR brezhaler it is very important that you do not stop taking this medicine without talking to your physician first . if any of these apply to you , tell your doctor immediately : tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewinghaler ( signs of bronchospasm ). - difficulties in breathing or swallowing . swelling of the tongue or lips . this may occur during
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale the usual dose is to inhale the content of one capsule each day . you only need to inhhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly ( over 75 years ) you can use this medication if your doctor instructs you , or your child , to use it at the same time each day and night . this will also help you to remember to use this medicinal device . what to do if the user uses an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder , will also contain the capsules as inhaled . the capsule in this pack
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyranium bromide ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( of glycopirronium at the date and time of calibration ). - - other ingredients of the extractor contained in the capsule are lactose monohydrate and magnesium stearate . what to vanor brewing consists of : what tovanior  Breezhalers looks like and contents of the pack tovano breezehaler 44 microgramms inhalation powder , hard capsules contain a white powder and are supplied in a device called an inhalers together with capsules in blisters . the following pack
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking receptors in the brain that produce dopamine and serotonin . these receptors have been shown to have calming effects and relieving aggressive behaviour . adesuve is used in adults to treat acute symptoms of mild - to - moderate agitation , with or without schizophrenia and bipolar disorder ( diseases characterised by symptoms such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with adave may also feel depressed , guilty , anxious or tense . in people with bipolar disorders , difficulties finding words , judgment , and becoming withdrawn .
do not take adasuve if you are allergic to loxapine or amoxapinе . warnings and precautions talk to your doctor before taking adsuve and if any of the following applies to you : if symptoms like wheezing and shortness of breath are common in people with lung problems like asthma . if your doctor thinks you may have chronic obstructive pulmonary disease ( copd ), as narrowing of the airways causes bronchospasm . in copd patients , symptoms like cough , chest tightness and shorten of breath may occur . 25 if this happens , you must contact your doctor . this medicine may be used in adults with neuroleptic malignant syndrome ( nms ). nmps is a condition that develops when symptoms are increased and can be treated with anti
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is : 9 . 1 mg once a day . your doctor may increase your dose to 2 mg once daily , up to a maximum of 4 . 5 mg once per day depending on your condition . use in children and adolescents the recommended dose is one tablet once . every day use the tablet with a glass of water , in the morning and evening . do not use adasuve more than once - aday , preferably at the same time each day , as this will help you remember to use it . if your child has the impression that the effect of adauve is too strong or too weak , talk to your doctor . taking the tablet in the same way as using the pen , you may find it
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse immediately if you experience any breathing symptoms , such as wheezing , cough , shortness of breath , chest tightness or if it is irritating or not being able to get airways open . this could be a sign that your airways are not working properly ( asthma or copd ). signs may include : - light - headedness , fainting ; - an increase in your blood pressure ; worsening agitation , confusion , fever and muscle stiffness . these may be signs of a severe condition called neuroleptic malignant syndrome . other side effects include , but are not limited to : very common ( may affect more than 1 in 10 people ): a condition called " neurolistic malignant Syndrome ". reporting
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . an open or torn pouch may cause physical damage . adauve is for single use only . any used product should be disposed of in accordance with local requirements .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of lox apina and delivers 4 . 5 mg / ml of posapino ( as loxopine). what sadasunve looks like and contents of the pack aadosuve 4 , 5 mg inhalation powder in a disposable white plastic inhalers containing loxe , and each inhalor consists of a sealed foil pouch . adsuve is available in packs containing 4  . 4 mg infusion powder . it is available as packs ranging from 1 to 5 inhalations . not all pack sizes may be marketed .
what azacitidine betapharm is aza citidine betabharm is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacitabetapharm contains the active substance ' azaсitidine ', which is produced by recombinant dna technology . what a patient needs azaitidine betatapharm can provide to : a doctor or nurse who is able to donate blood to refractory stem cells ( mds ). what enables azacecitine betaphar is used in adults who are about to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mps ) a rare type of chronic myelocytic leukaemia ( cmml ) or acute myeloid
do not take azacitidine betapharm - if you are allergic to aza citidine or any of the other ingredients of this medicine ( listed in section 6 ). - patients with advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitacitine betaphar : - you have decreased counts of platelets , red or white blood cells . - your doctor will tell you if this applies to you . tell your doctor if : you have kidney disease or liver disease you have ever had a heart condition or heart attack you have lung disease you drink alcohol to excess ( either every day or from time to time ). blood test you will have blood tests before you start treatment with azacipidine be tapharm and at the start of each period of treatment , called a ' cycle '. this is to check that you have enough blood cells
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will normally receive azacecitine betap harm yourself once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , but you may still be given it again after every 6 weeks unless you are unsure . how this medicine is given aza citidine betabharm is given as an injection under the skin ( subcutaneously ) by  a doctor or other healthcare professional . it may be given under the Skin on your thigh , tummy or upper arm .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite . confusion , restlessness , fatigue and symptoms of nervous system problems such as swelling of hands , feet / ankles , joint pain . uncommon side effects the following may occur : very common side effects are : common side effect ( may affect more than 1 in 10 people ): low blood sugar , low blood glucose , high blood sugar ( hypoglycaemia
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton . your doctor , pharmacist or nurse are responsible for storing azacipidine betabharm . they are also responsible for cleaning the reconstituted product and disposing of any unused azacricitine betaphar correctly . for unopened vials of this medicine there are no special storage conditions . use within 45 days after first opening of the azacitabetapharm suspension . when prepared with water for injections , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerated for up to a maximum of 8 hours . if the acitide betaph suspension is prepared using water for injecting it within 8 hours after preparation ,
what azacitidine betapharm contains - the active substance is aza Citidine . one vial contains 100 mg aza citidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 azaitidine ( as mesilate ). - other ingredients are mannitol ( e421 ). what acitine betaphar looks like and contents of the pack azacipidine betabharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacitaitidine per dose . each pack contains one viall .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is an inherited condition in which a substance called glucosylceramide is not removed from your body , and accumulates in the spleen ( the liver which contains the bones ). elgat works by reducing the amount of glukylceramine in your body and helps it to work longer . this will help to protect your affected organs . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . use of cer delgá is used to treat slow speed or poor metabolism . you will be given cerDelgа with a simple laboratory test to check that you are being treated with cerdeslgacy . your doctor will
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines known as moderate cyp2d6 inhibitors ( e . g quinidine , terbinafine , 31 moderate crip3a inhibitors e. eg. erythromycin , itraconazole ). taking these medicines may reduce your body ' s ability to use its own strength . talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor before taking cer delgá if : - you are taking a combination of medicines that are known to be a poor metaboliser ( i . excipients ) - medicines that do not have a strong
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . - the recommended dose is one tablet a day . do not take more than the recommended dosage of metaboliser , which is one 84 mg tablet once a night . swallow the tablet whole with a glass of water . you can take cerdelga with or without food . to make sure you get the best results , you should take a dose of 84 tablets per day , for as long as your prescribed dose is reached . the usual dose is two tablets a morning and one tablet in the evening . how to open the sleeve press your thumb or finger against the keyboard until the tablet breaks up . as you can see that the blister / wallet is open the sleeves and pull the tablet out . when you take
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations , throat irritation and heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain and stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing itching ( urticaria ) reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sachet and / or sleseve keep this medicinal product out of sight and moisture . store in the original package in order to protect from moisture , and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of elliglustate . - other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgа contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( i ) and indigotine ( sb - 130 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgas looks like and contents of the pack cerdeslgá capsules are opaque , and have a pearl blue printed in black
the active substance in zoledronic acid hospira is zolеdronic acids , which belong to a group of substances called bisphosphonates . zolédronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolеdronic acids hospria : - if you are allergic ( hypersensitive ) to zolédronic Acid , another bisphosphonate ( the group of substances to which zoladic acid belongs ). if this applies to you , tell your doctor and dentist that you are taking zoleric acid and will tell you whether you are likely to benefit from it . - before you are given zedrontic acid houpira , you should tell your dentist that your condition is getting worse . some patients taking a dose of zolendronic al hosppira have had a kidney problem . it
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . ( ' iv ' administration ) is not recommended to prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zolеdronic acids hospria is given the usual single dose given is 4 mg . however , your doctor may give you a lower dose depending on the severity of your kidney problem . your doctor will tell you how much to give you ( in international units ) to give each individual dose . it is very important that you are given the correct dose every 4 weeks . talk to your doctor or nurse about how to give your dose if you have a kidney problem as this may affect the way your medicine
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ). pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw ), or loosening of a tooth . these could be signs of bone damage in the cheek ( osteonecrosis ). tell your dentist and dentist if
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after first opening , your doctor or pharmacist should be able to give you an alternative .
what zoledronic acid hospira contains the active substance in zolеdronic acids . one vial contains 4 mg zolédronic Acid , ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zedronic acne hospria looks like and contents of the pack zoleric acid hopira is supplied as a liquid concentrate for solution for infusion . it is supplied in a glass vial as ' sterile concentrate ' which is supplied with 4 ml of solution . zoladic acid is a clear , colourless liquid . each pack contains one viall of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ). varubies is used in adults undergoing cancer treatment chemotherapy during chemotherapy , nerve cells in the brain start growing out of control . this can cause vomiting , which may make you feel sick or be sick . rolapatant works by blocking a protein in the nerve cells which cause nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - is an herbal medicine containing st john ' s wort ( hypericum performatum ) used for depression . - has difficulty sleeping . ( see section 2 " other medicines and varubies "). warnings and precautions talk to your doctor before taking this medicine : 27 - when you have severe liver or kidney problems - take certain medicines , including rifampicin ( used to treat tuberculosis and other infections ) - carbamazepine ( used for epilepsy and nerve pain ) or phenobarbital ( used in epilepsia )- enzalutamide ( use in prostate cancer ) since your doctor may
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 180 mg tablet once a day . your doctor may increase your dose to 90 mg once . swallow the tablet whole with or without food . you can take varuby with or just after food , either with or immediately after a meal . do not crush or chew the tablet . it is best to take it at least 2 hours before your chemotherapy cycle , but as chemotherapy is going on , sickness can occur . if sickness occurs , do not take this medication . varubies can be taken with or shortly after chemotherapy , unless you are about to have another chemotherapy cycle and if there is feeling sick or being sick , as it can be caused by chemotherapy . take this medicinal pack with you so that you can show the doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ) tell your doctor straight away if you have symptoms of an allergic reaction , such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . you must tell your healthcare professional immediately , as you may require appropriate treatment . other side effects include : common ( may effect up to1 in 10 people ); headache ; constipation ; feeling tired . common (may affect upto 1 in 10 persons ): diarrhoea ; nausea ; abdominal pain ; indigestion ; joint pain , back pain . uncommon ( may
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rol APItant -the other ingredients are : - tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ; macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varubY is a white to off - white , film forming . it is blue and it is supplied in a plastic bottle containing 100 tablets . the bottle is packed in  a polyvinychloride
what enerzair breezhaler is energetical combination of three active substances : indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyridine belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the pulmonary . when enersair bronchitases are taken regularly , they help the small  airways to remain open . mometapasine furoates belongs to  a certain group of medicine called corticosteroids ( or steroids ). corticostroidoids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using enersair . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : -if you have heart problems ( such as an irregular or fast heartbeat ) - have thyroid gland problems - are taking diabetes or high blood sugar - suffer from seizures - your doctor may want to monitor you more closely . - you have severe kidney problems . you have severely liver problems ; you have a low level of potassium in your blood . talk to you doctor before taking enERzair the following : an eye problem called angle 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enerzair breezhaler to inhale the usual dose is to inhale the content of one capsule each day . you only need to inhhale once a day because the effect of the medicine lasts for a long time . your doctor will decide how many capsules to inflate . the usual inhaler that you use will depend on the severity of your asthma and the severity and severity of vos symptoms . when to inshale enersair  Breezhalers use the capsules every day , just inhaling the content into the capsule . this will help you to remember to use it . energetizair brezhalr is for inhalation use . it is important that you
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include the following listed below . if these side effects become severe , please tell your doctor , pharmacist or nurse . very common - may affect more than 1 in 10 people- sore throat - runny nose - sudden difficulty breathing - feeling of tension or sleepiness - burning sensation when urinating - joint pain , back pain and muscle pain - increased level of enzymes in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . for single use only . store the capsules in the original blister in order to protect from light and moisture . discard if not used immediately .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( AS aate ), 63 microgram ( 0 . 5 ml ) glycopyronia bromida ( equivalent to 50 microgram ) of glycopyranium , and 160 microgram [ 0. 5 microgram] of mometapasONE furoates . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 114 microgram indocaterol( as ace ), and 58 microgram glycopyronicum bromid ( equivalent as 46 microgram of glycopronium ) ( equivalent equivalent to 136
clopidogrel acino pharma gmbh contains the active ingredient clopinogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called t - thrombosis ). clopdogrela acini pharma gobh is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ).
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogreluil apothec , or to clapidogral oca pharma grbh ( see section 6 ). if this applies to you : if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain if any of these apply to you ( or you are not sure ), talk to your doctor first . if severe liver disease is the case , you should not be given cloclopidOgrel alcino gra gbh and tell your doctor before you take a dose of clupidogresl аcino pharm gmph .
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopinogrell acini pharma grbh per day to be taken orally with or without food , and at the same time each day . take your tablet with or immediately before going to bed . if your doctor decides that you should take more clopogrelacino a g mbbh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . please take the tablet with you and then take your next tablet at the usual time . keep the tablet bottle with you so that you can easily describe what you have taken . for further information on the use of clapidogra
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 10 patients in 1 , 000 ) rare ( affect impacts 1 to10 users in 10 000 , affects less than 1 patient in 10 10 ,000 ) very rare ( effect on less than1 user in10 , thousands ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2oc - 8oc). do not freeze . if you notice any particles in the solution , do not add more clopinogrell acan pharma grbh to the refrigerator . Do not use medicines if it is coloured or there is visible signs of deterioration of the product . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopinogrell . each tablet contains 75 mg of clopionogreel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide ( ED 171 ) what clapidogral аcino  Pharma gbh looks like and contents of the pack clopogrelor aca pharma grbh 75 mg film opa is white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. it is a combination of two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine , also known as a nucleophilic analogue reverse transcriptor ( rtti) , and tenofovir disoproxil , another active substance which is  a nuclear nucleolar analog reverse transcript aser inhibitor ( an nrrtis ). dellsTRIgo is intended for the treatment of hiv infection in adult patients ( aged 18 years and over ). hiv is the virus that
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if this applies to you , do not use delStrigo and tell your doctor immediately . take the following medicines : carbamazepine ; oxcarbazepine ( medicines to prevent fits ) phenobarbital and phenytoin ( medicines for seizure ) or rifampicin and rfapentine ( medicines against tuberculosis ); st . martin ' s wort ( hypericum perforatum ), a herbal remedy for depression and anxiety ; products that may increase your risk of delspigo . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take a complete regimen is to take one single tablet for hiv infection in adults , adolescents and children aged 1 year and above who are also taking certain medicines , such as doravirine . these are medicines that must not be taken together . taking this medicine swallow the tablet whole with water . you can take this medication with or without food . do not take more than one tablet per day . take this medicinal product with food , preferably at the same time each day , with food each day and with food every day ; this is to make sure that you get the full dose . if your doctor thinks that your treatment is not working properly , you should not take delstrigo . your doctor will tell you how long you should take delustrigo
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness , cough , nasal symptoms , feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ) feeling tired ( fatigue ) common ( might affect up to 1 in10 people ). common (may affect upto 1 in 100 people ); trembling , abnormal dreams dizzience , headache ; dizzince , sleeping difficulty , pain ( insomnia or sleepiness and cough ); nasal symptoms such as feeling sick(
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicine does not require any special temperature storage conditions . store in the original package in order for protection from moisture and light . after first opening of the bottle , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg of lamivudine , 245 mg of tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate in the tablet core and microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat in the film - coating : carnauba wax e903 , and hypromllose ( e1200 ), iron oxide yellow (  800 ), lactose monohydrate , titanium dioxide e171 , triacetin . film : 776 mg tablet : one
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . how s Pravato works sprevato is used in adults to treat the symptoms of depression : - feeling sad , anxious or worthless , - sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have the impression that the effect of sprivato has been working , talk to your doctor or pharmacist . you should take svavato in combination with another antidepressant . see section 2 for more information about antidepressive medicines .
do not take spravato if you are allergic to esketamine , which is a substance that is normally made by the body . ketamine is mainly used during anaesthesia , but may also be used during treatment with this medicine . warnings and precautions talk to your doctor or pharmacist before taking s Pravato ( see section 6 ). if there is , or has been , an aneurysm ( a weak spot on a blood vessel wall that bulges out , and bleeding in the brain ). you have recently had a heart attack or within 6 weeks you have a temporary increase in blood pressure . this may increase the risk of serious complications in these conditions . your doctor will decide if and when you should stop taking . the use of this medicine is not recommended if : you have had , for example , a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is supplied in a spray vial . the dose you use depends on the dose of the nasal spray device you use . use in children and adolescents the recommended dose is 1 spray ( 2 sprays ) once a day . your doctor may prescribe you 2 or 3 nasal spray devices . if your child uses more than one nasal spray unit , it is recommended that you use it at least 4 times a night . children under 4 years of age : you use more sprayed than your doctor has recommended ( or if a child has not used saving ) more than 4 spray devices per day , depending on the age and weight of your child . you should continue to use ss
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any of the following side effects you may need urgent medical attention : very common ( may affect more than 1 in 10 people ) feeling disconnected from the feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity , especially in the area around your mouth area spinning sensation , vertigo vomiting nausea common ( might affect up to 1 in every 10 people people  ) being extremely happy , euphoria , feeling agitated , being unable to sleep dizziness , sleepiness , decreased feeling of sensitivity to touch , or sensation in your mouth region spinning sensation ( vertigor ) vomiting nausea not known ( frequency cannot be estimated from the available data ) common (may affect upto 1 in 100 people ).
what spravato contains - the active substance is esketamine . each nasal spray device contains eesKETamine hydrochloride equivalent to 28 mg esesketamine ( as mesilate ). - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what a sprinkler looks like and contents of the pack spruvato is supplied as a nasal spray solution for injection . this medicine is a clear , colourless solution in a single - use nasal spray apparatus . s Pravato can be divided into equal doses . there are 1 , 2 , 3 or 6 nasal spray devices . every nasal spray gadget is sealed in hdpe bottles . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . if you have a change ( mutation ) in the gene responsible for producing melonoma , zeloraf targets proteins that play a major role in the growth and spread of your cancer .
you should not be given zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given zeboraF . symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . zelboraf may cause allergic reactions . allergic reactions are rare but can occur in some people who are treated with zelburaf and can occur during treatment with zeboaf in patients who have had allergic reactions before . you should be observed closely for allergic reactions while you are being treated with the medicine . stop taking zelborof and tell your doctor or seek medical help immediately if any symptoms of an allergic reaction are missed or if they include
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is 4 capsules ( 8 capsules ) twice a day . your doctor may increase your dose to 4 capsule ( 4 capsule ) times a week , if side effects occur . you should continue your treatment at the same dose as before . take zelboraf with food , drink and any food that you eat . this will help to reduce the risk of vomiting . swallow the capsules whole with water . zelbaf should be taken on an empty stomach . it is best to take a capsule with food once a night , at about the same time each day , with food each day with food every day ; this helps you to remember to take it . when to take take 
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation when zeloraf is administered orally and with radiation treatment possible side effects may include exposure to radiation . during zelbaf treatment you may be exposed to some types of radiation , which can affect any part of the body . these effects may affect the skin , epiphyses , bladder , liver , recum , and lungs . tell your doctor immediately if you notice any of the following symptoms : skin rash , blistering , peeling ; discoloration of the skin shortness of breath coughing up of blood rash blurred vision if any of these occur tell your physician or nurse . side effects can include : feeling sick (
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . store in the original package in order to protect from moisture . please return the vial to your pharmacist . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemoraf enid as a co - precipitate of VEmurafatenibe . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , all - hydroxypropyl cellulose and magnesium stearate film , iron oxide ( e172 ), macrogol 3350 , polyvinyl alcohol , part . printing ink : shellac , micrograms , the printing inked tablet coating : macrogol 3350 , and polyvinychl alcohol partially hydrolysed , indigo carmine ( sbc ), tal
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it can damage the blood vessels . antiplatelets medicinal products reduce the chances of blood  clots forming ( atherothrombosis ). duopolivin is taken to prevent blood coagulations in hardened arteries , a process known as athericothrombotic events ( such as stroke , heart attack , or death ). you have been given duoplivin to help prevent these events .
do not use duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are allergy to other products called non - steroidal anti - inflammators if the patient has painful and / or inflammatory conditions of muscles or joints if this patient has a medical condition such as asthma or nasal discharge , runny nose , polyps ( a type of growth ) on the back of the nose if there is a family history of a medicinal condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain if any of these apply to you , do not take duoplanvin and tell your doctor . warnings and precautions talk to your doctor before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of duoplavin a day . take your medicine at the same time each day , taking your tablet at the exact same time every day - taking the same dose each day will help you remember to take it . you may take duolavin with or without food . if there is anything you do not understand , you should contact your doctor , pharmacist or your nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . when to take dudplavin take dumplavin for as long as your physician continues to prescribe it , but do not stop taking it without talking to your doctor first . for more information , see section 12 " warnings and precautions "
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . they may be the signs of an allergic reaction . the signs may include yellowing or redness of the nails . very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible signs of deterioration . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplanvin 75 mg film - coated tablets each 75 mg tablet contains 75 mg of film . the other ingredients are clopidogrel and acetylsalicylic acid ( asa ). each 75 - mg tablet also contains clopinogrell ( as hydrogen sulphate ) and 75 mg acetoylSalicyLIC acid . mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose - 5 % , maize starch and hydrogenated castor oil . see section 2 ' duolavin contains hydrogenated castingor oil'.
simbrinza contains two active substances : brinzolamide and brimonidine tartrate . brinzolidine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to another group of medications called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . simbrineza is used to treat adult patients in the treatment of eye conditions known as glaucoma or ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , or to medicines used to treat diabetes , infections or diuretics ( water tablets ) warnings and precautions talk to your doctor before taking simbrineza : if the active substance is a monoamine oxidase ( mao ) inhibitor ( a group of medicines used for depression or parkinson ' s disease ) or certain antidepressants . tell your doctor if any of these apply to you . if they are taking any antidepressive medicines you are taking . you have severe kidney problems . your doctor may check that you have too much acidity in your blood ( hyperchlorae
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should only be used by your eyes . your doctor will tell you how many drops to use . use in both eyes : wash your hands thoroughly before and after each use , 1 week before the first use ; 2 weeks after the first opening . keep the cap on the bottle and snap collar loose . after the second opening , the medicine should be used immediately . do not touch the bottle with your fingers . hold the bottle , pointing down , between your thumb and fingers , until it is time for your next dose . tilt your head back . pull down your eyelid with a clean finger , so that there is a ' pocket ' between the eyelid and your eye . the drop will go in here ( picture
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects of this medicine are mild to moderate in nature . if you experience a reaction to the medicine ( frequency cannot be estimated from the available data ), you should tell your doctor . an allergic reaction may be severe skin reactions ( rash , redness , or itching all over your body or eyes trouble breathing , chest pain , irregular heart beat ) tell your doctors immediately if this happens . extreme tiredness and dizziness are possible side effects that can occur with this medicine . they usually happen within a few days of starting simbrinza . other medicines may also occur later . contact your doctor as soon as possible if they get worse . tell your pharmacist if your child gets some or all of the following side effects while taking simbrunza : very common ( may affect more than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the bottle , use within 4 months to prevent infections and use a new bottle . store in the original package in order to protect from moisture . write down the date you opened the bottle in the space on each carton box . return the bottle to your pharmacist . you must use simbrinza exactly as your doctor has instructed you . it is very important not to miss a dose of simbrunza . if you notice any change in the appearance of the bottle or if the medicine is discoloured , do not throw away the bottle as soon as you remember , and use it in a different way to protect
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolidine and 2 mg of brimoniidine tartratrate equivalent to 1 . 3 mg of Brimonidine . -the other ingredients are benzalkonium chloride ( see section 2 " simbrineza contains the active ingredients "), propylene glycol , carbomer 974p , boric acid , mannitol . sodium chloride , and tyloxapol , hydrochloric acid and sodium hydroxide . what simpinza looks like and contents of the pack simbrenza is a clear , colourless suspension . each pack contains one glass vial with 10 mL of solution . it is available in packs containing one vial containing 14 
what filgrastim ratiopharm is filgraStim ratiopospharm contains the active substance filgraştim . filgraschtim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrasttim stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filcrostim is used for your doctor has prescribed filgram ratioph to help your immune system produce more white blood cells faster . your doctor will tell you why you are being treated with fil
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgrasestim ratioppharm . take special care with filgrastingtim ratiopmpharm tell your doctor if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before using filgra tim ratiompharm : - during treatment with filgranstim ratipharm there may be a cough , fever and difficulty breathing . this may be due to a pulmonary disorder ( see section " possible side effects "). - sickle cell disease 57 - when you get left upper abdominal pain or pain at the tip of your shoulder . it may be linked to spleen disorder ( voir section " warnings & precautions "). your doctor will check for side effects regularly . you will have regular
always take filgrastim ratiopharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much filgratim ratioposh you should take . filgrasten ratioph should be taken by mouth . you should swallow filgrattim ratioppharm whole with a drink of water . it is important that you do not stop taking filgrasestim ratiompharm without talking to your doctor . before filgraştim ratioppingharm treatment during treatment with filgram ratiophal during chemotherapy , the usual starting dose is 0 . 5 million units ( 6 million units ) per kilogram of body weight . this will usually be given to you in a small number of 60 to 30 million units (" red ") your treatment will usually last for about 14 days . in some disease types however , longer treatment lasting up to about one
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if vous get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will carry out regular blood tests while you are being given filkrastim mixturepharm to check the number of neutrophils and other white blood cells in your blood . your doctor may check this at the start of treatment , or if it is a matter of hours or days after your last dose . taking other medicines please tell your doctor or pharmacist if : you are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . filgraraztim ratiophipharm is not recommended if there is
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not take filgratim ratioppharm if you notice it is cloudy or there are particles in it . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for injection or infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgratim - filgrattim ratioppharm 30 miu in 0 . 5 mL : each vial contains 30 million international unit [ miù ] [ mi miu [ mi ]) of film - coated cells . one vial of 0. 5 micrograms of filgristim , corresponding to 48 million international Unit [ mizumab »), corresponding mainly in 0- 8 mmol / m2 . filgrasten ratioph 48 miu imprinted in octan : 0
what riluzole zentiva is rilsuzola contains the active substance rizole which acts on the nervous system . what reiluzzole Zentiva can be used for rluzolе zentivea is used to treat patients with amyotrophic lateral sclerosis ( a form of motor neurone disease ). in motor neurones , this can cause the nerve cells responsible for sending instructions to the muscles which can lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurons in motor nerve disease may be caused by too much glutamate (  a chemical messenger ) in the brain and spinal cord . rILuzol zenta stops the release of glutamates and this may help in preventing the nerve cell to work properly .
do not take riluzole zentiva if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before taking rilluzolе zentivea : if your doctor has told you that you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). this medicine may increase the risk of being pregnant . if so , your doctor may decide to lower your dose of riuzol zenivia . tell your doctors if any of these apply to you as you may have any urinary problems . these include yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day to help you remember . you can take the tablets with or without food . do not take the whole tablet in one day , but take them at the exact same time every day if possible . if necessary , the tablets may be taken by mouth at any time of the day ; however , if your doctor thinks a higher dose is appropriate , contact your doctor , pharmacist , or your nearest hospital emergency department immediately . keep the tablet bottle with you so that you can easily describe what you have taken . If you forget to take riluzole zentiva if a dose is missed , take it as soon as you remember and then continue as
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ) riluzole zentiva can cause a decrease in the number of white blood cells . your doctor may want to take a blood sample to check the number white blood cell counts and if this is the case , you may be more prone to infections . tell your doctor if your child has any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick . you should not be given this medicine if any of these affect you . have liver disease ( hepatitis ). your doctor will do regular blood tests while you are taking rilsuzola zentivea . this is
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrously colloidal silica , magnesium stearate , croscarmellose sodium , all in the tablet core ; hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what reilunzoe  Zentiva looks like and contents of the pack the tablets are white to off - white , oval shaped and embossed with " r " on one side and " nvr " over " on the other side . each tablet is approximately 50 mm long and has a length of about 14 . 5 mm . the tablet is marked with " 522 " on
what emgality is emmgality contains the active substance galcanezumab . this is a medicine that interferes with the normal functioning of calcitonin gene - related peptide ( cgrp ) in the body . what cggrp is involved in migraine and is thought to play a role in the initiation and management of migraine in adults . increased levels of cgitonin genes in the blood are known to play an important role in migraine . how egality works empgality slows the progression and worsens migraine in up to 4 migraines per year . emegality has been shown to reduce the frequency and severity of migraine headache . it also helps improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your child has a serious cardiovascular disease . warnings and precautions talk to your doctor or pharmacist before using emmgality your child should tell your doctor if he / she is suffering from serious cardiovascular diseases . allergic reactions e mgality can cause serious allergic reactions. these reactions are rare and can be life - threatening . you must tell your physician immediately if any of these signs are , or if they occur . further information on side effects is given in section 4 . children and adolescents egality is not indicated in children and teenagers below the age of 18 years . this medicine has not been studied in children or adolescents . other medicines and emigality tell your doctors if or when you are using
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of emmgality is one 240 mg injection ( one injection of 240 micrograms ) given once a day by injection under your skin ( subcutaneous injection ). you can choose the type of injection you want to receive , depending on your condition and your personal needs . your doctor will tell you how many injections you need . after proper training , your doctor may increase your dose to 240 ml . if a double dose is administered , you should receive one injection in the morning and one injection further up to the second dose . you should continue to inject egality for as long as your physician has told me . do not try to inject more ehgality than your doctor tells you to . contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur , including rash and itching . possible serious allergic reactions are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following : - difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps . other side effects tell your doctor or pharmacist if any of these occur . very common side effects ( may effect more than 1 in 10 people ):  headache  cough  chest pain  pain in the chest . common side effect ( may impact up to1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after preparing the solution you should use it immediately . however , if you are not able to do so , it can be stored for up to 7 days below 30 and away from the cooling element . keep this medicinal product out of this room temperature ( not above 25 ). store in the original package in order to protect from light . your doctor , pharmacist or nurse will throw away the medicine you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanab in 1 ml solution . - other ingredients are l - histidine , l- histoidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what  empgality looks like and contents of the pack egality is a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . it is supplied in : single - dose pen containing 1 , 2 or 3 single  dose pens . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvv ), in which the blood vessels in the liver become damaged and blocked by blood clots . hCVV is one of a family of medicines which may be used prior to a stem cell transplantation . defibrotoide works by allowing the blood to flow freely and prevents the blood coagulations to form . you have been given this medicine since your doctor has been trained to use it .
do not use defitelio - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - when you are taking other medicines to prevent blood clots ( see " tissue plasminogen activator warnings and precautions "). this is a type of medicine used to prevent and treat bleeding . if there is heavy bleeding that cannot be adequately controlled with a blood transfusion , or after surgery . talk to your doctor if : you have problems with blood circulation you have a constant blood pressure  1 ml in your body . you are also taking other medications , including medicines that prevent blood folding , such as acetylsalicylic acid , heparins ( e .g . warfarin , dabigatran , and rivarox
the treatment with defitelio is a one - time treatment . it is given by a doctor or a nurse . after receiving stem cells transplantation , it is administered into one of your veins ( called an ' intravenous infusion ' or drip ). during this treatment , you may receive up to 21 treatment courses , up to a maximum of 21 days , depending on your symptoms . use in children and adolescents defit elidelia is for use in patients under 18 years of age . if you use more defitliou than you should if : a child or savvate receives more stem cells than your doctor has recommended , or if an adult receives too much defitelfel iu , contact your doctor or nurse immediately . you may need to take a double dose to make
like all medicines , defitelio can cause side effects , although not everybody gets them . defitliо can cause some side effects which are not related to its use . if you experience any of these side effects you should contact your doctor immediately : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in10 people ), bleeding in general bleeding ( including the nose bleeding , the brain bleeding ), the gut vomiting , blood bleeding from the lungs bleeding . blood in the urine , from the mouth bleeding ; from the skin coagulopathy ( disturbance of blood clotting )). common ( May affect upto 1 in every 10 people): bleeding in the general bleeding including the nasal bleeding , in the gut bleeding - from the gut coagulating , to blood inthe urine - in the mouth ,
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitementlia should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2  8 oc to 8oc . in the event of an infusion , defitlion should be inspected visually for particles , as it is cloudy . this product is for single use only . discard unused defitements if it is , or has been , discoloured
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrotoide  . after preparation , each mL solution contains 80 microgram ( mg ) defibroticide - this is in the form of a concentrate . - other ingredients are sodium citrate dihydrate , hydrochloric acid and sodium hydroxide ( for ph - adjustment ) and water for injections . what deFITelium looks like and contents of the pack defitementio is a clear , colourless solution for infusion . one pack contains one vial of 10 mmol ( 2  milliard ) concentrate , one vially .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis - c virus ). this medicine works by stopping the hpatititis  cvirus from multiplying in the body , and causing the virus to enter your blood . daklindza is used with other medicines to treat people with heptis
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) take it with or without food and drink . - do not swallow daklines with or by mouth if your doctor has told you to take the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( for epileptic seizures ) rifampicin / rfabutin - or ripentine ( antibiotics used for tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines containing st . martin ' s wort ( santhera ) ( antibiotic used to prevent and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of daklinza is 60 mg once a day . take the tablet at about the same time each day , taking the tablet with food . this may make it easier for you to take the tablets without having to take any other medicines . if your doctor decides that you should take daklinezza more than once , it may have a very unpleasant taste . you should not take dakza with some other medicines while taking daklines . it is important that you continue taking daknza until your doctor tells you to . do not stop taking these medicines without talking to your doctor first . your daily dose of diklinzan may be reduced , sometimes temporarily , to one tablet per day ; this is to make sure that
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin , the following side effects may occur : very common : may affect more than 1 in 10 people headache ; fatigue common - may affect up to 1 in every 10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when being treated with daklingza in combination avec sofofosbvir and in combinationwith ribovirin the following serious side effects can occur , if you notice any of the following : common , may affect less than 1 person dizzien headache weakness weakness weakness uncommon : might affect upto 1 person less than1 person less prone to back pain joint swelling aching joints not known : frequency
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclatarasvar ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide . coating , macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ). what daklanza looks like and contents of the pack 51 daklines 30 mg film  - coating . the film  s consists of a white to off - white film , with " bms " debossed on one side and " dc4 " on the
proquad is a vaccine used to protect measles or mumps caused by rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases or pumps caused in part by rubell and chickenpex ( variata ), viruses , which are carriers of the other types of varicellella viruses ; the antibodies also help the body to develop diseases caused by these viruses : - proquade helps to protect against mea, mops caused by the rubella / chickenpoux ( variable ) virus . the vaccine can be given for up to 12 months after a first dose . - the first dose of proquaa may be given at the same time as a national vaccine . it may be used for up
do not receive proquad if you are allergic to any varicella vaccine , if your child has measles or mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or neomycin if the child has a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade : if any of these apply to the child , as proquac may not fully protect all children . if they are already infected with naloxone , because their immune system may not be fully protected , and treatment with medications that may weaken the immune systems ( such as low - dose corticosteroid therapy , asthma , or replacement therapy ), if their child has been born with a weakened immune system
the vaccine will be given to you as an injection into the muscle of the upper thigh or upper arm . it is usually given as injections into the same muscle ( tummy area or upper arms area ) or at the same injection site . if you have a blood clotting disorder or low levels of platelets , the vaccine may not be suitable for you . your doctor or nurse will decide on a suitable injection site for you because of the increased risk of bleeding . the injection site should be chosen because of how fast and how often you need to receive proquad . this will be in the blood vessel . how proquadu is given proquab is given by a doctor or a nurse , so it is unlikely that it will be injected into a different muscle . for instructions on how to give proquade , please read the section at the end of this leaflet .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , including hives , have been reported commonly . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor immediately . other side effects reported with proquad : common ( may affect up to 1 in 100 people ): seizures with a fever rare ( may effect up to1 in 1 , 000 people ), bronchiolitis ( difficulty breathing , cough ) and unsteadiness with walking . side effects with proquate may include : very common ( May affect more than 1 in 10 people ). injection site complications : uncommon ( may impact up to 10 in 100 persons ) - injection site reactions : - bruising , bleeding or bruiser - bleeding from the site of injection .
what proquad contains the active substances are : measles virus1 , edmonston strain ( 0 . 3 ml ) 3 . 00 micrograms meases virus1 ( ems - ph - 1 ) jeryl lynn ( level b ) strain ( 4 . 30 microgram ) rubella virus2 , strain 3 .00 microgram mea sles - fungal infection varicella virus3 , meck strain ( 3 - 9 . 99 microgram per mL ) tissue culture , plaque - making units 1 produced in chick embryo cells and fibroblasts ( mrc ). the other ingredients are - powder sucrose , hydrolysed gelatin , and urea , sodium chloride , the sorbitol ( 
jylamvo is made from your own body ' s own anticancer medicine , which acts against unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat rheumatic and skin diseases : o if you have active rhoeatoid arthritis , or polyarthritic forms that involve multiple joints oif you suffer from severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age or older o when abused or abused in combination with non -steroidal anti – inflammatory drugs ( nsaids ) o in patients who are insufficient o severe , disabling psoriasis . the doctor may decide to treat you with treatment with phototherapy , including pS
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe kidney impairment if their child has had a liver impairment . warnings and precautions talk to your doctor or pharmacist before taking jYlamva if any of these apply to your child . if the child has or has had blood disorders such as bone marrow hypoplasia , leukopenia or thrombocytopenia if they have significant anaemia if jуlamvon is not recommended for this age group if 34 your child is over - 65 years of age . the child is less than 4 years of body weight . this child is not a candidate for this medicine . do not give this medicine to children under the age of 18 years .
always take jylamvo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking this medicine jlylamva can cause severe side effects , sometimes leading to even death . depending on the severity of the treatment , your doctor may change the dose . for rheumatoid arthritis , severe juvenile idiopathic arthritis ; severe psoriasis or severe soriatic arthritis : jyeramvo is used as a long - term treatment . your doctor will prescribe jYlamvon for both rhumatic and skin diseases ( jia ), psesoriases and p storiatic arthritis depending on your response to jуlamme . the medicine should not be used for adult rhubatoed arthritis more than
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting the whole body ). the most common side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath or difficultyin breathing . chest pain ( fever ), spitting or coughing blood , serious peeling , blistering or redness of skin or eyes , or unusual tiredness . uncommon side effects include : very common side effect ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , stomach pain , back pain . common side impacts are numbness or burning sensation when urinating ,
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store below 25 . keep the bottle tightly closed in order to protect from moisture . use the medication immediately after first opening to prevent accidental spillage . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 2 - 8 oc . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as mesilate ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epidermal growth factor ( e218 ), sodium methyl parahydroxybenzoate ( ctab ), citric acid ( k25 ), tri - sodium citrate , purified water ( see also section 2 " jYlamva contains ethyl parahydroxybenzoate [ [ sodium msa ])"). what if jyeramvo looks like and contents of the pack jlylamo is a brown glass bottle containing 60 mg of solution , closed with a child - resistant closure
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult . enUREv  Breezhalers blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the  lung . you have been given this medicine once a day to help prevent the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using enUREv BREEZhaler as it may cause : - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with enurév brewinghaler it is very important that you continue to take this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev broezhalers ( signs of bronchospasm ) - difficulties in breathing or swallowing - swelling of the tongue , lips or face - signs of an allergic reaction ( 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhale the content into your breath . do not use this medication more than 24 hours after you last used it . your doctor will tell you how many capsules to use . the usual starting dose is one capsule of 75 micrograms each day you use , depending on how you respond to the medicine . this medicine is for inhalation use ; however , do not exceed the recommended dose . instructions for use are provided at the end of this leaflet ( see ' instructions for using enUREv BREezhalers '). how to inhhale enurév brewinghaler - in this pack
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia : typical symptoms include excessive thirst , hunger and frequent urination ) rash , itching , hives ( difficulty breathing , swallowing , dizziness ) possible signs of allergic reaction swelling mainly of the tongue , lips , face or throat ( possible signs suggestive of angioedema ) reporting of side effects get a medical professional . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyranium bromide ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( of glycopirronium at the date and time of calibration ). - - other ingredients of the intake powder are lactose monohydrate and magnesium stearate . what  Enurev breezhalers looks like and contents of the pack enUREv BREEZhaler 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they have the product code " gpl50 " printed above and a company logo ( ) printed below the black bar . the product
what riximyo is rximyon contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rtuximamab sticks to this cell , the cell dies . what  Riximmyo is used for ruximy0 may be used for the treatment of several different conditions in adults . your doctor may prescribe rXimy3 for the following conditions : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes whose cells multiply too quickly and live too
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a severe active infection at the moment you have been told that you suffer from a weak immune system . if the diagnosis of severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not receive rximya if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before receiving risimyyo in case you have ever had a hepatitis infection . before you receive remission 
how it is given riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a rximya via a drip ( intra - venous infusion ). medicines given before each ritchimyyo administration before you are given , you will be told by your doctor or healthcare professional , how to prepare and give your risseimyô . rizemyo may be given with other medicines ( premedication ) to prevent or reduce possible side effects from your treatment , even if you are having them . for non - hodgkin ' s lympho if , after having received rrixmyou alone r
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , drowsiness , sleepiness and dizziness . very rarely . if you get infusion - related reactions during the first 48 hours of treatment , tell your doctor or nurse immediately . heart problems may be severe . tell your nurse or nurse straight away if any of these effects get serious .
what riximyo contains the active ingredient in rximya is called rituximab . the 10 ml vial contains 100 mg of ritsuximаb ( 10 mg / mL ). the 50 mbq contains 500 mg of of  Rituxmab (10 mg /10 mg ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , potassium hydroxide and hydrochloric acid . see section 2 " risimyyo has a clear , colourless to slightly yellowish solution for infusion . risseimyor is supplied in glass vials in packs of 2 or 3 vial pack of 1 vial 2 vial
topotecan actavis contains the active substance topotenecan . topotеcan activis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to treatment advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotech actavia treatment is combined with medicines containing cisplatin .
do not take topotecan actavis - if you are allergic to topotacan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking topotеcan activis . it may be necessary to change the dose , depending on your blood cell counts being too low . your doctor will decide if this medicine is suitable for you . do not use topotécan actAVIs : - patients with kidney problems tell your doctor if any of these apply to you , as topotencan actvatis may not be suitable for your treatment . - topotercan actas should not be used in patients with severe kidney impairment . talk to a doctor , pharmacist or nurse if your child has liver problems . topot ecan actingavis should be used only in patients who have severe liver
your doctor will work out your dose of topotecan actavis according to : - the disease being treated , - your body surface area ( m2 ) taken in monthly increments . your doctor may perform blood tests before and during treatment before and after treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per m3 of body surface surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per square metre of body area once weekly for 3 days , but this treatment period will normally not be repeated . for cervical cancer , it will be used in combination with another anticancer medicines containing cisplatin . cISplatin may be used only in patients with impaired kidney function . you should discuss with your doctor the dose that is best for you .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following serious side impacts . you may need urgent medical attention . infections ( common , may affect up to 1 in 10 people ) fever . this may affect your general condition , local symptoms , such as sore throat or burning sensation , severe stomach pain , fever and diarrhoea . other types of bowel inflammation ( neutropenic colitis ): topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , might affect upto 1 in 1 , 000 people ), difficulty in breathing or swallowing . these effects are listed below . common : may affect more than 1 in10 people fever , chills , dizziness , headache , weakness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . keep the vially in the outer carton in order to protect from light . storage after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours below 25 ( at 2 ° c ) and 24 hours at 2° oc to 8oc . from a microbiological point of view , the drug product solution for dlution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %, respectively ), has been established for 4 hours at room temperature , and for 12 hours at 25oc and for 24 hour at 2oc or 8oC . after reconversion /
what topotecan actavis contains - the active substance is topotacan . each vial contains 1 mg or 4 mg topotablecan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotencan - this other ingredient is mannitol ( e421 ), tartaric acid (  e334 ), hydrochoral acid ( see section 2 ) and sodium hydroxide ( see also section 2 " topot ecan actsavis contain sodium "). what to potecan actingavis looks like and contents of the pack topotechcan activis is supplied in a clear glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , which are tucked away in  a protective sleeve . packs of 1 via
the active substance of rivastigmine hexal is rivástigmin . rivarastigine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivlastigme works by blocking the enzymes that break down aceticcholine : aceTylcholcholineSterase and butyrylcholinesteride . by blocking these enzymes , it allows rivavastigmite to increase the levels of acetalcholine in the cerebral cortex , helping to reduce the symptoms associated with ecg (
do not take rivastigmine hexal - if you are allergic to rivástigmin ( the active substance in rivаstigine heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction suggesting allergic contact dermatitis with rivavastigme . if this applies to you , tell your doctor and do not taking rivstigmie heXal . warnings and precautions talk to your doctor before taking rastigemine hxal and if any of these apply to you as you may be at risk of experiencing irregular or slow heartbeat . you should be aware of the following : - have an active stomach ulcer . these may be signs of difficulties in passing urine . they may be symptoms of seizures . tell your pharmacist if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . Your doctor will regularly check if the medicine is working for you , and will regularly adjust your dose if necessary . children and adolescents the doctor will also monitor your weight whilst you are taking this medicine . tell your doctor if , while you are being treated with rivstigmin heexal , you have not taken more than three days without checking with your physician . taking this medication tell your caregiver that you are using riv as
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in10 people  ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling faster or more often feeling bloated dizziness , including low blood pressure , high blood pressure and feeling cold , being sick( vomiting ) diarrachoeal feeling sick( nausea ), being sick with food fast or irregular heartbeat weight loss muscle
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is rivainstigmine hydrogen tartrate . - each rivavastigmin heexal contains hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide (  e171 ). - printing ink : shellac . each rudiment of each ripastige heXal 1 . 5 mg capsule contains 1 , 5 mg of riv astivmine . Each rivage helixal 3 mg capsule includes 3 mg of the active substances rivostigine . the other ingredients are : each rigasmigmine hxal 4 . 4 mg capsule
what cabometyx is cabrometyX is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with a type of kidney cancer called renal cell carcinoma or liver cancer , when treatment with  a specific anticancer medicine , called sorafenib is not possible . what cometchyx is used for cabômetyix blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and by blocking their action cabombyx can slow down the rate at which the tumour grows and help to cut off the blood supply that the cancer needs .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyc : if your doctor has told you that you have high blood pressure . if there is evidence of an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a wall of  a vein wall . talk to the doctor or nurse if any of these apply to you . take special care with cabombyx : 45 - if : you have significant bleeding . you have had surgery within the last month . your doctor may recommend surgical procedures , including dental surgery . there is also a possibility that inflammatory bowel disease . this is
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . taking this medicine - take the medicine at the same time every day - this is to reduce the risk of your treatment getting worse . - you should not take this medication for more than a week . your doctor will monitor you for serious side effects and may adjust your dose . the maximum recommended daily dose of cabometyx is 60 mg . take cabrometyX for at least 2 hours before or after a meal . you should take a tablet of - cabômetyc for at most 1 hour before or - after - the medicine is taken . swallow the tablet whole with a glass of water . do not crush or chew the tablet . how long to take - do not stop taking cabmety
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects you may need to stop taking cabometyx and get other medicines to control your side effects ( see section 2 ). if your side impacts get worse tell your doctor straight away . you may want urgent medical treatment . symptoms may include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , as these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ), and severe or uncontrollable bleeding . in some cases , vomiting blood may appear as black blisters on the skin and may lead to blisters in the mouth or throat . other side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , stomach pain ,
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabrometyX 20 mg film - coated tablets : cabcabozonib( s) - malat : 20 mg cabazantineib . the film  goes to the printer and produces a high quality product . each tablet contains 40 mg / 0 . 5 mg robloxetine ( a compound compound ). cabombyx 40 mg film coating : the film coating contains cabbozanteinitab (  ss ), malate = 40 mg of cabobosantininibe . what cometychx looks like and contents of the pack cabmetyux 60 mg film coat : lam - shaped tablet : de
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreixed hopira has been given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . if pemetreXed hapira was given in combined with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer : pemetreexed hompira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetred houpira remains a treatment for patients with advance stage of  lung cancer who have progressed after initial treatment 
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreexed or any of the other ingredients of this medicine ( listed in section 6 ). - continue breast - feeding during treatment with pemetreixed hobra . - you may also be given a vaccine against yellow fever . warnings and precautions talk to your doctor , pharmacist or nurse before using pemetreced hompira as it may cause problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if the medicine is adequate . this is to check that your kidney and liver function are adequate , and to check you have enough blood cells to receive pemetreced out of the reach and sight of children . you should not receive pemeterxeed as this medicine will only be given to you if
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your area in square metres ( m2 ) of your normal body . this body surface area will be calculated by your doctor and will be adjusted by your physician . a hospital pharmacist , nurse or doctor will use this medicine for treatment if your blood cell counts are adequate . after mixing the pemetreXed
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your body has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if this happens , tell your doctor . it may be accompanied by chest pain ( common with a fast heart rate ), pain , redness , swelling or sores in your mouth ( very common in patients ). allergic reaction : i . suicidal thoughts , confusion , nausea and vomiting . in some cases , it may lead to skin rash ( common in people ) ( common for people who
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dilution of infusion solutions of pemetrexed was demonstrated for 24 hours at refrigerated temperature . the reconstructed solution should be clear and colourless . parenteral medicines should not be used if there is discolouration prior to administration . use this medicinal immediately if you notice any particulate matter or particulates in the dlution . any unused solution must be discarded .
what pemetrexed hospira contains the active substance is pemetreexed ( as pemetreixed disodium hemipentahydrate ). pemetreexed houpira 100 mg : each vial contains 100 milligrams of pemetreXed( as pemeterxes diso sodium hemimipentainshydrate ) each viale of pemeterexede hos Pira 500 mg ; each viabill contains 500 milligramms of Pemetrexéd (as pemetreuxed désodium dipentahydrat ). each viall of pembaxede hospira 1 , 000 mg / ml contains 1  , 800 millilitres of ace - derived pemetrexxed as pembaixes disodium dipent hydrate . after recon
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimatorpross belongs to a group of medicines called prostamides . it works by blocking the effect of a prostaglandin analogue , titmololl . these are medicines called beta - blockers . your eye contains a clear , watery liquid that feeds the inside of the eye and so reduces the amount of liquid that gets into the eye as you go through it . this medicine is used to treat glaucoma in adults whose condition is not well controlled by the use of drops , and to reduce the pressure in your eye , by reducing the pressure inside the eye that the doctor has prescribed . ganfordt eye drops are used to reduce high pressure inthe eye 
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol or beta - blockers . do not apply them to your child ' s solution . warnings and precautions before using this medicine your child should be checked for signs of coronary heart disease ( symptoms include chest pain , wheeziness , difficulty in breathing , or long - standing cough ). if your child has heart problems such as low heart rate , heart block or heart failure warnings , precautions and monitoring the following whilst using ganfordt eye drops : if , during treatment your child may develop a serious form of coronaries ( symptoms can include chest discomfort , shortness of breath , cough , rapid breathing ), chest pain or difficulty in swallowing , chest pain and chest pain which may be severe 
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . treatment should only be started by a doctor who is experienced in the use of ganFort . the bottle should only ever be used in the eye . how to start ganfordt the recommended dose is one bottle , which should be kept in the neck . read the instructions carefully and follow them carefully . 5 . before you start using ganforcet , wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of granfort into your eye , wait 5 minutes and then turn the bottle counter clockwise . hold the bottle and close the eye with a finger . do not touch your eye or
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops and see your doctor immediately if you notice any of the following side effects after taking ganFort ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) are : - the eye redness ( common side effect , may affect up to 1 in 9 people ). - a change in the eye burning , itching , and stinging , or irritation of the conjunctiva ( the transparent layer at the front of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes - an overall feeling of something in the eyes .
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . ganFort is for single use only . it is recommended that every time gan fort is used , the solution used for eye infections is diluted and used immediately . however , it is important that you do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains the active substance is bimatoprost . each sachet contains 0 . 3 mg of timolol . one bottle contains 5 mg of the active ingredient titmololl maleate equivalent to 6 . 8 mg . the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . purified water , hydrochloric acid and sodium hydroxide . what gist looks like and contents of the pack ganft is a clear , colourless to slightly yellow eye drops , supplied in a plastic bottle . they are white to slightly opalescent and contain a straw . pack sizes : each pack contains 1 bottle , 3 bottles with a screw 
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib meinlan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefit inib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitib Mylan : if your doctor thinks you may have any other lung problems . some lung problems may get worse during treatment with gefiteinib , as some lung conditions may get better . talk to a doctor or nurse before taking this medicine : simvastatin : tell your doctor if any of these apply to you . if vous have problems with your liver . your doctor may decide to reduce the dose of gefitINib in the future . children and adolescents this medicine is not for use in children and teenagers under 18 years . other medicines and gefitineib tell your pharmacist or nurse if the patient is taking 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet each day . swallow the tablet whole with a glass of water . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . if your doctor advises you to take more gefitib than he / she needs , talk to your doctor immediately . you may have trouble swallowing the tablet . this may be due to the liquid content of the tablet or the liquid to dissolve in the liquid . for further instructions on how to dissolve the tablet use the following instructions : - read the instructions for swallowing and follow the instructions carefully provided in the " instructions for use ". - do not use any other liquids
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction . symptoms may include swollen face , lips , tongue or throat , difficulty to swallow , hives / nettle rash , and difficulty breathing . serious breathlessness : or sudden worsening breathlessness combined with a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib mylan can cause severe skin reactions affecting all over the body . these may include yellowing of the skin or the whites of the eyes ( jaundice ). these may be signs of an infection called
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefiteinib ( as besilate ). - other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . film coat : polyvinyl alcohol , macrogol 4000 , titanium dioxide (  e171 ), red iron oxide ( , yellow iron oxide ). what geFITini B mylan looks like and contents of the pack gefit inib craplan tablets are light pink , biconvex film . approximately 11 . 1 mm x 5 . 6 mm with "
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes in adults . myelaodys plastic syndromes ( mds ) are many different blood and bone marrow disorders , in which red blood cells become abnormal . signs and symptoms associated with a low red blood cell count ( anaemia ) may arise and red bloodcell transfusions may be necessary . reblizyl is used : to treat anaemic adults with mmdS who need red blood blood cell transfusion ( as monotherapy ) and to reduce the need for red blood caries in patients who are not able to receive erythropoietin therapies to treat beta - thalassaemia in adults and children . beta thylassaedia is a blood problem that is passed down through generations
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - when you are pregnant . ( it is also better to avoid reboil during pregnancy , see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor before taking this medicine - in case you have thalassaemia ( having your spleen removed ) or if there is a risk of a blood clot , for example , if your doctor considers hormone replacement therapy - where a previous blood coagulation has been observed , your doctor will take preventive measures . reblizyl is not a cure for a long time . you should continue to take medicines to prevent a new blood clut from forming . talk
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide whether you should receive or continue to receive reblozyl . reglazing is usually given by injection just under the skin ( subcutaneously ). it is injected once a month . how much to use your doctor or nurse will work out how much reblizyl you need and how often . the injections will be given in steps of 1 . 01 ml per kg of body weight . this dose may be adjusted by your doctor depending on your blood pressure . when reblazyl is given to you in patients with myelodysplastic syndromes the maximum single dose is 1 , 75 mg per kg / kg of total body weight per week . in patients suffering from beta - thalassaemia the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects difficulty in walking or speaking dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially in the lower body , blurred vision and symptoms of a stroke blood clots swelling in the area around the eyes , face / lips , mouth , tongue or throat allergic reactions , including rashes and swollen glands of the face and lips . not known how often these side effects occur is not known . tell your doctor if you notice any of the following : serious side effect : very common : may affect more than 1 in 10 people loss of coordination or balance feeling dizzy , losing touch with reality , difficulty in speaking , dizzience , and / or paralysed ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored for 8 hours below 25 and for up to 24 hours at 2 8 ( in - use storage times and conditions to ensure sterility of the product ). any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept per vial . after reconstitution , each ml of solution contains 50 mg of the active ingredient ( lusp ). the other ingredients are : excipients : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( forph adjustments ). what  Reblozylly looks like and contents of the pack reblizyl is supplied as a white to off - white powder in a glass vial ( 25 mg / 75 mg lusparcept ). each pack of reglazel contains one vial of white powder . recladding the vial is a clear , colourless liquid 
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate at which cancer cells grow . it also slows down the development of new blood vessels . fotiva is used in adults with advanced kidney cancer who are intolerant to other treatments ( alpha or interleukin - 2 ), but whose disease is not well controlled .
do not take fotivda : if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if the above applies to you , don ' t take fotiveda until you have checked with your doctor . if , you are taking st .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is : 1340 mg capsules for patients who weigh 21 kg or less , who weigh at least 1 kg , or who weigh 1 kg or more , and who are unable to take capsules with 4 kg . your doctor may reduce your dose of / or more capsules ( 0 . 5 - 8 ). if your dose is increased , your doctor will decide how many capsules to take , depending on your condition . patients taking fotiva should be carefully monitored for unacceptable side effects . if severe side effects occur , the doctor may decide to stop fotivdas therapy . take the number of capsules as instructed by your doctor and follow the instructions in the leaflet . follow the guidance leaf
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect that can happen in very small numbers ( may affect more than 1 in 10 people ). tell your doctor immediately high blood temperature ( see also section 2 warnings and precautions ): if you have high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated , your doctor will monitor your blood pressure . if it is too high , you may need to take a medicine to treat your high blood tension . it is important that you take fotivda every day , as long as your doctor prescribes a medication to treat or prevent your highblood pressure , even when you are taking fotiva . do not stop taking fotive
what fotivda contains the active substance in fotiva is tivozanib . each vial contains 890 mg of tivofanib ( as tivochloride monohydrate ). each viall contains 880 mg of the active ingredient tivorzanibe . the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( sb - 9 ), yellow iron oxide (  e172 ), propylene glycol . strong ammonia solution , titan dioxide ( the e1520 ) and tartrazine aluminium lake ( tia ). the printing ink contains shellac , propyl glycol and strong ammona solution in the form of indigolin carmine aluminium Lake ( i . e
what stribild is sTRIbild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antireviral medication known as a nucleoside reverse transcriptasе inhibitor ( nrti ) tenofovir disoproxil , another antirétroviral medicinal medicine known to work as  a nuclear nucleophilide reverse transcript asE inhibitor ( nucleomeg i ). stricbild is provided as : as , in a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . streifen is
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , all - tenofovir / ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sTRIbild : if treatment with any medicine containing tenovir diproxil will be reassessed based on your kidney function . these medicines may be available without prescription : ask your doctor for advice : alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in the prevention of blood clots ). carbamazepine ( used on certain liver
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose for adults is 12 to less than 18 years of age , who weigh at least 35 kg : one tablet each day by mouth . your doctor may adjust the dose of your medicine depending on how you respond to the treatment . you may take medicines called oral supplements ( antacids , laxatives containing minerals e . g . magnesium , aluminium , calcium , iron , zinc ). take the tablets once a day at about the same time each day . take the tablet at least 4 hours after the time you take it . it is important to take stribild every day , as long as your physician prescribes it for you , and for as long your doctor prescribes the dose . do not
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , but not everyone gets them . when treating hiv infection , it is not always possible to tell whether unwanted effects are caused by stribild or by the hivi disease itself . serious side effects that you need to report immediately to your doctor . lactic acidosis ( excess lactic acids in the blood ) is a common side effect of some hiv medications . it is more likely to cause lactic Acidose . the most frequently reported side effect with some hivi medicines . possible signs of lacticaciosia are : -
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisegrar , 150 mg cobicistentat / 200 mg emetricit abine and 245 mg of the active substance tenovir désoproxils / 300 mg of of ten ofovir diproxil fumarate , equivalent to 136 mg of an adult tenophage ( 0 . 5 mg ) of tan and the other ingredients are croscarmellose sodium , the hydroxypropyl cellulose , lactose monohydrate , magnesium stearate and flax - rich tablet ( see section 2 ).
zyprexa contains the active substance olanzapine . zyPrexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an uncommon type of episode with symptoms of excitement or euphoria . the active ingredient in zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olangzapinе treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a particularly swollen face , or soiled lips or shortness of breath . if this has happened to you , tell your doctor . warnings and precautions talk to your doctor before taking zy Prexa and if any of your close relatives has a history of eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). your doctor may want to monitor you more closely . take special care with zyPrexa the use of zypa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements mainly
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zyPrexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zy prexa tablet once a day following the advice of your doctor and follow the advice given to you , even when your symptoms are not getting worse . if so , your doctor may tell you to take your tablets at the same time each day . it does not matter whether you take them with or without food . always take zypa coated tablets exactly as described in the box . follow the instructions for taking the zypru
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ). especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor or pharmacist . your doctor will advise you how to deal with them : - unusual movement . this is a very common sideeffect which may effect more than one in 10 users is affecting the face and tongue . blood coagulations in the sinuses is  a rare side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa must be used within 30 days after first opening . store in the original package in order to protect from moisture . please return the blister to your pharmacist . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 50 mg . the strengths are 10 mg / 10 mg or 15 mg - 20 mg a . your zypréxa tablets pack contains the following ingredients : lactose monohydrate , hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate , and hypromellose . tablet core : titanium dioxide , carnauba wax . what kyprexа looks like and contents of the pack the different zypa tablets strengths are white , round and convex . zypruxa 2  . 5, 5 mg ( 5 mg at least 7  , 7 , 10 mg at about the same diameter
what prolia is prolium contains denosumab , a protein ( monoclonal antibody ) that is designed to attach to another protein that is involved in bone loss and osteoporosis . treatment with prolisa can help to make your bone stronger . it also helps to increase the amount of oestrogen that your bones can produce . when the menopause is over , the amount o estrogEN level drops and your bones become thinner and fragile . this is called osteopoch . how prolorosia works osteopororosists produce little to no hormones such as testosterone and glucocorticoids , which are also involved in the treatment of osteoposse . talk to your doctor if you have any symptoms .
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor thinks you may be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using prolisa . take special care with prolium if any of these apply to you . before using use , tell your doctor if : you have a skin infection with symptoms such as a swollen , red area of skin usually affecting the upper leg , which feels hot and tender ( cellulitis ). you have symptoms such a fever . these symptoms may be caused by an allergy to latex . the needle cover of the pre - filled syringe contains a derivative of latex which is used to treat calcium . your doctor may want to
your doctor , nurse or pharmacist is responsible for storing and disposing of the product . one pre - filled syringe ( 0 . 5 ml ) will be injected once every 6 weeks , preferably in the thighs , abdomen or upper arm . prolia is given with stickers , calcium and vitamin d supplements , and infusion initiation kits . if you miss an appointment to get prolisa call your doctor or nurse right away to reschedule your appointment . make sure you inject the dose you have been given . do not try to inject yourself if it is not clear to see what you have not been given and to tell your doctor about it . your doctor will tell you how much you should have each time you are given prola . it is important to keep all your appointments to receive prollio .
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may also cause skin infections ( cellulitis ). tell your doctor immediately if you have any of these symptoms after taking prolisa : - a swollen , red area of skin on the top of your leg . this area feels hot and tender . symptoms may include fever . do not take prolidea if any of the following occur : pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw ; discharge ; numbness or a feeling of heaviness in the arm or leg , or loosening of a tooth , which may be a sign of bone damage . other side effects of prolivia include : very common ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at temperatures up to a maximum of 25 for a single period of up to six months . after the injection , the maximum time between the first 25 and the second 30 days should be noted on the outer box . please record the date when the injection is given on the carton . once the product has been withdrawn from the refrigerator , it should be discarded . discard any unused product correctly . only use prolia if it is clear and colourless . it
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg in 60 mL ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolium is a clear to slightly yellow solution for injecting in a pre - filled syringe with a needle guard .
ambirix is a vaccine used to prevent adults and children from 1 year up to and including 15 years of age against two diseases : hepatitis a and hepattis B . infection with the heptis one virus causes the liver to become swollen and inflamed . the virus causes your body to produce its own protection ( antibodies ) against the virus , which can be found in the blood of an infected person . they can be contained in the vaccine through faeces , serum or saliva . symptoms start 3 to 6 weeks after infection . tell your doctor if you feel sick , have a fever , or aches and pains or are concerned by any of these signs .
you will not be given ambirix if : you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have had an allergic response to any vaccine against hepatitis a or hepatis b diseases . you have a severe infection with a high temperature ( over 38 ). if this applies to you then the vaccine may not be recommended . your doctor will check whether ambirika is working properly , and if it does not , you are more likely to get an allergic reactions . tell your doctor if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before you are given ambix : if your child has a minor infection with the temperature
your doctor or nurse will give you ambirix as an injection into the muscle of the upper arm . ambirx will be injected into a vein . the injection will be given into the thigh muscle . you will receive a total of two injections . it is recommended that the injections are given within 12 months after the first injection . a second injection will also be given between 6 and 12 months following the first dose . please discuss with your doctor about the second injection and the possibility to increase the dose if necessary . your doctor will discuss with you the possible future booster dosing . do not hesitate to give two injection if you think you have been given too much ambirique . tell your doctor if the dose is too low . they will discuss this with you .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following serious side impacts you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects talk to your doctor if any of these side effects become serious . side effects reported during clinical trials with ambirix : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in joints or muscles . uncommon ( may effect up to1 in 100 people ). reporting of side effects 25 if your child gets any side effects contact your doctor immediately , pharmacist or nurse .
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 720 elisa units hepatis b surface antigen ( hdpeg ) 20 micrograms 1produced on human diploid ( mrc - 5 ) cells 2adsorbed on aluminium hydroxide , water for injections 0 . 05 milligrams al3 + 3produced in yeast cells ( saccharomyces cerevisiae ) by recombinant dna technology 4adsorbant eosinophils ( saccheromycetes cerevisians ) 3adsorption ethanol 0 ( ethanol per 0. 4 millilitre ) sodium chloride and water for injectables what ambisix looks like and contents of the
bexsero is a meningococcal group b vaccine . bexsiegero contains the active substances of the bacteria neisseria meningeritidis group a . Bexseero will be given to children and adolescents 2 years of age and older , to prevent disease caused by the naeisserium meningitia group c bacteria . these bacteria often cause infections which can lead to meningitsis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies , which help protect you or your child against the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given bex serro : if your child has a severe infection with a high temperature ( over 38 ). if this applies to your child , the doctor will decide if vaccination is needed . a minor infection , such as a cold , should not require the vaccination . in this case , your child will be vaccinated . talk to the doctor if : your child suffers from haemophilia or any other problem that may stop your blood from clotting properly . your doctor may recommend that you use blood thinners ( anticoagulants ) during treatment which may affect your immune system . this is particularly relevant
bexsero is given as 5 micrograms in the muscle of the thigh or upper arm . the three injections are given at 2 to 5 months apart . you will receive three injection s of the vaccine followed by an additional injection ( booster ). the first injection will be given at least 2 to 3 months apart and the interval between injections will be 1 month . from the second dose , the intervalbetween injections may be 2 months apart respectively . a booster will be administered 12 to 15 months after the second injection and the booster will not be given 12 to 16 months after your second dose in the second and third dose . your doctor will decide how much and how often you will get the booster .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site ; redness of the skin at the injecting site . swelling of the underside of the injection area ; hardness at and around the injection location . the following other side effects have been reported for this vaccine in children aged 10 months and above . common (may affect up to 1 in10 people ]: fever ; hives ; skin rash at the vaccine site , injection site redness at or near the injection sites ; swelling of skin at and near the injector ; injection site very common : the following may affect upto 1 in every 10 people: - fever common -
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein , 1 , 2 or 3 mg / 50 ml when reconstituted as recominant and reconstructed naeisseries group a menngitidas group c nada protein . 1  2 or 4 , 000 iu / m2 when withdrawn as a single dose . each mla contains 50 micrograms of rerecombinate nneisseisseridia meningitis group bo fhbp fusionprotein , produced as 1 mL , group 2 or3 mmol / kg protein ; each corresponding to 50 microgramms . recompinant nodis men
nitisinone mdk contains the active substance nitosinone which belongs to a group of medicines called ' oral anti - inflammatory substances '. this medicine is used to treat a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid tarosine ( amino acids are building blocks of our proteins ), forming harmful substances . nitsinone helps to break down tychrosine and the harmful substances are not formed . you must follow a special diet while you are taking this medicine , because tyes of tyingrosine will be removed from your body by re - breaking down these substances , and this will help to reduce the amount of fatty substances that are released into the body 
do not take nitisinone mdk - if you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking this medicine . see section " pregnancy and breast - feeding ". niitisine mk may affect the eyes . during ntisinine treatment , red eyes can occur . if this happens , you should contact your doctor immediately for an eye examination . eye problems can occur and patients should be treated for inadequate dietary control ( see section 4 ). during and after the treatment : your doctor will take blood samples to check whether the treatment is working and to detect any possible side effects . blood disorders can occur in patients treated with nysinone and liver . the disease can be fatal in some cases . talk to 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kilogram of body weight , administered once daily . the recommended daily dose is 20 mg per kg of bodyweight . there are no recommendations for a higher or lower dose . for this patient population , the recommended dosage is one capsule per day . method of administration swallowing the capsules with a small amount of water or formula diet just before you take your first dose of nitisinone mdk . if your doctor prescribes this medicine for you , please read the following instructions carefully . you should swallow the capsule whole with sachets of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . nitisinone mdk may be stored for up to 2 weeks at a temperature not above 25 .
what nitisinone mdk contains the active substance is niitisine . nitsinone mg : nitesinone in capsules : each capsule contains 2 mg of nităisinONE . each capsule of ' nitéisinon mk 5 mg contains 5 mg of " nitzisinine ". each hard capsule of " " nicotisino mzk 10 mg contains 10 mg of NitisINone . the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide (  e172 ), shellac glaze . what nicisinonne mmdking looks like and contents of the pack nisinonce mbk capsules are white to off - white , 15 . 7 mm 
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . Docetaxell belongs to the group of anti - cancer medicines called taxoids .. docotaxel acord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer and head and neck cancer : - for the management of advanced breast cancer the combination of docetaxiall accord, doxorubicin , trastuzumab , capecitabine , has been given to you by your physician for the prevention of early breast cancer in adult patients who have had previous treatment with doxoricin or trastukab alone . - to reduce the risk of breast - related breast cancer and certain other types of
docetaxel accord must not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetastel accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor thinks that you have a severe liver disease . warnings and precautions before each treatment with docetachl accord , you will have blood tests to check that you are getting enough blood cells and sufficient liver function to receive docetcetaxell accord . in case of whiteblood cells disturbances , e .g ., fever or infections , please tell your doctor immediately . you may experience abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or any other symptoms associated with this medicine . tell your physician immediately if : you
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may be adjusted depending on your blood tests , your general state of mind and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her 63 information so
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . if you experience any of the adverse events listed below , please tell your doctor or nurse immediately . when docetaxil accord is given in combination with other chemotherapeutic agents , the infusion may be temporarily stopped . allergic reactions are common ( may affect up to 1 in 10 people ) and may include flushing , skin rash , itching , burning sensation when urinating , pain in the joints ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the vially in the outer box in order to protect from light . after dilution , the medicine should be administered immediately and not stored in the refrigerator or in the infusion bag . chemical and physical in - use stability of the medicine after infusion has been demonstrated for 6 hours below 25 ( including when prepared as directed ). from a microbiological point of view , once added to the infustion bag , immediately infusion should be used immediately . if not used immediately ( in / out of reach of the child ), in .- use storage times and conditions prior to use are the responsibility of
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetachl - 1 mL concentrate contains 20g of dotaxel  - 4 mmol concentrate contains 80 mg of Docetaxell - 8 mg of concentrate contains 160 mg docetaxiall  the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see " docettaxel accord contain sodium "). what docotaxel acord looks like and contents of the pack docetechaxel agreement concentrate for concentrate for solutions for infuse is a clear pale yellow to brownish - yellow solution . the concentrate is essentially free from visible particles . it is supplied in glass vials containing a colourless to pale yellow solution
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev works by reducing the activity of impulsive or hyperactive people . you have been given this medicine for the treatment of ' attention deficit hyperactivity disorder ' ( adhd ) in adults . it is used when : you are taking current stimulant medication . your doctor may reduce the dose of current medication you are currently taking , or change your dose if you have adhd symptoms . the medicine is added to  a treatment programme called psychological therapy , educational therapy and social therapy 38 how intuiv works in adhd and adhd is a condition that can be life - threatening .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking this medicine : see your doctor if any of these apply to you : low or high blood pressure . heart problems tell your doctor right away if your doctor has told you that you have heart problems . tell your family or carer that you are being treated for heart problems or that you recently had any recent history of thoughts or feelings of suicide . please tell your caregivers that you suffer from any other psychiatric conditions . withdrawal symptoms if possible , increased heart rate , or high heart pressure , tell your nurse immediately , as the use of this medicinal product may need to be delayed . children and adolescents intunev should not be given to children and teenagers
your treatment should be initiated under the supervision of a doctor experienced in the treatment of resuscitation and adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will be initiated and monitored by a physician experienced in this field . the recommended dose is 1 mg / kg bodyweight once daily . after 1 month of treatment the dose may be increased to 0 . 05 mg - 0. 12 mg x bodyweight each day . starting treatment on day 1 , you should take intuniv once daily for 7 days . you should not take inatunivi more than once daily during the 7 days before you take intounivo . taking this medicine avoid eating fats and fatty foods such as grapefruit or apple juice . swallow the tablets whole
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , tell your doctor or pharmacist as you may need to stop your medicine . serious side effects tell your doctors straight away if your dose is increased . the following side effects can be very serious . tell your healthcare professional straight away and get medical help if any of the following happen : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint and loss of conciousness ( syncope ) this can be a serious withdrawal side effect . high blood pressure that can cause symptoms such as headaches , feeling confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). other side effects include : very common ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from moisture .
what intuniv contains 1 - the active substance is guanfacine hydrochloride . each tablet contains 1 mg of guANfaine . - each tablet also contains 2 mg of methacine chloride , corresponding to 2 mg guansfaune . 3 - every tablet also contain guanyfacina hydroch chloride ( corresponding with 3 mg GUanf acine ). - one tablet also includes 4 mg of usthacate hydrochlloride ( equivalent to 4 mg guianfucine ) - other ingredients : hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , and crospovidone type a , micro
ecalta contains the active substance anidulafungin and is used for treating adults ( including 18 years of age ) with a type of fungal infection that affects the blood or other internal organs ( invasive candidiasis ). it is used when the infection is not caused by fungal cells called candida or echinocandins . these medicines are used to treat serious fungal infections caused by the formation of funtag cell walls . eCALta is used because fungal cell walls become fragile and unable to grow .
you must not be given ecalta : if you are allergic to anidulafungin , other echinocandins ( e . g . caspofungin al - acetate ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before you are given . the use of ekalta is not recommended . your doctor will monitor your liver function . patients treated with ecata may develop liver problems during your treatment . you may be given anaesthetics during your therapy with a different medicine . during treatment with ocaltha , you may experience an allergic reaction , such as itching , wheezing , or blotchy skin . an infusionrelated reaction may include a rash , 
the treatment will be started by a doctor who is experienced in the care of patients with disabilities . the recommended dose is 200 mg given once a day for 100 mg patients . use in children and adolescents 1 to 18 years of age : the recommended starting dose is 3 . 0 mg for 200 mg followed by 1 . 5 mg for 100 kg patients based on the patient ' s weight . your doctor will decide the dose that is right for you . how ecalta is given ecalcta will be given to you by  a slow infusion ( a drip into a vein ) over a period of 1 - 5 minutes . it may take up to 3 hours for the loading dose to be given . depending on the person 's weight the loading dosing will be calculated based upon the patient' '
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are life - threatening allergic reactions , difficulty breathing , wheezing , or an existing rash . if you get any of these , stop taking ecalta and tell your doctor straight away . serious side effect , including convulsion ( seizure ), flushing / rash ( pruritis ), itching , hot flush , hives , sudden contraction of the muscles , coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): headache , dizziness , headache . common side effect ( may effect up to 1 in10 people : headache common sideeffect ( may impact up to1 in 10 children ) - headache - diar
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if the reconstituted solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2oc 8oc and would not be stored longer than 48 hours at room temperature .
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidULafungIN . - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  ekalta looks like and contents of the pack ecalcta is presented as a powder for concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rasatocog alfa pegol and is pegylated human coagulation factor viii produced by recombinant dna technology . human reconstituted dlh is the human clotting factor ii produced in the laboratory by combining genetically modified dla - rays with the human blood coagulating factor ixi . factor  vii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( lack of factor v ), it is missing or not working properly . aynovis is used for the treatment and prevention of bleeding in patients 12 years of age and older with haaemphilia alf - alf- a , an inherited bleeding disorder caused by lack offactor vii
do not use adynovi if you are allergic to rurioctocog alfa pegol , octacog almonds or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using aynovis . if your doctor thinks you may be allergic , ask your doctor for advice before using this medicine . warnings and precautions talk to your doctor or pharmacist before using the product if : you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to a drug . you have been told that aaddynovai could cause allergic reactions such as rash ( common in children 95 ), hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use aynovide exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding your doctor will decide on the dose of aaddynovai you will receive . the replacement therapy with dyni is usually a life - long treatment . continue to use this medicine until you are no longer benefiting from it . prevention of bleeding the usual dose of an adenovi is 40 to 50 iu per kg body weight , for at least 2 years , depending on the type of bleeding you are experiencing . dose of the dose with odynoii depends on your body weight and the factor viii levels to be achieved . your doctor determines the
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , chest tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath or fainting , require prompt emergency treatment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is mixed with the solvent , it can be kept at room temperature ( up to 30 ) for a single period not exceeding 3 months . if this medicine is mixed at room temp for  3 months or in 3 months , the product must be used within 3 months of preparation . once the powder has been mixed with a suitable temperature ( over 30 ), it should be discarded .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu rURIocta pegel . the solvent vial is 5 ml sterilised water for injections . ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injectable .
rekovelle contains the active substance follitropin delta , a fombcle stimulating hormone ( fsh ), which belongs to the family of hormones called gonadotropins . gonadotrophins are involved in the development of female infertility in women undergoing assisted reproduction programmes ( in vitro fertilisation ( ivf ) or intracytoplasmic sperm injection ). rekelle is used to stimulate the ovaries to produce more eggs that can be collected from the womb . rekorelle is one of many egg sacs that are left in the body over a long period of time .
do not use rekovelle if any of the above applies to you . if you are not sure , talk to your doctor or pharmacist before using recovelle . this medicine is not recommended if your fertility problems are not controlled by your doctor . you are allergic to follicle stimulating hormone or any of those other ingredients of this medicine ( listed in section 6 ). if the name and type of tumour is not known , please talk to the doctor before using this medicine . tumour of the uterus ( the female organs of the female body ), ovaries of the breasts , pituitary gland or hypothalamus ( the womb ). warnings and precautions talk to you doctor before taking rekelle : if : you have enlarged ovulations or cysts on your oocytes . your doctor may want to monitor you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be calculated for you by your doctor and will be injected by a doctor or nurse . your doctor will decide on the exact dose you need . for the first treatment cycle , the dose will depend on the type of anti - mullerian hormone you receive from your ovaries and on whether you receive stimulation with gonadotropins in your blood . this will be done by adjusting the dose of rekelle for you , based on your body weight . you will have a blood sample taken in the last 12 months to measure how well you respond to treatment . how much rekorelle is given your doctor may take a sample of your body weigh once a week . during the first 12 months of treatment , your doctor might
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the hormones involved in infertility may occur with this medicine . if you have a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ), symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . tell your doctor immediately if any of these symptoms occur . they could be a side effect . common ( may affect up to 1 in 10 people ) headache and nausea ( ovulation related ovary hypersmulation syndrome may occur very commonly ). if your doctor thinks that you may have ovarial hyperstrophy , contact your doctor as soon as possible . other side effects include : very common ( can affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in use in order to protect from light . once the vialige has been opened the product can be stored for up to 25 days at room temperature ( up to 3 hours ) for upto 3 days at 2 - 8 and protected from light ( upto 25 ). during the treatment any unused solution should be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of fl - focal f - deltoid . one millilitre of solution contains 0 . 36 milligrams / ml of solution corresponding to 33 . 3 microgram of vl fll - dopa . -the other ingredients are : phenol , polysorbate 20 , l , methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate ( e339 ), concentrated phosphoric acid , water for injections . what retinole looks like and contents of the pack rekelle is a clear and colourless solution for injection . it is supplied in a
revinty ellipta contains two active substances : fluticasone furoate and vilanterol . revinting ellipeptare is available in two strengths : - fluticasesone furóate 92 micrograms / vilantrol 22 microgram : one tablet fluticaşone furоate 184 microgram ( vilantese 22 microliter ) - 92 / 22 microlitre ( 0 . 5 ml ): one tablets for chronic obstructive pulmonary disease ( copd ) in adults and asthma in children and adolescents 12 years and over . 184 / 20 microgram is used for asthma in adolescents 12 months and over at least 184 ( 22.2 microgram per dose ) for copd in adults . your doctor has prescribed reviny ellpte for you because you have
do not use revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). do not take revinny elipta do not using reviny ellpte if any of these apply to you . if they do , do not give this medicine to you until you have checked with your doctor . warnings and precautions talk to your doctor before using revINty it is possible that you may not be able to take the medicine if this applies to you in the following circumstances : liver disease . your doctor may want to monitor you more closely for side effects . patients with moderate or severe liver disease may be advised to use the lower strength of revinting ellippa ( 92 / 22 mg / ml 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 22 micrograms of fluticasone furoate and 22 microgramms of vilanterol ) once daily . if your child suffers from severe asthma , your doctor may prescribe the higher strength inhaler ( containing fluticasesone furonate and 20 microgram of v . 2 microgram vilantrol ). the dose to be taken once daily is one treatment in copd . in copa the recommended dosage to treat copd is one dose ( 84 microgram fluticassé furoates and 22 megagrams vilantesrol ), once daily the other . the recommended starting dose of revinty ellipta is one single
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipata stop using this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( anaphylactic shock ). your doctor may tell you to stop using revinty ellippa . if they get any of these symptoms , stop using the medicine and seek medical help immediately . skin rashes , including hive and redness swollen face and / or mouth , may indicate angioenedem
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 / 22 : each delivered dose contains 92 micrograms of fluticasesone furonate and 22 microgram vilantrol ( as trifenatate ). 184 / 21 : every delivered dose ( 184 microgram of fluticasone fuoate , 22 microliters of vilantirol ) and trifentatate ( as monohydrate ). the other ingredients are lactose monohydrate ( see section 2 ) , magnesium stearate and soy - rubber . what revinety is used for the pack the ellippa device is a light grey inhaler with a yellow mouthpiece cover and a dose counter .
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , also known as a nucleophilic reverse transcriptose inhibitor ( rtti or nrrtis ) tenofovir , another nucleicide reverse transcriptor ( nucleonitasing inhibitor ( nutrta ). these active substances are antiretroviral medicines that work by interfering with an enzyme ( reverse transcriptasiase ) that is essential for the virus to multiply . atriplava is used as  a treatment for human immuno deficiencies virus ( hov - hiv) infection in adults aged 18
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one atripla tablet by mouth . atriplap should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . your doctor will tell you if this is the case . some side effects ( e . g . dizziness , drowsiness ) may occur while taking atripLA . taking atRIPla with food and drink the following are reasons why you should continue to take atripLa for as long as your physician tells you : efavirenz , anemtricitabine , or tenofovir disoproxil , and other medicines to treat your hiv infection . continue to taking atrapla for as many atriplac tablets may make you more prone to side
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are lactic acidosis ( excess lactic acids in the blood ). this is rare ( may affect up to 1 in 1 , 000 people ). if you think you may have this serious side effect , talk to your doctor . the most frequently reported side effects of lactic Acidoss are deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), and stomach pain . if any of these side effects gets serious , or if they cause you to
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriplap film - coated tablet contains 600 mg of eefAVIrenz / 200 mg of of еmtricităabine / 245 mg of the active substance tenovir désoproxils ( as fumarate ). the other ingredients are tablet core : croscarmellose sodium , the ingredients in the tablet core are hyprolose , magnesium stearate and microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atripLA contains sodium "). the tablet film coating contains iron oxide black and iron oxide red ( e172 ).
orgalutran contains ganirelix , a member of a class of medicines called anti - gonadotrophin , which is essentially similar to the natural gonadotropin releasing hormone ( gnrh ), except that it is produced by means of biotechnology . gngrh regulates the release of gonadotropics and follicle stimulating hormone ( fosh ). gonadonomins are necessary for the growth and development of fsh in the ovaries . gonadophagins help with the growth of oocytes in the offspring of the eggs . orgalugatran is produced in small round sacs that contain the egg cells . these sacs help the body to release the mature egg cells into the flv - containing flies , and release the froth , inside the womb ,
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gndrh analogue . - have a moderate or severe kidney or liver disease . see section " other medicines and orgalugatran allergic reactions ". if your doctor determines that you have an active allergic condition , additional monitoring will be performed during treatment . warnings and precautions talk to your doctor , pharmacist or nurse before using orgal Utran allergic reaction . allergic reactions may occur as early as possible and may include generalised hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angioedema ) (
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine the dose and schedule of orgalutran , depending on your individual needs . the treatment is based on assisted reproduction techniques , such as in vitro fertilisation ( ivf ), ovarian stimulation , and follicle stimulating hormone ( fsh ), with the addition of corifollitropin on day 2 or 3 of each 3 - week cycle . orgalugatran is injected under the skin ( subcutaneously ), every 5 to 6 weeks . you may receive up to one additional dose of orgutran in women who are unable to fend off the fvh during the same cycle , or in women whose fh has been determined . for fcg 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . very common ( may affect more than 1 in 10 people ) local skin reactions , with redness and swelling . the local reaction usually disappears after 4 weeks . uncommon ( may effect up to 1 in 100 people  ) headache nausea and malaise very rare ( may impact up to1 in 10 , 000 people ). allergic reactions : rash facial swelling ; difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat causing difficulty in breathing or swallowing . swallowing or swallowed . not known ( frequency cannot be estimated from the available data ) allergic reactions including rash false sense
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be used within three months after first opening . they should be stored in clear , particle - free solutions . discard any unused solution .
what orgalutran contains - the active substance is ganirelix ( 100 mg / 0 . 5 ml of acetic acid ). - each vial contains mannitol and water for injections . - depending on the ph and the amount of sodium hydroxide needed , acettic acid may be added to the solution . what orgutran looks like and contents of the pack orgalugatran is a clear and colourless aqueous solution for injection . the solution for subcutaneous administration is clear and colorless . not all pack sizes may be marketed . each pack contains one vial with dry natural rubber / latex . orgalurtran is available in packs containing 1 or 5 vials , each containing one vially .
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rtuximamab sticks to this cell , the cell dies . what blitima is used for billetima may be used for the treatment of several different conditions in adults , including a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes , which accumulates in the blood . blizima can be given alone or with other medicines called " chemotherapy ". depending on the response to the treatment
do not take blitzima if you are allergic to rituximab , other proteins which are like ritsuximabib - like to other proteins , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if the medicine is not being used if : you have been told by your doctor that you suffer from a weak immune system . you have severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use billetima in these circumstances . talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor before using blitima you have ever had
how it is given blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a blitima via a drip ( intravenous infusion ). medicines given before each billetima administration before you are given  Blitzimа , you will be asked to take other medicines ( pre - medication ) to prevent or reduce possible side effects ( see section 4 ). how much and how often you will receive your treatment a list of all medicines ( see ' handling instructions '). if you are having non - hodgkin ' s lymphoma if blizima is given alone bitzima may be given for 4 weeks . repeated treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , drowsiness , sleepiness and dizziness . very rarely . if you get infusion - related reactions during the first 48 hours of treatment , you may experience chills or sweltering ; pain at at the site of infusion or at the location of infusing blisters or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituximabob . the 10 ml vial contains 100 mg of ritsuximаb ( 10 mg / mL ). the 50 m mlitre contains 500 mg of of  Rituximib (10 mg /10 mmol / ampoule ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what bmwima looks like and contents of the pack billetima consists of a clear , colourless solution for infusion . it is supplied in 2 glass vials ( 50 iu ) for 1 vial .
roactemra contains the active substance tocilizumab , a monoclonal antibody , designed to recognise a specific target substance in the body called interleukin - 6 ( ilk - 5 ). it works by blocking a protein called cgrp , which is found in large amounts on the surface of your body and reduces the inflammation in your body . rroaktemrova is used to treat symptoms such as pain and swelling in your joints . by blocking the damage to the cartilage and bone in your joint , it slows down the progression of the disease . the active ingredient in róactemara is indicated for the treatment of adult patients with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or have not work well enough 
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection at the time of the infusion . warnings and precautions talk to your doctor or nurse before you are given . before you receive róactemara , tell your doctor if : you experience allergic reactions such as chest tightness , wheezing , severely dizziness or light - headedness ; swelling of the lips or skin rash , may occur during or after the infected area . infection if any of these apply to you , or if they occur , contact your doctor immediately . if ever feel unwell , stop using rroaktemrana and tell your healthcare professional if your body ' 
roactemra is given into a vein by a doctor or a nurse . your doctor or nurse will give you the intravenous infusion as early as possible during the treatment . the recommended dose of rroaktemrana is 8 mg / kg given every 8 hours for up to 4 weeks . a second course is recommended after 4 weeks and then 8 weeks after the first course . you will be given ra in 4 stages : - as a drip in the vein ( intraveinenous infusion ) ( see section 2 ). róactemara 30 mg pfizer is usually given every 12 hours for one or two weeks , followed by raccoladement every 30 minutes for 8 hours . how much and how often you will receive rôactera varies depending on your body weight . adults the
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported : in 3 patients treated with rroaktemrana : serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , difficulty with breathing , chest tightness , light - headedness ; rash , itching , and hives ; swelling of the lips , tongue or face ; serious infections , including fever and chills , especially in the mouth and throat . uncommon ( may effect up to1 in 100 people ). tell your doctor if you notice any of the following : chills or rash in the stomach , mouth , throat or nose ; stomach pain ; diarrhoea ; vomiting ; abdominal pain . reporting of side effects
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vially in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . rroaktemrova is for single use only . once the vialic is opened , use it immediately . discard if not used immediately , out of date and time of opening .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tocilizub , corresponding to 20 mg / m2 after reconstitution . a 10 mL vial delivers 200 mg of Tocilizumаb ; a 20 m / 20 - m3 vial provides a deliverable dose of 400 mg of TOcilizum ab in 20 , 30 m4 , or 40 mmol / vial after reconstitute . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what - the pack rroaktemraza is a concentrate for solution for infusion . it is supplied
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . onbriez breezehaler relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . you can use onbez breEZhaler for any age - related breathing difficulties , as it is used for adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . when onbrés breezihaler works this medicine relaxed the muscle in the air spaces in the lung , allowing the air to get in and through the pulmonary chambers .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbez breezehaler for asthma ( see also section " other medicines and onbriez breezihaler "). - do not take onbre breEZhaler to treat heart problems . - epilepsy . talk to a doctor if your thyroid gland problems ( thyrotoxicosis ). if any of these apply to you , tell your doctor immediately . when you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs of a condition called bronchospasm . tell your physician immediately 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is to inhale the content of one capsule each day . you only need to inhake once a day because the effect of the 150 microgram capsule lasts for one to two days . your doctor may increase your dose to 300 micrograms each day depending on how you respond to the treatment . do not use more than your doctor tells you to use . use your inhaler at the same time each day and not only when you have not inhalation powder . this will ensure that there is always enough medicine in your body to help you breathe more easily throughout the day and night . how to inhhale onbrez breezhaler - onbez breezehaler is for inhalations use - the medicine is a white to off
what onbrez breezhaler contains - each onbriez breezehaler 150 microgram capsule contains 150 microgrammes of indacaterol as indocaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbez brezhaler 300 micrograms capsule contains 300 microgramms of Indacatrol as Indocatrol maleat . each onberez  Breezhalers 300 microcapsul capsule contains 30 microgram inddaCatrol maleates . lactoses and the cap is made from gelatin and is clear . what onbeezhaling looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . not all pack sizes may be marketed . capsules are white and contain a white powder
clopidogrel hcs contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this cluming , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopigrel hocs is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopionogreL hhcS to help prevent blood blood - clotes ( t 
do not take clopidogrel hcs if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use clopinogreil hccas : if any of these apply to you . warnings and precautions before taking clopionogregrel hacs you should tell your doctor if : you have a risk of bleeding such a situation that puts you at risk of internal bleeding ( such as such  as : stomach ulcer ). you have been told you have or have had a blood disorder that makes you prone to internal bleeding (" bleeding inside any tissues , organs or joints 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor advises you to take clopinogrell hccas . you should have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral HSHCs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , once at rest , with or immediately after taking clopogrela
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel hcs contains the active substance is clopinogrell . each film - coated tablet contains 75 mg of clopdogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' clopirogreel  hhcS contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  e172 ), yellow iron oxide , the printing ink contains talc and macrogol 3000 . what ccs looks like and contents of the pack the film  - coating is a pale yellow to brownish
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help to fight bacteria which cause infections . fеtcroj is used to treat infections caused by bacteria that have been previously treated with other antibiotics , in adults and children .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic at the same time as other antibiotics , such as cephalosporins . warnings and precautions talk to your doctor or pharmacist before taking ftcroj if : you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). you have ever had severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . talk to you doctor or nurse before taking your first dose of fеtcroje if any of these apply to you . you have experienced any allergic reaction with other antibiotic ( s ) while taking
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes 3 to 2 hours for fetcroja treatment to start . talk to your doctor or healthcare professional if you are not sure . how much ftcroje is given your doctor will decide how much medicine to give you . your doctor may decide to reduce your dose depending on the severity of infection . if your infection is serious or if there is any pain you experience during the fentcroja infusion , the doctor or health care professional will check you for kidney problems . patients with kidney problems your doctor should decide if it is necessary to give faja . you will be given your dose of ffettingcroja every three weeks . this is to make sure that you receive the correct dose . tell your doctor if ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction . the signs may include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may also be preceded by diarrhoea and may progress to worsening of stools or blood or mucus . your doctor may decide to reduce the dose , stop treatment and start you on medicines that slow bowel movement . reporting of side effects get more information if your doctor gets any side effects you can report them to your doctor . very common reported side effects ( may affect more than 1 in 10 people ): - cough - diarrachoean
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefizideroCOL . - other ingredients are sucrose , sodium chloride and sodium hydroxide . what etcronja looks like and contents of the pack fеtcroj is a white to off - white powder for concentrate for solution for infusion supplied in a vial . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatomus meningităis is a condition in which tumour cells form within the membranes of the brain and spinal cord . depcyto works by blocking the growth of lymphoma tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - have a meningeal infection . - suffer from severe neurological side effects . warnings and precautions talk to your doctor or pharmacist before taking dep cell . symptoms of the nervous system may include convulsions , pain , numbness or tingling , blindness and visual disturbances . tell your doctor immediately if any of these symptoms occur . do not continue taking any depamethasone tablets for longer than a day . it is important to tell your healthcare professional if : you experience unwanted effects and monitor your side effects more closely , or if they continue for a long time . you should tell your physician if your side impacts are severe and any new side effects
you will not have to store depocyte if you are being treated for cancer . the doctor treating you will administer dep cell to you by a doctor or nurse . they will also instruct you how to store and dispose of it . dep cells will be given to you in a hospital or clinic , under the supervision of a physician experienced in the care of patients with lumber sac . it is important to follow the instructions of the doctor or health care professional that you are given depcytoc , in order to keep the product clear and colourless . after injections , the recommended starting dose is 1 ml ( 5 mmol ) dexamethasone 5  m2 of solution . each depoocyte dose will be monitored carefully in order for you to minimise any side effects . before depcell is withdrawn from the vial , it should be thrown away
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . the frequency of possible side events listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects in 1 to 10 users in 100 ) uncommon ( effects on 1 to 100 users in 1 , 000 ) rare ( effects of 1 to 5 users in 10 000 ). very rare ( affect less than 1 users in 1000 ) not known ( frequency cannot be estimated from the available data ) adverse events have been reported when depocyte was given alone . when depectoris or other chemotherapeutic agents were given together ( very common in more than1 user in 100 and less than1 utilizator in 10 patients ) very common adverse events ( effects for more than 10 users per
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). depocyte can be stored in the original carton for up to 4 weeks before being used . once dep cell has been reconstituted , it should be used immediately . this medicine should not be used if you notice severe discolouration , a changed appearance or a defective container . depcyto should not always be used together with cytarabine . any unused product should be discarded .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cyerabine ( 18 mg / 5 mL ). each vial contains 50 mg . - this is equivalent to 50 mg of cztarabin . the other ingredients are cholesterol , trioleoylphosphatidylcholine , dipalmitoyllphosphatidicylglycerol , sodium chloride , water for injections . what depepocyte looks like and contents of the pack depcyto is a solution for injection in a vial ( 5 mg ). it is supplied as a single injection or as ' single vial '.
what bemrist breezhaler is and how it works bemmrIST breezehaler contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the lining of the air . when bemreist  Breezhalers is used , it helps the small lungs to remain open . mometapasine furoates belongs to one of a a family of medicines named corticosteroids ( or steroids ). corticostroidoids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using bemmrIST breezehaler and during treatment : if any of these apply to you ( or you are not sure ), talk to a doctor before you are given bemreist  Breezhalers if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . tell your boss if your daily dose is too high . if so , you have ever been told you have diabetes or high blood sugar . or you have had seizures
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhale the content of one capsule each day . you only need to use the medicine once a day , so you only use the dose that is effective to control your asthma and your symptoms will get worse . when to inhhale bemmrrist brezhalers the usual way to inhume the content in this pack . the inhaler and capsules in this package will contain the medicine and will help you to inshale it throughout the day and night . only use it when your symptoms are controlled by your doctor . once you have used bem breezehaler , your doctor may need to adjust the dose or to adjust it if your asthma is not controlling
like all medicines , this medicine can cause side effects , although not everybody gets them . they are usually mild to moderate . some side effects may be serious . tell your doctor straight away if you get any of the following : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ). swelling mainly of the lips / face or throat ( angioedema ). other side effects include : very common ( might affect more than 1 in every 100 people and may affect more people ), swelling of your tongue / lips - face or neck ( signs indicate angio edematus ). if your doctor tells you to stop using this medicine , tell your dentist immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . discard unused capsules .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each bemmristic breezehaler 125 micrograms / 62 . 5 microgram inhalation provides a delivered dose ( the dose leaving the mouthpiece of the inhaler) of 127 . 4 microgram ( the equivalent of 173 microgram ) inddacatrol aate to 150 microgram of indаcaterol and 80 microgram( ml ) mometapasONE furoates . the delivered dose , the dose that leaves the mouth piece of the breezihaler ( the amount that leaves your mouthpiece ) is equivalent to 125 milligrams of indeacaterolul and 62. 5 millilitres of mome
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this cluming , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zylt is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , which can lead to atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zyllingt to help prevent blood blood - clotes from forming .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not continue taking zylt . warnings and precautions before taking a dose of zyllingt , tell your doctor if any of these apply to you . tell your healthcare professional before taking the medicine if : you have a risk of bleeding such a medicine that puts you at risk of internal bleeding ( such as the case of a breast ulcer ). you have been told that you have or have had a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has told your doctor that you have severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cytokines ( cytokine ) once at the start of treatment . then , the recommended dosage is one75 mg tablet once at start of therapy . you should take zyllingt for as long as your physician continues to prescribe it . take zllt for at least 32 hours before or with food . contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in some cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or redness on the skin . very common side effects ( may affect more than 1 in 10 people ): diarrhoea ,
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 ' zyllingt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose , titanium dioxide ( e171 ), red iron oxide ( е172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  sachets are available . not all pack sizes may be
lamivudine teva contains the active substance lamimivudines . lamimivucine is used to treat long term ( chronic ) hepatitis b infection in adults . Lamivine tingeva is an antiviral medicine that suppresses the hepatis - b virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis B is a virus that infects the liver , causes long term( chronic ), chronic , and liver damage . in this case lamvudince t Eva can be used in patients whose liver is damaged but still functions normally ( compensated liver disease ). treatment with lammivine to reduce the amount of heparin in the blood . this
do not take lamivudine teva if you are allergic to lamimivudines or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before taking lamivane toeva . taking lamevudinez t Eva at the same time as other similar medicines may cause serious side effects . you need to be aware of the extra risks : if , you or your child has liver disease , including hepatitis c . if your doctor thinks you are seriously overweight ( especially if the child is a woman ) talk to you doctor if any of these apply to you . your doctor may ask you to have blood tests before you start taking your medication , and at least 4 weeks after starting lamivine it may not be possible for your he
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . it is used when your doctor thinks your infection is getting worse . this is because it stops your illness getting worse and it keeps coming back . your doctor will tell you how long you should take lamimivudines t Eva . do not stop taking lamivane without your doctor' s advice . if your doctor has prescribed lamivine for you , your doctor may need to reduce the dose , temporarily stopping your kidneys from working properly . when lamiumudinе is used alone , it may be necessary to take it at a lower dose than with another medicine , which
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with lamivudine teva . some patients have other conditions that can be caused by hepatitis b . for these reasons , it is important that you also read the information under ' other possible side effects of therapy for hepatis c '. for further information , see ' serious side effects from therapy for all patients with hepitis ba ' and ' warnings and precautions ' in section 2 . in addition , other side effects reported during lamivine clinical trials were : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort and pain , nausea , vomiting , diarrhoea , increases in liver enzymes . not known ( frequency
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . lamivudine teva does not require any special storage conditions . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamimivudines . each film - coated tablet contains 100 mg of lamichivucine ( 84 mg ). - other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( s ), iron oxide red ( oblong ). what lamevudince t Eva looks like and contents of the pack orange , round , biconvex film . approx . 32 mm in diameter , debossed with " lilly " on one side and plain on the other side . lamvudi
nespo is an anti - anaemic . nnevo is used to treat your anaemia . anaesthesia occurs when your blood contains too many red blood cells . the symptoms are fatigue , weakness and shortness of breath . your doctor has prescribed n espo because you are already taking the natural hormone erythropoietin . in your body , erythropoetIN is important because it enables your kidneys to work harder . it also stimulates your bone marrow to produce more red blood cell ( erythema ). naspo is also used to increase the production of darbepooettingin alfa . what neverspo is used for negaspo is given to you to treat chronic renal failure in adults , with symptomatic anaedia . chronic
do not take nespo if you have high blood pressure that is not controlled with other medicines . do not use n espo ( darbepoetin alfa ) or r - hoepo if any of the above applies to you . if your doctor has told you that you have , or have ever had , high blood tension . take special care with nnespor : if - you are allergic to nyo , medicines used to treat sickle cell anaemia , epileptic fits ( seizures ), fits or seizures . warnings and precautions talk to your doctor before taking nеspo : when you have or have had liver disease or drugs used to suppress your immune system ( see other medicines and naespo for example , if the body is unable to fight anaemic ).
your doctor will carry out blood tests before and during treatment with nespo to ascertain whether you are able to control your haemoglobin level . if necessary your doctor may adjust your dose , up or down , depending on your haEmogin level ( in units or dl ). if you are not sure , talk to your doctor or nurse before using nnespor . your doctor should maintain your hamosphere level within the target range of 10 to 10 g / dL and must use a haemeglobin niveau above 10 ng / 12 g every 12 hours . how and when to inject n espo naemograms are given by a doctor or a nurse . chronic renal failure is given as a single injection under the skin or into a vein ( intravenous ). your
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( affect affects less than 1 user in 100 and affects 1 to 10 users of n espo ) are blood clots ( thrombosis ). pain in the area injected rash or redness of the skin rare ( affect 1 to10 users in 10 , 000 ) serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) which may include swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemo ) has also been
keep out of the reach and sight of children . store in the original package in order to protect from light and moisture . keep out the reach of children and other household members . do not use nespo after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . before first use store in a refrigerator ( 2 - 8 ). do not freeze . after first opening or if carried as a spare you can carry your syringe with you and keep it at room temperature ( not above 30 ) for up to 7 days . nnespor should not be used if it contains visible particles . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is naloxetin alfa . nnespor is available as a pre - filled syringe with 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms of the active ingredient darbepoetine alf . the other ingredients of n espo are sodium phosphate monobasic , sodium phospho dibasic ( e339 ), sodium chloride , polysorbate 80 and water for injections . what ' nеspo looks like and contents of the pack nnemspo is a clear to slightly opalescent , colourless to slightly pearly liquid , with no particles visible , and no water . it is supplied
macugen is a solution which is given by injection into the eye . the active substance in macuGEN is pegaptanib . this medicine works by inhibiting the abnormal formation of new blood vessels in the eye and slowing down the rate of growth . macuogen is used for the treatment of patients with macular degeneration ( amd ). this disease can lead to vision loss and damage to a part of the retina called the macula , which is at the back of the eye ( maculus ). the macula is the light - sensitive layer at the front of the lens of the main eye in adults . in amd, abnormal blood vessels grow and the retina becomes thin , with the maculate . if you have any questions about how macugène works or why this medicine has been prescribed for you , ask your doctor .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around the eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macuogen . there is a small chance that you may have an infection . bleeding in the eye may occur following macuGEN injection . tell your doctor immediately if : you experience any of following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . if any of these occur , stop the injection and seek medical help immediately . the injection serious allergic reactions can occur . you should seek medical assistance immediately , if the symptoms do not improve or get worse ( see section 4 
the doctor treating you will give macugen under the supervision of a doctor experienced in the use of injections . macuogen must be given by a healthcare professional . the recommended dose of macuGEN is a single injection into your eye . it will be given every 6 to 9 weeks . during the first week , the injection will be administered under the responsibility of  a physician . your doctor will remove the vitreous layer from your eye and will clean the affected eye if necessary . before using macu Gen , your doctor may use antibiotic eye drops to clean your eye before and after the injection . you may also be given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection and to reduce the risk of allergic reactions . if you are allergic to antibiotic eye drops , you should be given antibiotic treatment to prevent eye infection
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) has been reported in association with angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been observed in patients undergoing macugen treatment . it is possible that these symptoms may be increased in up to 2 in 10 patients . see also section 2 . if you experience any of these symptoms , tell your doctor immediately . 2 - if these symptoms become severe , they are usually mild to moderate and go away within
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once the bottle is opened , the medicine should be used immediately . store in the original package in order to protect from moisture .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegappanib in 90 mg / ml solution for injection . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuogen solution for injecting in a single dose pack is a pouch packed in  a pre . a ready to use pre – filled cylinder containing 0
kepivance contains the active substance palifermin which is produced by recombinant dna technology in bacteria called escherichia coli . palifERmin is produced in the epithelial cells and is carried around the mouth and in the digestive tract ( where it enters the tissues below the skin ). by combining with palifersmin , kepepivaance is used to treat oral mucositis ( a condition where soreness , dryness and inflammation of the mouth is a common side effect of treatments to treat your blood cancer , or if your blood tumor is not adequately controlled with chemotherapy or radiotherapy or with autologous hematopoietic stem cell transplantation ( hh ).
do not use kepivance : - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . do not take kepitivance with heparin . tell your pharmacist , pharmacist or nurse if : you have recently taken hepivaine . pregnancy and breast - feeding kepingivance is not recommended if there is a possibility that you may be pregnant , think you may have a small risk of becoming pregnant . if this applies to you , do not breast  - feed while you are taking
kepivance should be given under the supervision of a doctor experienced in cancer treatment . the recommended dose of kepepivace is 60 mg . kepenivance is given as an intravenous injection into a vein . it is given to you if you : - are being treated with kepativance . you will be given kepitivance three days before chemotherapy and radiotherapy . at least three days after chemotherapy and radiation therapy . after chemotherapy , you will receive chemotherapy andradiotherapy , which will take 24 to 48 hours . your doctor will decide when to give the chemotherapy and how long the chemotherapy will last . following the chemotherapy / radiotherapy you will also receive the chemotherapy during the off period . depending on the side effects of the chemotherapy your doctor may decide to give you an additional dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects may include : skin rash , itching and redness ( pruritus , erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue ; generalised swelling ( oedema ); swelling of hands , ankles or feet ; pain ; fever ; aching joints ( arthralgia ); altered taste ( lipase levels ) uncommon ( may effect up to one in 100 people ). not known ( frequency cannot be estimated from the available data ): amylase levels very low ( may impact up to1 in 10 , 000 people ), not known : frequency cannot been estimated from available data not known frequency cannot yet
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of palifersmin - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivancing looks like and contents of the pack kepepivace is a white powder that comes in a glass vial and is supplied in packs of 6 vials .
cinacalcet accordpharma contains the active ingredient cinacacalcet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parat thyroid glands . the parathormons are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( pmr ). cinacinacalce accordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ). in patients suffering from parathian cancer to reduce calcium inthe blood ( hypocalcaedia ) in patients having primary hyperparathhyroidismus when removal of the gland is not possible . cinaccet accord pharmaceutical is used in adults
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor , pharmacist or nurse before taking cinacet accord pharmaceutical . cinacinacalce accordpharma has not been studied in adults . speak with your doctor before taking the medicine : - you may experience seizures ( fits or convulsions ). these are rare cases of seizures . tell your doctor immediately if any of these apply to you . you may have liver problems , heart failure and may have been involved in the manufacturing process . in this case cinaccet accord pharmacy may increase calcium levels and may increase life threatening events and fatal outcomes associated with low calcium levels ( hypocalcaemia 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be swallowed with some water . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . in adults with secondary hyperparathyroidism the usual starting dose for cinacinacalce accordpharma is 30 mg . children and adolescents ( 3 to less than 18 years of age ) the usual dose is 0 . 20 mg of cinaccalcet agreementpharma per kilogram of body weight . therefore , your doctor may tell you to take cina Calcet accord pharmaceutical 30 mg twice a day . this medicine must always
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). signs include : swelling of the face , lips , mouth / tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). common ( may affect up to 1 in 10 people ) nausea and vomiting . if any of these side effects causes unusual behaviour , tell your pharmacist . very common ( might affect more than 1 in10 people ). dizziness , headache and diarrhoea . common (may affect upto 1 in every 10 people and may cause dizzience ). uncommon ( may effect up to1 in every 100
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacinacalce ( as hydrochloride ). - its derivatives include cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide , triacetin , indigo carmine aluminum lake , iron oxide yellow ( e172 ). what ccalcet acordpharma looks like and contents of the pack cinaccet accord pharmacy 30 mg film  - coating are light green colored , oval shaped ( approximately 9 . 65 mm x 6 . 00 mm in diameter ) biconvex , film  coated tablet debossed with " c7 " on one side and plain on the other
jentadueto contains two different medicines called linagliptin and metformin . linaligptIN belongs to a class of medicines called " dpp - 4 inhibitors " ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of drugs called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps control the level of sugar in your blood when you have this medicine with insulin . this medicinal product can be used alone or with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin , or insulin ). it is used when you do not have type 2 Diabetes .
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - have severely reduced kidney function - suffer from uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - Coma . symptoms include stomach pain , fast and deep breathing , abnormal liver function , and liver enzymes build - up of acid in the urine . the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the amount of jentadueto that you currently take is based on your weight and the strength of metformin . this medicine is available as individual tablets containing linagliptin and metformine . your doctor will tell you how many tablets of this medicine to take . take the number of tablets following your meal . swallow the tablets whole . if your stomach is not well controlled , your doctor may prescribe half the dose of 5 mg linaligptIN per day , or 2 , 000 mg metforminer hydrochloride , as a single tablet . taking jenteduet at the same time each day will help control your blood sugar . you should continue to take this medication until your doctor tells you to
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ), trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypogliescaemia ( frequency not known : cannot be estimated from the available data ) is a common ( may affect up to 1 in 10 people ). this side effect is more likely to occur when jantaduеto plus sulphonylurea or the combination jenteto plus insulin : tremor , shaking , confusion , sleepiness , dizziness . common (may affect upto 1 in every 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : keep the bottle tightly closed in order protect from light . does not use if the package is damaged or shows signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jsentaduеto 2 . 5 mg / 850 mg film - coated tablet contains 2 : 5 mg of linaguiptIN and 850 micrograms of metformine hydroch chloride  . each juentaDUeto 2 2  : 1 , 000 mg film coated tablet contient 2 , 5 mg de linaligtin , and 1 : 000 mg metformink hydrochchlorides . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc ,
edurant contains the active substance rilpivirine and it is used for the treatment of human immunodeficiency virus ( hiv ) infection in adults . ecedent belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is for use in adults only . it is to be used in combination with hiv medications to treat adults and adolescents 12 years of age and older who are infected with hivi and who have not used other hiv remedies before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ecedent . if this applies to you , tell your doctor before taking your first dose . do not combine e pendant with any of these medicines : carbamazepine , oxcarbazepine ( e . G . pantoprazole , and phenytoin , medicines used to treat epilepsy and prevent seizures ) rifampicin and rfapentine ( medicines used for some bacterial infections such as tuberculosis )) omeprazole / esomeprazola , or lansoprazolе , pantopraco
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults 18 years and over the recommended dose is one tablet twice a day . edurant must be taken with food . do not chew , crush or split the tablet . your doctor will tell you if e pendant needs to be changed . take e during meals . 1 . swallow the tablet whole . you may take rifabutin , a medicine used to treat some bacterial infections . it is important that you do not take a tablet of ecedent with food that contains rfabutun . how to take - e durant take / swallow the tablets whole , with or without food ; - do not split , break , or chew the tablet before swallowing . 2 .
like all medicines , this medicine can cause side effects , although not everybody gets them . you should see your doctor immediately if you experience : headache , nausea , difficulty falling asleep , insomnia or dizziness . these may be due to changes in your routine liver tests ( transaminase , increase in cholesterol and pancreatic amylase in your blood ), or to abnormal dreams , rash , or stomach pain , depression , tiredness , vomiting , and drowsiness or decreased appetite . sleep disorders , stomach discomfort , depressed mood , confusion , nervousness / confusion . this may be a sign of a condition called ' hla - b * 5701 '. reporting of side effects 25 if any side effects become severe , talk to your doctor , pharmacist or nurse . the following side
what edurant contains the active substance is rilpivirine . each tablet contains rilspiviline hydrochloride . e durant contains rachirine hydroch chloride equivalent to 25 mg rillpivitine . the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . in addition , the film coat contains lactse monohydrate . it is also composed of hypromellose 2910 ( approx . 6 mm ), titanium dioxide , macrogol 3000 , triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabetic can either not make enough insulin ( a hormone that controls blood sugar levels ), or don ' t respond normally to the insulin their body makes . rosivitazon and met formin work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar . when avandagemet is used in combination with a sulphonylurea ( another medicine for diabetes ).
avandamet is not recommended for you if you are not sure . do not take avandаmet if : you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandhamet ( listed in section 6 ) you have had a heart attack or severe angina , you have heart failure or have had heart failure in the past you have severe breathing difficulties you have liver disease you have diabetic ketoacidosis ( a complication of diabetes with rapid weight loss , nausea or vomiting ) your doctor has told you you have kidney disease 107 you are very sleepy and you are more sleepy than usual . you are also more likely to have kidney problems . your doctor will tell you : 107 it is important to keep following the advice about diet and exercise given to you by your doctor , pharmacist or nurse 
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended starting dose is one 2 mg tablet of rosiglitazone and 1000 mg of metformin per day . this dose is taken on day 1 and on day 8 of each 3 - week cycle . your doctor may adjust the dose depending on your response to this dose . from day 4 onwards , your doctor will increase your dose to one 4 mg tablet in the morning and one tablet in a day , depending on how well the medicine works for you , based on your condition . doses of  Rosiglinazone + 1000 mg metformine are not recommended for children . adults taking this dose should take 2 tablets in the evening with food . if taking avandat at the same time each day take the tablets with food
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are very rare in people taking avandаmet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . if you get any of these symptoms seek medical advice immediately . stop taking a medicine and call your doctor straight away . your doctor may decide to reduce your dose of avandhamet , or stop it altogether . also , there may be a condition called lactic acidosis , which causes a build - up of lactic acids in the blood ( lactic Acidosia ). this side effect is more likely when taken with metformin . the doctor also wants to reduce the dose . severe kidney disease . symptoms
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don ’ t need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avandemet tablets come in different strengths . one contains 1 mg rositazone + 500 mg metformine . each 2 mg - dose tablet contains rosiltazon + 500 micrograms metformIN . Each 2 mg tablet contains 2 mg of rosivita zone and 1000 microgram of metforminer . every 4 mg , tablet contains 3 mg  Rosiglitabzone + 1000 microgramms met formin - its constituents are : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose - free . not all pack sizes may be marketed .
clopidogrel mylan contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this cluming , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopdogrelan mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , that can lead to atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogral myLAN to help prevent blood
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain .if you suffer from severe liver disease . warnings and precautions talk to your doctor before taking clopinogrela mylan . before you take a dose of clopionogrelan mylan it is important to tell your dentist if any of these apply to you before you start to take cologne : if your family has a risk of bleeding such a clinical condition that puts you at risk of internal bleeding ( such as such as the case of a breast ulcer ).if you have a blood disorder that makes you 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor thinks that you may have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 4 tablet of 75 milligrams ) taken or given alone . you should take clopinogrelan mylan for as long as your physician continues to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . you may have been told by your doctor that you have an allergic reaction . the signs of an allergic attack are listed below . they usually go away within a few days . very common side effects ( may affect more than 1 in 10 people )
what clopidogrel mylan contains the active substance is clopinogrell . each film - coated tablet contains 75 mg of clopdogrelly ( as hydrochloride ). the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopirogreel myLAN contains hydrogenated castingor oil ') tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  e172 ), yellow iron oxide , the printing ink contains talc and macrogol 3000 . what clupidogral mylang looks like and contents of the pack the film  - coating is brown , oval shaped and
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelt is used to treat chronic liver disease with low platelet count ( thrombocytepenia ) in adults who need a medical procedure to prevent bleeding . it works by increasing the number of platelets in the blood . platelets are blood cells that help the blood to clot , which in turn reduces the risk of bleeding  .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - blood clots may form in the veins or arteries . this is because blood coagulations are more likely to happen . - it is important to tell your doctor if any of these apply to you . warnings and precautions talk to your doctor before taking dop Telet . blood  clotes : tell your healthcare professional if : you have had blood cluts in the past . your doctor may want to monitor you more closely . you have cancer . have recently taken the contraceptive birth control pill or hormone replacement therapy . or you have recently had surgery or are injured . 23 - you are overweight - your doctor will decide if doptelt is suitable
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for your procedure is one 5 mg tablet 8 times a day . you should take doptelet at about the same time each day , preferably in the morning . your doctor will decide the dose that is right for you , depending on the dose you take . dose the recommended daily dose of dop Telet is 20 mg , 40 mg or 60 mg . dosage the recommended starting dose may be reduced to 5 mg once a week , but your platelet counts may be checked at regular intervals . use in children this medicine can be used in adolescents and children of 10 to less than 13 years of age , at the same dose as in adults . in this case , your doctor may reduce the dose of your planned medical procedure . swallow the tablets whole with a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) feeling tired uncommon ( may effect up to1 in 100 people  ) low red blood cell count ( anaemia ) blood clot in the portal vein ( blood vessel in the liver ) not getting out of the intestines upper abdominal pain swelling bone pain muscle aches fever reporting of side effects 4 . 5 million people if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine to help provide better information on side effects for your benefit .
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatarombog maleate equivalent to 20 mg avatombopag the other ingredients are : lactose monohydrate ( see section 2 " dopelet contains lactoses "), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , titanium dioxide ( e171 ), iron oxide yellow (  172 ). what dopet looks like and contents of the pack doptelt 20 mg film opteles tablets are pale yellow , round and rounded , marked " 20 " on one side . the tablets are provided in one aluminium blister .
rapiscan belongs to a group of medicines called ' coronary vasodilators ', which work by allowing the muscles in the heart to relax . they work by relaxing the heart arteries , allowing them to relax more easily . rapican is used for a type of heart scan called a ' myocardial perfusion imaging '. the scan contains a radioactive substance called , called  a ‘ radiopharmaceutical ' which helps to improve the images of the muscles of the heart and allows the blood to be scanned using a treadmill or a machine . this helps to get the best pictures of the whole body ' s heart . it is given to adults only . after a scan , your doctor may give you a small amount of radiopharmaciaceuticals to be given to you by a doctor or nurse 
do not use rapiscan - if you have slow heart rate ( high degree heart block , sinus node disease ) or if your doctor has told you that you need a pacemaker . - when you have chest pain ( unstable angina ) your doctor may decide to reduce your dose , stop treatment temporarily or permanently . warnings and precautions talk to your doctor before using rapistcan : - contact your doctor if : you have low blood pressure ( hypotension ) you have heart failure you are allergic to regadenoson , or any of the other ingredients of regadanoson ( listed in section 6 ). if any of these apply to you , tell your doctor about your experience with rapican . talk to you doctor before you use a dose of rapissecan , if there is a possibility that you may not be 
rapiscan is administered to you by a doctor who is experienced in measuring your heart and blood pressure . it is given into a vein by delivering 400 micrograms of a 5 ml solution the injection will take about 5 to 10 minutes . your dose is based on your weight . the recommended dose is an injection of sodium chloride 9 mg / m2 for each kilogram of body weight , and the dose is 9 mg per kg of bodyweight . you will be given 5 microgram / kg body weight given once a week . a radioactive substance ( radiopharmaceutical ) will be added to rapistor . how rapissecan is given rapican will be injected at regular intervals , depending on your heart rate , your heart speed and bloodpressure . at the time of the rapisécan injection , you will have to
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects related to the rapistcan injection are usually mild to moderate and of a short duration . they usually disappear within 30 days after the last dose . tell your doctor or nurse immediately if you notice any treatment related to side effects you may need urgent medical attention : sudden stopping of the heart , which may cause damage to the heart and heart block , or a disorder of the hearts electrical signal , rapid heart beat low blood pressure fainting , mini strokes weakness of the face or inability to speak . you may also be given rapican to reduce the chance of having a stroke ( or cerebrovascular accident ). tell your healthcare professional if he / she is having an allergic reaction , such as rash , wheals / weals or hiccups
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penia when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . this is a treatment for adult men with erectile dysfunction , sometimes known as impotence . these are situations when a man cannot get , or keep a hard , white , and ect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not use viagra if any of these apply to you . - are taking medicines called nitrates . this may lead to a dangerous fall in your blood pressure . tell your doctor if this applies to you and / or you are not sure . warnings and precautions talk to your doctor before taking these medicines , as they may increase your risk of angina pectoris ( or " chest pain "). if the medicines are made from nitric oxide donors such as amyl nitsitrite (" poppers "), this may also lead to the possibility of a terrifying fall in votre blood pressure. if so , your doctor may recommend that you take riociguat . This drug is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . your doctor may advise you to take viagra film - coated tablets or viagra orodispersible tablets . this will help you to get an erection . if your doctor tells you to , you should stop taking viagra . taking viagra will usually help you get an anerector . it will only help you if the effect of viagra is greater than it should . for the best results , your doctor will tell you to do so . do not take more viagra than your doctor told you to stop . take your tablet at the same time each day , with or without food . swallow the tablet whole with some water . how long to take this medicinal product you should
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and tell your doctor straight away : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). if this occurs after an eretic , lasting 4 hours
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , oblong , and a rounded - diamond shape , marked " 25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamamine receptors in the brain . stimulation of the dopa receptors triggers nerve impulses inthe brain that help to control body movements . sIfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons '
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of your family , friends , or carer knows - you have any medical conditions or symptoms , especially any of them . please tell your doctors if they have kidney disease . simirol has been associated with hallucinations ( seeing , hearing or feeling things that are not there ). most hallucings are visual . dyskinesia ( e .g . abnormal , uncontrolled movements of the limbs ). if your doctor thinks you may have advanced parkinson ' s disease and are also taking levodopa , you may develop dyskinei
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . sifrol should be prescribed by a doctor experienced in the treatment of parkinson ' s disease . the recommended dose is 3 tablets per day . during the first week , the usual dose is 1 tablet of sIFrol 0 . 088 mg / 0. 264 mg taken orally on day 1 , then again on day 2 , again on sIfrol 0- 088 / 1 . 028 mg or 0.00 264 , once daily , with meals 1 tablet ( s ) of ' normal dose ' ( 0 to 0 1 ) tablet of the same dose as 0/ 264 when your symptoms are not controlled or are not relieved . your doctor may prescribe tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect 1 in 1 , 000 people very rare may impact up to 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as a result of the use of sifrol : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there 
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 0. 35 mg . every tablet contains approximately 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur in the eye and the reaction is severe . in some cases the allergic reaction may be severe , and allergic conjonctivits may be caused by exposure to some materials ( allergens ) which may cause allergic reactions . signs include itching , redness and swelling of the surface of your eye if you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using e madine . children and adolescents do not give this medicine to children under the age of 3 years . do not take benzalkonium chloride as described in section 7 . please read the information under ' use of ema - 9 '. there have not been clinical trials on the use of the product in children and teenagers . there are no data available on the safety and efficacy of a meta - toxic substance in the treatment of children and young children ( below the age range ). other medicines and emagine tell your doctor or pharmacist if your child is using , has recently used or might use any other medicines . if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . one drop in each affected eye is recommended . do not use this product in other eyes . see section 3 . how to use wash your hands before you start . before you open the emadine bottle , write down the date you opened the bottle in the space on each dropper . wash your hand before you use it . take the bottle and write down any remaining drops you have used . twist off the cap . after cap is removed , if the tamper evident snap collar is loose , remove before using the bottle . hold the bottle as a thumb and middle finger , tilt your head back . pull down your eyelid with a clean finger . there should be a ' pocket ' between the eyelid and your eye
like all medicines , this medicine can cause side effects , although not everybody gets them . you may need to stop using the drops for a short time . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects that may affect ( up to1 in 100 people  ) effect in the back of the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ) eye irritation or blurred lens . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . You can also report side effects directly via the national reporting system listed in appendix 
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep the blister in the outer carton in order to protect from light and moisture . your doctor will check whether the tablets are still working , and if they do not , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains - the active substance is : ema - 1 . 5 ml solution for injection ( difumarate ). - other ingredients are : in the concentrate : benzoalkonium chloride , trometamol , sodium chloride ( see end of section 2 ). in the solvent : pregelatinised maize starch , hypromellose , purified water , hydrochloric acid and sodium hydroxide ( to adjust acidity levels or ph levels ). what ' e madine looks like and contents of the pack emagine is a liquid ( a solution ) for injection in a 5 - mL plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiractam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilema . epilemy is a condition where the patients have repeated fits ( seizures ). the epilepian form is based on the size of the fits , which initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ).  levetiratetam has been given to you by your doctor to reduce the number of fits . as an add - on to other antiepiceptic medicines to treat partial - onset seizures or myoclonic seizures ( minor fits
do not take levetiracetam actavis if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetistetam actingavis talk with your doctor if any of these apply to you . if your kidney problems are getting worse , follow your doctor' s instructions . follow your gut health advice . it is important that you continue to take levracetm actaviS until your doctor tells you otherwise . patients who suffer from kidney problems should be monitored carefully . tell your doctor about any slow down in the growth or unexpected puberty development of your child . some patients have been treated with anti - epileptics such as levetiretam actsavis have had thoughts of harming or killing themselves .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis should be taken twice a day , once in the morning and once inthe evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 300 mg each day when you wake up . when you will first start taking levetiracam act Avis , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1  , 500 mg . add - on therapy dose in teenagers ( 12 to 17 years ) weighing 50 kg or more : general dosage : Between 1 . 000
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ( 20 - 25 ) and increased levels of liver enzymes seen in blood tests ( increase in a type of white blood cell 56 ( eosinophilia )) and enlarged lymph nodes ( drug reaction with tetanus ) ( see section 2 ); side effects not known (
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetiratam activis 250 mg contains 250 mg of levracetnam . levetiretam actsavis 500 mg contains 500 mg of Levetiracem . each tablet of lavetiracetham act Avis 750 mg contains 750 milligrams of leveracetm a . two tablets of levaitracetham actavises 1 , 000 mg contains 1 - grams ( 9 . 7 millilitres ) of levantracetan a the other ingredients are crospovidon , povidone , silica colloidal anhydrous and magnesium stearate . what levatiracetami actavisent looks like and contents of the pack levetirasetam reactavis 250 milliliter tablets
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incruses ellippta is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs slowly become damaged , leading to breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the airway , causing difficulties in breathe . this medicine blocks the tightener of these muscles in the air , making it easier for air to get in and out of the pulmonary system to control your breathing difficulties and reduce the effects of copd on your everyday life . you should use incrussant ellipase eelliptic
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incrusese elipta : - patients with asthma ( do not inhale incrussanta unless your doctor has told you to ). this medicine should not be used in patients with heart problems . - people with an eye problem called narrow - angle glaucoma . talk to you doctor if your doctor thinks you have an enlarged prostate , difficulty passing urine or a blockage in your bladder . incrusted ellimpta is not recommended in patients of all ages with severe liver problems , so immediate
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use increse
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other possible side effects common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may also be signs that you are prone to infection ). common : rash or itching in the chest and forehead feeling tired ( nausea and vomiting ) uncommon ( might affect upto 1 in 1000 people !) if your kidneys are not working properly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaler inside the sealed tray to protect from light . after first use , the inhaler can be used for up to 6 weeks . once the inhhaler has been removed from the refrigerator , write the date on the inhabitant in the space provided . write the new expiry day on the product carton including day / month / year . when you start using the inHALER , store the inflater at room temperature for at least 30 . always keep the cap on the tray when you are not using it in order to protect it from light and to protect the product from light until it
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ). - other ingredients : lactose monohydrate ( see section 2 under ' incruses ellippa contains lactoses ') and magnesium stearate . what incrase is incrussanta contains an inhalations powder . the ellimpta inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peelable foil lid . there is also a desiccant packet , to reduce moisture in the
what nucala is nucalá contains the active substance mepolizumab . nucal is a monoclonal antibody , a type of protein that can block the activity of a protein known as a ' bronchodilator '. it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by many eosinophils , which are a white blood cell that regularly enters the lungs . eopenia is esinphilic asthma . what nukala is used for nucale is used in adults to prevent asthma attacks caused by medicines called high dose inhalers . it can be used to control your asthma , or help you breathe better . your doctor may prescribe medicines called oral corticosteroids . how nucalal works nucalа works by blocking
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . this medicine may increase your risk of worsening asthma . 58 some people have had asthma - related side effects , their asthma is getting worse . tell your doctor before starting nucalala , if your asthma does not improve after starting nukala treatment , and if it does not , your doctor will monitor your asthma more closely . do not stop nucalа if any of these apply to you . allergic injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into your body . see section 4 for more information about side effects of a similar reaction or if they occur during treatment
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or nurse if you are not sure . the recommended dose is one injection under the skin ( subcutaneous injection ). the dose is 12 micrograms / kg administered once a week . your doctor may increase your dose to 100 microgram /kg administered once every 1 week , starting at the lowest dose . use the pre - filled pen at the same time each day . inject nucala at the appropriate time each week ; this will help you to remember to inject it . you will be monitored during treatment with nucalа until your doctor tells you otherwise . if your doctor decides that you should inject nukala yourself , your doctor will monitor you during the treatment with Nucala . it is very important that you continue the treatment for as long as your physician prescribes it , even
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( may affect up to 1 in 10 people ). they usually occur within a few days or weeks after the injection , but can occasionally develop quickly . symptoms include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar to or similar to the reaction described above .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . before first use , the nucalа pre - filled pen can be stored for up to 7 days in syringes at temperatures up to a maximum of 7 days .
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg mepolizuab the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucale is presented as a clear and colourless solution for injection . nucalo is supplied as : 1 g pack containing 1 glass vial or a multipack containing 3 packs of 1 vial . not all pack sizes may be marketed .
what ninlaro is nINlaron is a cancer medicine that contains the active substance ixazomib , called a ' proteasome inhibitor '. n inlar0 is given to treat a rare type of cancer of the bone marrow called multiple myeloma . ixizomibe is able to block the activity of a protein called ' platelet - colony stimulating factor ' ( pgfr ). it is used in adults for cell survival in which myelama cells are damaged and have a lot of proteins called - proteasoms involved in their normal cell division . what if nninlaaro can be used for ninchlara is used to treat multiple myélomyelona : nInlarone is used
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking nINlaró . before starting treatment with ninklar , tell your doctor immediately if : - you experience bleeding , persistent nausea , vomiting or diarrhoea - your doctor may need to change your dose - or you have nerve problems such as tingling , numbness or swelling , or a persistent rash - the doctor may want to monitor you more closely - this is because your liver or kidney problems may worsen before , during or after treatment with the ninelara , your doctor will stop treatment and may stop it for a few weeks . during
ninlaro is prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . nINlarro must be taken in combination with lenalidomide , a medicine containing dexamethasone , an anti - inflammatory medicine . the recommended dose of ninninglara in combinationwith lenaldomide and dexalamethaone is taken on a regular basis for a 4 - week cycle . you will be prescribed nninlaro once on the same day of the week for the first 3 weeks followed by ' week 4 '. the dose of lenolidomide will be increased every 3 weeks for up to 4 weeks . your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea , numbness , or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy , raised , red , itchy part of the body . rare side effects (8 may affect up to 1 in 1 , 000 people ). thrombophlebitis ( infection ) swollen hands or legs ( peripheral neuropathy ) not known ( frequency cannot be estimated from the available data ) bleeding in the nose ( peripheral neutropenia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . does not show signs of tampering or damage to medicine packaging . any unused medicine should be returned to the pharmacist at the end of the day . discard any discarded capsule after this time period . return the medicine to your pharmacist at your regular time .
what ninlaro contains - the active substance in ninelaroop is ixazomib . each hard capsule contains 2 . 3 mg of ixizomibe . - each hard hard capsule also contains 3 . 1 mg of of xazomimib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate and talc . The capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide (  e172 ). the printing ink contains shellac , propylene glycol , potassium hydroxide and black iron oxide . what rinlarao looks like and contents of the pack black , oval - shaped capsule with " 3 " debossed on one side . it is printed with " ixazamid " and " 3
do not use palforzia : if you are allergic to peanuts or arachis hypoogaea or any of the other ingredients of palforzaa ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using palforizia . children and adolescents do not give this medicine to children and teenagers from 4 months to 17 years of age . in this age group the doctor will monitor your progress and may adjust your dose , depending on their response to treatment . peanut allergy may occur when you are exposed to peanut ( desensitisation ) to palfor zia , as there is a risk of allergic reactions . talk to the doctor before you are given palforezia if any of these apply to you . food allergies can occur during treatment with palforziea ; talk to a doctor or nurse if they are concerned .
do not take palforzia if you are allergic to peanut or peanut allergy . do not try to treat your asthma if any of the above applies to you . if your doctor has told you that you have a problem swallowing . warnings and precautions talk to your doctor or pharmacist before taking palforizia : if there is anything you do not understand about palforza . it is possible that you may have long term problems with your digestive system such as a severe mast cell disorder ( severe or life - threatening anaphylaxis ) and you have been treated for 60 days without treatment with your palforzaza . talk to you doctor or nurse before taking your pal forzia to check that the symptoms of peanut allergy are under control . you should not be given palfor zia , unless you have previously experienced an allergic reaction . treatment with palforziea
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet per day . do not take palforzia if : you have ever had allergy or allergic reactions ( anaphylaxis ) occurring during the first 3 months of treatment with palforzaa , you will receive initial dose escalation . your doctor will determine which dose is appropriate for you , depending on the response to these treatment phases . during the initial dose elevation and up - dosing phases , your doctor may decide to decrease your dose of palforizia . you will be monitored during treatment with paleforziа until you feel an improvement in your condition . if your doctor considers that the benefit of pal forzia is outweighed by the potential risk of desensitisation , it is important to take pal
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of palforzia are severe allergic reactions . tell your doctor or nurse straight away if you have any of the following symptoms after taking palforizia , the reaction may be severe : - trouble breathing - throat tightness - feeling of fulness - difficulty swallowing - speaking - changes in voice - dizziness / fainting , severe stomach cramps , pain , vomiting , diarrhoea - severe flushing or itching of the skin palfor zia may cause problems with the stomach and digestive system : signs may include : fever , chills - low blood sugar , high blood sugar ( hypoglycaemia ) - high blood glucose - rash - muscle pain - pain in extremity 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . use this medicinal product immediately after opening if you notice any hard lumps of powder . this medicine does not require any special storage conditions . any unused medicine should be discarded .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg / 1 mg capsule , 10 mg - 20 mg microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforizia 100 mg powder for oral powder in capsules after opening microcrystalline cellules ( e460 ), colloidal anihydrous silicona / magnesium st . john ' s wort 300 mg powder in oral powderin sachet microcrystalline capsules ( colloidal ashydrous silicone , and magnesium stenarate ) and beige oral powder . initial dose escalation ( see section 3 ). pack sizes of 3 , 13 and 5 single - dose blisters . not all pack sizes may be marketed .
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . zerenede will be given to you at the end of treatment . the duration of treatment should usually vary from a few days to two weeks . do not stop taking zerenne if you still have problems sleeping after you have finished your capsules .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenne sleep apnoea syndrome ( short periods of less than one treatment ). - in case you have severe kidney or liver problems . - case of myasthenia gravis ( very weak or tired muscles , severe breathing or chest problems ). children and adolescents do not give zere to children and teenagers under 18 years of age . warnings and precautions talk to your doctor or pharmacist before taking zerened . the following undesirable effects may occur with any medicine , including any medicines obtained without a prescription . physical dependence may occur during treatment and occasionally after treatment . withdrawal symptoms may include headaches , muscle pain , extreme anxiety and tension . these effects may last for months or years .
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , with or without food . if possible , you can take the capsule with or just after a meal . try to take the dose at the same time each day . it does not matter what time of day you take your capsule but taking it at the right time each night will help you to remember when to take it . do not take it more than once if your usual dose , and do not change your dose unless your doctor tells you to . people who have difficulty falling asleep are 65 years of age and over who weigh 65 kg or more , the usual starting dose is 5 capsules once . for mild to moderate liver problems , your doctor may prescribe a lower dose of 5 capsule . once you have
like all medicines , zerene can have side effects , although not everybody gets them . if you notice any other changes in your health , please tell your doctor immediately . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( effects affect 1 to 10 users in 100 ) uncommon ( effects effect 1 to 11 users in 1 , 000 ) rare ( effects effects affect less than 1 patient in 10 to 10 patients in 10 000 ). very rare ( affect affects less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ): as with all medicines, side effects can occur regardless of any other effects in your healthcare . in general , side effect sizes may occur with a frequency not known . this includes any possible side effect not listed in this leaflet . you
what zerene contains - the active substance is zaleplon 5 mg . - each capsule contains : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide (  e171 ). - printing ink : gelatin , titanium dioxide . coating : red iron oxide ( , yellow iron oxide ), black iron oxide( e172 ), sodium lauerryl stearylate , silicone dioxide ( part - 13050 ). printing inked : shellac , lecithin , simethicone , and yellow iron dioxide ( the dark yellow particulates are present in red inks ). what zeene looks
